"","YearStart","YearEnd","LocationAbbr","LocationDesc","DataSource","Topic","Question","Response","DataValueUnit","DataValueType","DataValue","DataValueAlt","DataValueFootnoteSymbol","DatavalueFootnote","LowConfidenceLimit","HighConfidenceLimit","StratificationCategory1","Stratification1","StratificationCategory2","Stratification2","StratificationCategory3","Stratification3","GeoLocation","ResponseID","LocationID","TopicID","QuestionID","DataValueTypeID","StratificationCategoryID1","StratificationID1","StratificationCategoryID2","StratificationID2","StratificationCategoryID3","StratificationID3"
"171",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"1415",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"","Number","11315",11315,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","NMBR","GENDER","GENM",NA,NA,NA,NA
"2338",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"","Number","23781",23781,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","NMBR","GENDER","GENM",NA,NA,NA,NA
"4749",2017,2017,"TX","Texas","YRBSS","Alcohol","Alcohol use among youth",NA,"%","Crude Prevalence","19.5",19.5,"","",12.1,29.9,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC1_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"4817",2017,2017,"TX","Texas","YRBSS","Alcohol","Alcohol use among youth",NA,"%","Crude Prevalence","27.6",27.6,"","",23.5,32.1,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC1_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"5390",2017,2017,"TX","Texas","YRBSS","Alcohol","Binge drinking prevalence among youth",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_1","CRDPREV","RACE","ASN",NA,NA,NA,NA
"5877",2017,2017,"TX","Texas","YRBSS","Alcohol","Binge drinking prevalence among youth",NA,"%","Crude Prevalence","11.8",11.8,"","",10,14,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"6458",2017,2017,"TX","Texas","YRBSS","Alcohol","Alcohol use among youth",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC1_1","CRDPREV","RACE","ASN",NA,NA,NA,NA
"7982",2017,2017,"TX","Texas","YRBSS","Alcohol","Alcohol use among youth",NA,"%","Crude Prevalence","28.5",28.5,"","",24.7,32.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC1_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"9757",2017,2017,"TX","Texas","YRBSS","Alcohol","Alcohol use among youth",NA,"%","Crude Prevalence","26.8",26.8,"","",24,29.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC1_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"10345",2017,2017,"TX","Texas","YRBSS","Alcohol","Binge drinking prevalence among youth",NA,"%","Crude Prevalence","12.1",12.1,"","",10.3,14.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"10629",2017,2017,"TX","Texas","YRBSS","Alcohol","Binge drinking prevalence among youth",NA,"%","Crude Prevalence","11.8",11.8,"","",9.4,14.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"11867",2017,2017,"TX","Texas","YRBSS","Alcohol","Binge drinking prevalence among youth",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_1","CRDPREV","RACE","AIAN",NA,NA,NA,NA
"12033",2017,2017,"TX","Texas","PRAMS","Alcohol","Alcohol use before pregnancy",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC1_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"13246",2017,2017,"TX","Texas","YRBSS","Alcohol","Alcohol use among youth",NA,"%","Crude Prevalence","25.1",25.1,"","",21.5,29.1,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC1_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"14055",2017,2017,"TX","Texas","YRBSS","Alcohol","Binge drinking prevalence among youth",NA,"%","Crude Prevalence","11.8",11.8,"","",9.6,14.5,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"16872",2017,2017,"TX","Texas","YRBSS","Alcohol","Alcohol use among youth",NA,"%","Crude Prevalence","28.9",28.9,"","",26.3,31.5,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC1_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"16955",2017,2017,"TX","Texas","YRBSS","Alcohol","Binge drinking prevalence among youth",NA,"%","Crude Prevalence","13.9",13.9,"","",10.9,17.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"16960",2017,2017,"TX","Texas","YRBSS","Alcohol","Binge drinking prevalence among youth",NA,"%","Crude Prevalence","7.9",7.9,"","",3.8,15.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"18042",2017,2017,"TX","Texas","YRBSS","Alcohol","Alcohol use among youth",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC1_1","CRDPREV","RACE","AIAN",NA,NA,NA,NA
"18631",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"cases per 100,000","Age-adjusted Rate","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"19204",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"cases per 100,000","Age-adjusted Rate","13.6",13.6,"","",13,14.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"19401",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","NMBR","RACE","API",NA,NA,NA,NA
"19940",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"cases per 100,000","Age-adjusted Rate","7.2",7.2,"","",6.3,8.1,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"20115",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"20338",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"","Number","2709",2709,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","NMBR","GENDER","GENM",NA,NA,NA,NA
"20686",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"cases per 100,000","Crude Rate","9.8",9.8,"","",9.3,10.3,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"20965",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"cases per 100,000","Crude Rate","14.4",14.4,"","",13.7,15.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","CRDRATE","RACE","HIS",NA,NA,NA,NA
"21096",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","CRDRATE","RACE","HIS",NA,NA,NA,NA
"21627",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"21741",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"","Number","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","NMBR","OVERALL","OVR",NA,NA,NA,NA
"22139",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"22164",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"22184",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"","Number","4107",4107,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","NMBR","OVERALL","OVR",NA,NA,NA,NA
"22711",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"22867",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"cases per 100,000","Age-adjusted Rate","13.9",13.9,"","",13.5,14.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"22963",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"cases per 100,000","Crude Rate","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"23595",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"24276",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","CRDRATE","RACE","BLK",NA,NA,NA,NA
"24773",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","NMBR","RACE","AIAN",NA,NA,NA,NA
"25464",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"","Number","1609",1609,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","NMBR","RACE","HIS",NA,NA,NA,NA
"25657",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"cases per 100,000","Age-adjusted Rate","9.1",9.1,"","",8.6,9.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"25666",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","CRDRATE","RACE","WHT",NA,NA,NA,NA
"25768",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","NMBR","GENDER","GENM",NA,NA,NA,NA
"26172",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"26237",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"26405",2017,2017,"TX","Texas","APIS","Alcohol","Amount of alcohol excise tax by beverage type (wine)",NA,"$","US Dollars","0.20",0.2,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC8_0_2","USD","OVERALL","OVR",NA,NA,NA,NA
"26421",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"cases per 100,000","Crude Rate","14.5",14.5,"","",14.1,15,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"26511",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"","Number","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","NMBR","RACE","AIAN",NA,NA,NA,NA
"27130",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","NMBR","GENDER","GENF",NA,NA,NA,NA
"27180",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"","Number","2164",2164,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","NMBR","RACE","WHT",NA,NA,NA,NA
"28302",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","NMBR","RACE","BLK",NA,NA,NA,NA
"28732",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"","Number","247",247,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","NMBR","RACE","BLK",NA,NA,NA,NA
"28737",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","NMBR","RACE","WHT",NA,NA,NA,NA
"28865",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"29004",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"cases per 100,000","Age-adjusted Rate","19.2",19.2,"","",18.4,19.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"29283",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","AGEADJRATE","RACE","API",NA,NA,NA,NA
"29890",2017,2017,"TX","Texas","APIS","Alcohol","Amount of alcohol excise tax by beverage type (beer)",NA,"$","US Dollars","0.19",0.19,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC8_0_1","USD","OVERALL","OVR",NA,NA,NA,NA
"30047",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"","Number","53",53,"","",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","NMBR","RACE","API",NA,NA,NA,NA
"30081",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"cases per 100,000","Age-adjusted Rate","4.5",4.5,"","",3.3,5.9,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","AGEADJRATE","RACE","API",NA,NA,NA,NA
"30632",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"cases per 100,000","Crude Rate","19.3",19.3,"","",18.5,20,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"30704",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"30959",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"cases per 100,000","Crude Rate","7.1",7.1,"","",6.2,8,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","CRDRATE","RACE","BLK",NA,NA,NA,NA
"31123",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"cases per 100,000","Crude Rate","17.9",17.9,"","",17.1,18.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","CRDRATE","RACE","WHT",NA,NA,NA,NA
"31124",2017,2017,"TX","Texas","APIS","Alcohol","Amount of alcohol excise tax by beverage type (distilled spirits)",NA,"$","US Dollars","2.40",2.4,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC8_0_3","USD","OVERALL","OVR",NA,NA,NA,NA
"31514",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"cases per 100,000","Age-adjusted Rate","19.8",19.8,"","",18.8,20.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"31668",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","NMBR","RACE","HIS",NA,NA,NA,NA
"31742",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"","Number","1398",1398,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","NMBR","GENDER","GENF",NA,NA,NA,NA
"32728",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","CRDRATE","RACE","API",NA,NA,NA,NA
"32787",2017,2017,"TX","Texas","SEDD; SID","Asthma","Emergency department visit rate for asthma",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST2_1","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"33034",2017,2017,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality",NA,"cases per 100,000","Crude Rate","3.6",3.6,"","",2.7,4.8,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC6_0","CRDRATE","RACE","API",NA,NA,NA,NA
"34953",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"35847",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"","Number","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","NMBR","OVERALL","OVR",NA,NA,NA,NA
"36329",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","AGEADJRATE","RACE","API",NA,NA,NA,NA
"38622",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"38975",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"39449",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"39976",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"40515",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","NMBR","RACE","AIAN",NA,NA,NA,NA
"41638",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","NMBR","GENDER","GENF",NA,NA,NA,NA
"41761",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","NMBR","RACE","HIS",NA,NA,NA,NA
"42951",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"43653",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"44166",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","CRDRATE","RACE","WHT",NA,NA,NA,NA
"44570",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","CRDRATE","RACE","BLK",NA,NA,NA,NA
"45029",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"45301",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"46521",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","NMBR","RACE","API",NA,NA,NA,NA
"46693",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"47620",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","NMBR","GENDER","GENM",NA,NA,NA,NA
"47688",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","CRDRATE","RACE","API",NA,NA,NA,NA
"48136",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","NMBR","RACE","BLK",NA,NA,NA,NA
"48196",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","NMBR","RACE","WHT",NA,NA,NA,NA
"48822",2017,2017,"TX","Texas","SEDD; SID","Asthma","Hospitalizations for asthma",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST3_1","CRDRATE","RACE","HIS",NA,NA,NA,NA
"49396",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"","Number","35",35,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","NMBR","RACE","HIS",NA,NA,NA,NA
"49752",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"cases per 1,000,000","Crude Rate","6.3",6.3,"","",5,7.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"50874",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"cases per 1,000,000","Age-adjusted Rate","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","AGEADJRATE","RACE","API",NA,NA,NA,NA
"50960",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"","Number","58",58,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","NMBR","RACE","BLK",NA,NA,NA,NA
"52071",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"cases per 1,000,000","Age-adjusted Rate","6.6",6.6,"","",5.2,8.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"52273",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"","Number","232",232,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","NMBR","OVERALL","OVR",NA,NA,NA,NA
"53035",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"","Number","144",144,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","NMBR","GENDER","GENF",NA,NA,NA,NA
"54189",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"","Number","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","NMBR","RACE","AIAN",NA,NA,NA,NA
"54687",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"cases per 1,000,000","Crude Rate","8.2",8.2,"","",7.1,9.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"55072",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"cases per 1,000,000","Age-adjusted Rate","17.4",17.4,"","",13.1,22.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"55706",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"cases per 1,000,000","Age-adjusted Rate","9.6",9.6,"","",8,11.2,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"57087",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"cases per 1,000,000","Age-adjusted Rate","8.3",8.3,"","",7.2,9.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"57484",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"cases per 1,000,000","Crude Rate","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"57656",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"","Number","127",127,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","NMBR","RACE","WHT",NA,NA,NA,NA
"57682",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"cases per 1,000,000","Age-adjusted Rate","3.6",3.6,"","",2.5,5.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"58001",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"cases per 1,000,000","Crude Rate","10.5",10.5,"","",8.7,12.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","CRDRATE","RACE","WHT",NA,NA,NA,NA
"58390",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"","Number","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","NMBR","RACE","API",NA,NA,NA,NA
"59330",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"cases per 1,000,000","Crude Rate","10.1",10.1,"","",8.5,11.8,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"59696",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"cases per 1,000,000","Crude Rate","3.1",3.1,"","",2.2,4.4,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","CRDRATE","RACE","HIS",NA,NA,NA,NA
"59899",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"cases per 1,000,000","Age-adjusted Rate","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"60472",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"cases per 1,000,000","Crude Rate","16.7",16.7,"","",12.7,21.6,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","CRDRATE","RACE","BLK",NA,NA,NA,NA
"60479",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"","Number","88",88,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","NMBR","GENDER","GENM",NA,NA,NA,NA
"61199",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"cases per 1,000,000","Age-adjusted Rate","8.4",8.4,"","",6.9,9.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"62435",2017,2017,"TX","Texas","NVSS","Asthma","Asthma mortality rate",NA,"cases per 1,000,000","Crude Rate","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST4_1","CRDRATE","RACE","API",NA,NA,NA,NA
"218244",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"cases per 100,000","Age-adjusted Rate","65.9",65.9,"","",64.7,67.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"218303",2017,2017,"TX","Texas","USRDS","Chronic Kidney Disease","Incidence of treated end-stage renal disease",NA,"cases per 1,000,000","Number","12251",12251,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD2_1","NMBR","OVERALL","OVR",NA,NA,NA,NA
"218502",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"cases per 100,000","Age-adjusted Rate","110.9",110.9,"","",106.7,115.1,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"218990",2017,2017,"TX","Texas","USRDS","Chronic Kidney Disease","Incidence of treated end-stage renal disease",NA,"cases per 1,000,000","Adjusted by age, sex, race and ethnicity","436.0",436,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD2_1","AGESEXRACEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"219148",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"","Number","10267",10267,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","NMBR","GENDER","GENM",NA,NA,NA,NA
"219511",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"","Number","38",38,"","",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","NMBR","RACE","AIAN",NA,NA,NA,NA
"219956",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"cases per 100,000","Crude Rate","44.5",44.5,"","",43.3,45.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","CRDRATE","RACE","HIS",NA,NA,NA,NA
"221050",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"cases per 100,000","Crude Rate","63.7",63.7,"","",62.4,65,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"221296",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"cases per 100,000","Age-adjusted Rate","47.1",47.1,"","",42.5,51.7,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","AGEADJRATE","RACE","API",NA,NA,NA,NA
"221901",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"cases per 100,000","Crude Rate","89.8",89.8,"","",88.1,91.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","CRDRATE","RACE","WHT",NA,NA,NA,NA
"222147",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"cases per 100,000","Crude Rate","85.6",85.6,"","",82.5,88.6,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","CRDRATE","RACE","BLK",NA,NA,NA,NA
"222818",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"cases per 100,000","Crude Rate","36.3",36.3,"","",25.7,49.8,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"223064",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"","Number","9076",9076,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","NMBR","GENDER","GENF",NA,NA,NA,NA
"223323",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"cases per 100,000","Crude Rate","73.0",73,"","",71.6,74.4,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"225064",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"","Number","2968",2968,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","NMBR","RACE","BLK",NA,NA,NA,NA
"225407",2017,2017,"TX","Texas","USRDS","Chronic Kidney Disease","Incidence of treated end-stage renal disease attributed to diabetes",NA,"cases per 1,000,000","Adjusted by age, sex, race and ethnicity","225.0",225,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD2_2","AGESEXRACEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"225655",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"","Number","10879",10879,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","NMBR","RACE","WHT",NA,NA,NA,NA
"226022",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"cases per 100,000","Age-adjusted Rate","74.2",74.2,"","",72,76.4,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"227018",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"cases per 100,000","Age-adjusted Rate","36.8",36.8,"","",25.7,51.2,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"227571",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"cases per 100,000","Age-adjusted Rate","87.7",87.7,"","",85.9,89.4,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"227706",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"","Number","19343",19343,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","NMBR","OVERALL","OVR",NA,NA,NA,NA
"228864",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"","Number","444",444,"","",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","NMBR","RACE","API",NA,NA,NA,NA
"229935",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"cases per 100,000","Age-adjusted Rate","72.0",72,"","",71,73,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"230411",2017,2017,"TX","Texas","USRDS","Chronic Kidney Disease","Incidence of treated end-stage renal disease attributed to diabetes",NA,"cases per 1,000,000","Number","6750",6750,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD2_2","NMBR","OVERALL","OVR",NA,NA,NA,NA
"230755",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"","Number","4970",4970,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","NMBR","RACE","HIS",NA,NA,NA,NA
"231394",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"cases per 100,000","Crude Rate","30.5",30.5,"","",27.7,33.4,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","CRDRATE","RACE","API",NA,NA,NA,NA
"231430",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"cases per 100,000","Age-adjusted Rate","60.0",60,"","",58.8,61.3,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"231855",2017,2017,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease",NA,"cases per 100,000","Crude Rate","68.3",68.3,"","",67.4,69.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD1_0","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"232693",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"","Number","774",774,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","NMBR","RACE","BLK",NA,NA,NA,NA
"233037",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"","Number","934",934,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","NMBR","RACE","HIS",NA,NA,NA,NA
"233432",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"cases per 100,000","Crude Rate","18.5",18.5,"","",14.9,22.8,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","CRDRATE","RACE","API",NA,NA,NA,NA
"234154",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"cases per 100,000","Age-adjusted Rate","102.8",102.8,"","",100.1,105.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"234367",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"cases per 100,000","Crude Rate","48.7",48.7,"","",30.1,74.4,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"234850",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"","Number","10308",10308,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","NMBR","OVERALL","OVR",NA,NA,NA,NA
"235082",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"","Number","8461",8461,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","NMBR","RACE","WHT",NA,NA,NA,NA
"235157",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"","Number","88",88,"","",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","NMBR","RACE","API",NA,NA,NA,NA
"235904",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"","Number","5387",5387,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","NMBR","GENDER","GENF",NA,NA,NA,NA
"236669",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"cases per 100,000","Age-adjusted Rate","126.6",126.6,"","",123,130.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"237388",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"cases per 100,000","Age-adjusted Rate","54.8",54.8,"","",33,85.5,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"237428",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"cases per 100,000","Crude Rate","101.0",101,"","",99.1,103,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"238459",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"cases per 100,000","Age-adjusted Rate","90.2",90.2,"","",83.5,96.8,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"238597",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"","Number","4921",4921,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","NMBR","GENDER","GENM",NA,NA,NA,NA
"239654",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"cases per 100,000","Age-adjusted Rate","46.4",46.4,"","",43.3,49.4,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"240435",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"cases per 100,000","Crude Rate","101.4",101.4,"","",98.6,104.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"240789",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"cases per 100,000","Crude Rate","151.4",151.4,"","",148.2,154.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","CRDRATE","RACE","WHT",NA,NA,NA,NA
"241602",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"cases per 100,000","Age-adjusted Rate","112.7",112.7,"","",110.5,114.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"241878",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"cases per 100,000","Age-adjusted Rate","30.3",30.3,"","",24.2,37.6,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","AGEADJRATE","RACE","API",NA,NA,NA,NA
"242558",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"cases per 100,000","Crude Rate","31.6",31.6,"","",29.6,33.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","CRDRATE","RACE","HIS",NA,NA,NA,NA
"243319",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"cases per 100,000","Crude Rate","100.7",100.7,"","",98,103.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"243953",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"","Number","21",21,"","",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","NMBR","RACE","AIAN",NA,NA,NA,NA
"244037",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"cases per 100,000","Age-adjusted Rate","144.7",144.7,"","",141.6,147.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"244133",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years",NA,"cases per 100,000","Crude Rate","67.7",67.7,"","",62.9,72.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_1","CRDRATE","RACE","BLK",NA,NA,NA,NA
"245269",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"","Number","2210",2210,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","NMBR","RACE","HIS",NA,NA,NA,NA
"245409",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"cases per 100,000","Age-adjusted Rate","298.3",298.3,"","",293.8,302.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"245660",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"cases per 100,000","Crude Rate","35.4",35.4,"","",30,40.7,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","CRDRATE","RACE","API",NA,NA,NA,NA
"245806",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"cases per 100,000","Age-adjusted Rate","202.8",202.8,"","",198.9,206.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"246910",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"cases per 100,000","Age-adjusted Rate","114.9",114.9,"","",82.8,155.3,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"247870",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"cases per 100,000","Crude Rate","313.9",313.9,"","",309.2,318.5,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","CRDRATE","RACE","WHT",NA,NA,NA,NA
"247954",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"","Number","1985",1985,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","NMBR","RACE","BLK",NA,NA,NA,NA
"248076",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"cases per 100,000","Crude Rate","74.8",74.8,"","",71.7,78,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","CRDRATE","RACE","HIS",NA,NA,NA,NA
"248790",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"cases per 100,000","Age-adjusted Rate","237.4",237.4,"","",234.2,240.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"249466",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"","Number","168",168,"","",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","NMBR","RACE","API",NA,NA,NA,NA
"250183",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"cases per 100,000","Age-adjusted Rate","107.5",107.5,"","",102.9,112.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"250201",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"cases per 100,000","Crude Rate","106.6",106.6,"","",78,142.2,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"250780",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"","Number","10698",10698,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","NMBR","GENDER","GENF",NA,NA,NA,NA
"251093",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"","Number","17542",17542,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","NMBR","RACE","WHT",NA,NA,NA,NA
"252052",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"cases per 100,000","Crude Rate","215.7",215.7,"","",212.9,218.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"252745",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"","Number","46",46,"","",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","NMBR","RACE","AIAN",NA,NA,NA,NA
"253516",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"cases per 100,000","Age-adjusted Rate","222.5",222.5,"","",212.2,232.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"253705",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"cases per 100,000","Crude Rate","199.9",199.9,"","",196.2,203.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"254456",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"cases per 100,000","Crude Rate","233.2",233.2,"","",228.9,237.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"254645",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"cases per 100,000","Age-adjusted Rate","284.3",284.3,"","",278.9,289.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"255167",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"","Number","22013",22013,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","NMBR","OVERALL","OVR",NA,NA,NA,NA
"255205",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"cases per 100,000","Age-adjusted Rate","56.1",56.1,"","",47.3,64.9,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","AGEADJRATE","RACE","API",NA,NA,NA,NA
"255975",2017,2017,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years",NA,"cases per 100,000","Crude Rate","173.7",173.7,"","",166,181.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD1_2","CRDRATE","RACE","BLK",NA,NA,NA,NA
"256836",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"256890",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","CRDRATE","RACE","WHT",NA,NA,NA,NA
"257031",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"257095",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"257344",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"257617",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","NMBR","OVERALL","OVR",NA,NA,NA,NA
"258380",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"259045",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","NMBR","RACE","HIS",NA,NA,NA,NA
"259378",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","CRDRATE","RACE","API",NA,NA,NA,NA
"259604",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"259715",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"259857",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","NMBR","GENDER","GENF",NA,NA,NA,NA
"259875",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"260181",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","NMBR","GENDER","GENM",NA,NA,NA,NA
"260325",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","CRDRATE","RACE","HIS",NA,NA,NA,NA
"260418",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","NMBR","RACE","AIAN",NA,NA,NA,NA
"261023",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","NMBR","RACE","WHT",NA,NA,NA,NA
"261326",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","NMBR","GENDER","GENF",NA,NA,NA,NA
"262107",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"262263",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","CRDRATE","RACE","BLK",NA,NA,NA,NA
"262567",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","NMBR","RACE","API",NA,NA,NA,NA
"262817",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","AGEADJRATE","RACE","API",NA,NA,NA,NA
"263605",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"263944",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","CRDRATE","RACE","WHT",NA,NA,NA,NA
"264100",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","NMBR","GENDER","GENM",NA,NA,NA,NA
"264340",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"264610",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","NMBR","RACE","HIS",NA,NA,NA,NA
"264712",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","NMBR","RACE","AIAN",NA,NA,NA,NA
"264718",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","AGEADJRATE","RACE","API",NA,NA,NA,NA
"264928",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","NMBR","RACE","BLK",NA,NA,NA,NA
"265026",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"265127",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"265241",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","NMBR","RACE","BLK",NA,NA,NA,NA
"265481",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"266564",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"266618",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","CRDRATE","RACE","HIS",NA,NA,NA,NA
"266878",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"267110",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"267178",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"267338",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","CRDRATE","RACE","API",NA,NA,NA,NA
"267354",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"267481",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","NMBR","RACE","WHT",NA,NA,NA,NA
"267854",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"268040",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","NMBR","RACE","API",NA,NA,NA,NA
"268689",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","CRDRATE","RACE","BLK",NA,NA,NA,NA
"268926",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_2","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"269093",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"269258",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_1","NMBR","OVERALL","OVR",NA,NA,NA,NA
"281527",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","10.26",10.26,"","",9.62,10.89,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","CRDRATE","RACE","HIS",NA,NA,NA,NA
"282287",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"","Number","12162",12162,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","NMBR","GENDER","GENM",NA,NA,NA,NA
"282333",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"","Number","61",61,"","",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","NMBR","RACE","AIAN",NA,NA,NA,NA
"282986",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","19.42",19.42,"","",18.7,20.14,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"283031",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","13.77",13.77,"","",13.59,13.94,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"283693",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","13.84",13.84,"","",13.62,14.05,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"284278",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"","Number","992",992,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","NMBR","RACE","HIS",NA,NA,NA,NA
"285425",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"","Number","27411",27411,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","NMBR","OVERALL","OVR",NA,NA,NA,NA
"285831",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"","Number","227",227,"","",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","NMBR","RACE","API",NA,NA,NA,NA
"286580",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","13.41",13.41,"","",13.19,13.62,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"287605",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"","Number","2958",2958,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","NMBR","RACE","BLK",NA,NA,NA,NA
"287855",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","12.95",12.95,"","",12.8,13.1,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"288652",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","13.79",13.79,"","",13.54,14.04,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"288706",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","5.82",5.82,"","",5.06,6.57,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","CRDRATE","RACE","API",NA,NA,NA,NA
"288858",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"cases per 100,000","Crude Rate","140.8",140.8,"","",138.9,142.8,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"289265",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","12.42",12.42,"","",12.2,12.64,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"289419",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"","Number","15249",15249,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","NMBR","GENDER","GENF",NA,NA,NA,NA
"290164",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"","Number","22877",22877,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","NMBR","RACE","WHT",NA,NA,NA,NA
"290805",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","6.57",6.57,"","",5.7,7.43,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","AGEADJRATE","RACE","API",NA,NA,NA,NA
"291194",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","13.76",13.76,"","",13.59,13.92,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"291535",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","17.78",17.78,"","",13.36,22.2,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"291881",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","13.08",13.08,"","",12.91,13.25,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","CRDRATE","RACE","WHT",NA,NA,NA,NA
"292445",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","19.81",19.81,"","",14.85,24.78,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"292947",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","11.20",11.2,"","",10.5,11.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"292981",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as first-listed diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","18.16",18.16,"","",17.51,18.8,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_3","CRDRATE","RACE","BLK",NA,NA,NA,NA
"293585",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","NMBR","GENDER","GENF",NA,NA,NA,NA
"293590",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","NMBR","RACE","AIAN",NA,NA,NA,NA
"293853",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","43.36",43.36,"","",41.18,45.54,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","AGEADJRATE","RACE","API",NA,NA,NA,NA
"294133",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"294475",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","89.24",89.24,"","",88.82,89.66,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","CRDRATE","RACE","WHT",NA,NA,NA,NA
"294755",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","126.03",126.03,"","",124.42,127.64,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","CRDRATE","RACE","BLK",NA,NA,NA,NA
"295467",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"295542",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","122.74",122.74,"","",111.38,134.1,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"295776",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"295817",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"295928",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"","Number","6564",6564,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","NMBR","RACE","HIS",NA,NA,NA,NA
"296087",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"296213",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","99.58",99.58,"","",98.94,100.21,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"296341",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","38.02",38.02,"","",36.12,39.92,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","CRDRATE","RACE","API",NA,NA,NA,NA
"296461",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"296797",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","NMBR","RACE","API",NA,NA,NA,NA
"296927",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","88.48",88.48,"","",88.1,88.87,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"297073",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"","Number","20533",20533,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","NMBR","RACE","BLK",NA,NA,NA,NA
"297664",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"","Number","156090",156090,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","NMBR","RACE","WHT",NA,NA,NA,NA
"297712",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","NMBR","GENDER","GENM",NA,NA,NA,NA
"298048",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","NMBR","OVERALL","OVR",NA,NA,NA,NA
"298309",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","94.02",94.02,"","",93.61,94.42,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"298921",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","67.88",67.88,"","",66.29,69.46,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","CRDRATE","RACE","HIS",NA,NA,NA,NA
"299491",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","CRDRATE","RACE","HIS",NA,NA,NA,NA
"299505",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"","Number","187301",187301,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","NMBR","OVERALL","OVR",NA,NA,NA,NA
"299794",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","90.08",90.08,"","",89.54,90.61,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"300418",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"","Number","1484",1484,"","",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","NMBR","RACE","API",NA,NA,NA,NA
"300587",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","NMBR","RACE","WHT",NA,NA,NA,NA
"300765",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"300913",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","CRDRATE","RACE","API",NA,NA,NA,NA
"301062",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","73.50",73.5,"","",71.79,75.21,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"301296",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"","Number","88254",88254,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","NMBR","GENDER","GENM",NA,NA,NA,NA
"301383",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"301482",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"","Number","398",398,"","",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","NMBR","RACE","AIAN",NA,NA,NA,NA
"301751",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","NMBR","RACE","BLK",NA,NA,NA,NA
"302683",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","AGEADJRATE","RACE","API",NA,NA,NA,NA
"303088",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"303145",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","87.07",87.07,"","",86.55,87.59,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"303318",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"303573",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","94.07",94.07,"","",93.62,94.51,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"303715",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","133.61",133.61,"","",131.85,135.37,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"303865",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","CRDRATE","RACE","WHT",NA,NA,NA,NA
"304293",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","116.00",116,"","",105.29,126.72,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"304564",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"304647",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"","Number","99047",99047,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","NMBR","GENDER","GENF",NA,NA,NA,NA
"304859",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","CRDRATE","RACE","BLK",NA,NA,NA,NA
"304876",2017,2017,"TX","Texas","CMS Part A Claims Data","Chronic Obstructive Pulmonary Disease","Hospitalization for chronic obstructive pulmonary disease as any diagnosis among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","90.13",90.13,"","",89.56,90.69,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD5_4","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"305331",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as first-listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_1","NMBR","RACE","HIS",NA,NA,NA,NA
"305705",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"306554",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"306583",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","NMBR","RACE","API",NA,NA,NA,NA
"306742",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","NMBR","OVERALL","OVR",NA,NA,NA,NA
"307494",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"307543",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","NMBR","RACE","AIAN",NA,NA,NA,NA
"307683",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"308151",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"310065",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"310245",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","NMBR","GENDER","GENM",NA,NA,NA,NA
"310797",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"312805",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","CRDRATE","RACE","BLK",NA,NA,NA,NA
"312817",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","CRDRATE","RACE","HIS",NA,NA,NA,NA
"313858",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"314002",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"314575",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"314836",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","CRDRATE","RACE","API",NA,NA,NA,NA
"314995",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","NMBR","RACE","WHT",NA,NA,NA,NA
"315762",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"316463",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","NMBR","RACE","HIS",NA,NA,NA,NA
"317671",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","NMBR","GENDER","GENF",NA,NA,NA,NA
"318060",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","CRDRATE","RACE","WHT",NA,NA,NA,NA
"318749",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","AGEADJRATE","RACE","API",NA,NA,NA,NA
"318951",2017,2017,"TX","Texas","SEDD; SID","Chronic Obstructive Pulmonary Disease","Emergency department visit rate for chronic obstructive pulmonary disease as any diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD6_2","NMBR","RACE","BLK",NA,NA,NA,NA
"319799",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"","Number","28161",28161,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","NMBR","GENDER","GENF",NA,NA,NA,NA
"320749",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"cases per 100,000","Crude Rate","231.5",231.5,"","",226.4,236.6,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","CRDRATE","RACE","BLK",NA,NA,NA,NA
"321020",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"cases per 100,000","Crude Rate","227.6",227.6,"","",225.1,230.1,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"321393",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"cases per 100,000","Crude Rate","79.3",79.3,"","",63.2,98.3,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"321889",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"cases per 100,000","Age-adjusted Rate","235.9",235.9,"","",233.6,238.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"322843",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"","Number","8030",8030,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","NMBR","RACE","BLK",NA,NA,NA,NA
"323687",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"cases per 100,000","Age-adjusted Rate","180.4",180.4,"","",177,183.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"324490",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"cases per 100,000","Crude Rate","322.5",322.5,"","",319.3,325.7,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","CRDRATE","RACE","WHT",NA,NA,NA,NA
"325927",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"","Number","60169",60169,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","NMBR","OVERALL","OVR",NA,NA,NA,NA
"325988",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"","Number","1156",1156,"","",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","NMBR","RACE","API",NA,NA,NA,NA
"326387",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"cases per 100,000","Age-adjusted Rate","274.1",274.1,"","",271,277.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"326804",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"cases per 100,000","Age-adjusted Rate","185.1",185.1,"","",182.9,187.3,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"327443",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"cases per 100,000","Age-adjusted Rate","121.7",121.7,"","",114.3,129.1,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","AGEADJRATE","RACE","API",NA,NA,NA,NA
"327696",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"cases per 100,000","Crude Rate","104.7",104.7,"","",102.8,106.6,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","CRDRATE","RACE","HIS",NA,NA,NA,NA
"328249",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"cases per 100,000","Age-adjusted Rate","225.6",225.6,"","",223.7,227.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"328970",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"","Number","39090",39090,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","NMBR","RACE","WHT",NA,NA,NA,NA
"328992",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"cases per 100,000","Crude Rate","212.6",212.6,"","",210.9,214.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"329019",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"","Number","11678",11678,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","NMBR","RACE","HIS",NA,NA,NA,NA
"329547",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"cases per 100,000","Crude Rate","79.5",79.5,"","",74.9,84,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","CRDRATE","RACE","API",NA,NA,NA,NA
"330837",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"cases per 100,000","Age-adjusted Rate","302.5",302.5,"","",295.5,309.4,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"331964",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"","Number","83",83,"","",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","NMBR","RACE","AIAN",NA,NA,NA,NA
"332460",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"","Number","32008",32008,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","NMBR","GENDER","GENM",NA,NA,NA,NA
"332872",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"cases per 100,000","Age-adjusted Rate","78.7",78.7,"","",62.1,98.4,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"333615",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases",NA,"cases per 100,000","Crude Rate","197.7",197.7,"","",195.4,200,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_1","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"334480",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"","Number","8587",8587,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","NMBR","RACE","HIS",NA,NA,NA,NA
"335852",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"cases per 100,000","Crude Rate","247.0",247,"","",244.2,249.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","CRDRATE","RACE","WHT",NA,NA,NA,NA
"336130",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"","Number","25287",25287,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","NMBR","GENDER","GENM",NA,NA,NA,NA
"336785",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"","Number","791",791,"","",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","NMBR","RACE","API",NA,NA,NA,NA
"337690",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"cases per 100,000","Crude Rate","54.4",54.4,"","",50.6,58.2,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","CRDRATE","RACE","API",NA,NA,NA,NA
"337823",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"cases per 100,000","Age-adjusted Rate","215.3",215.3,"","",212.5,218,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"337843",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"cases per 100,000","Age-adjusted Rate","65.2",65.2,"","",50.2,83.2,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"338799",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"","Number","20059",20059,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","NMBR","GENDER","GENF",NA,NA,NA,NA
"338855",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"cases per 100,000","Age-adjusted Rate","180.5",180.5,"","",178.4,182.5,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"339870",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"","Number","5866",5866,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","NMBR","RACE","BLK",NA,NA,NA,NA
"340789",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"cases per 100,000","Age-adjusted Rate","82.0",82,"","",76,88,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","AGEADJRATE","RACE","API",NA,NA,NA,NA
"342018",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"","Number","45346",45346,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","NMBR","OVERALL","OVR",NA,NA,NA,NA
"342440",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"cases per 100,000","Crude Rate","179.8",179.8,"","",177.6,182,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"342957",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"","Number","69",69,"","",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","NMBR","RACE","AIAN",NA,NA,NA,NA
"343368",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"cases per 100,000","Age-adjusted Rate","131.8",131.8,"","",128.9,134.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"343902",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"cases per 100,000","Crude Rate","169.1",169.1,"","",164.8,173.4,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","CRDRATE","RACE","BLK",NA,NA,NA,NA
"345030",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"cases per 100,000","Age-adjusted Rate","131.5",131.5,"","",129.7,133.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"345973",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"cases per 100,000","Crude Rate","77.0",77,"","",75.3,78.6,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","CRDRATE","RACE","HIS",NA,NA,NA,NA
"346051",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"cases per 100,000","Crude Rate","160.2",160.2,"","",158.7,161.7,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"346845",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"","Number","29934",29934,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","NMBR","RACE","WHT",NA,NA,NA,NA
"346903",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"cases per 100,000","Crude Rate","65.9",65.9,"","",51.3,83.4,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"346911",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"cases per 100,000","Age-adjusted Rate","217.2",217.2,"","",211.4,223.1,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"348200",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart",NA,"cases per 100,000","Age-adjusted Rate","169.2",169.2,"","",167.6,170.7,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_2","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"348755",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"","Number","2994",2994,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","NMBR","RACE","BLK",NA,NA,NA,NA
"348843",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"","Number","25585",25585,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","NMBR","OVERALL","OVR",NA,NA,NA,NA
"349933",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"cases per 100,000","Age-adjusted Rate","47.1",47.1,"","",42.5,51.6,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","AGEADJRATE","RACE","API",NA,NA,NA,NA
"350084",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"cases per 100,000","Crude Rate","110.0",110,"","",108.3,111.8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"352239",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"cases per 100,000","Age-adjusted Rate","66.1",66.1,"","",64.8,67.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"352321",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"cases per 100,000","Crude Rate","139.3",139.3,"","",137.2,141.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","CRDRATE","RACE","WHT",NA,NA,NA,NA
"352860",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"cases per 100,000","Crude Rate","90.4",90.4,"","",89.3,91.5,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"352918",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"cases per 100,000","Age-adjusted Rate","78.9",78.9,"","",76.7,81.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"353243",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"","Number","38",38,"","",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","NMBR","RACE","AIAN",NA,NA,NA,NA
"354169",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"cases per 100,000","Age-adjusted Rate","130.2",130.2,"","",128.1,132.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"355162",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"","Number","10111",10111,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","NMBR","GENDER","GENF",NA,NA,NA,NA
"355842",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"cases per 100,000","Age-adjusted Rate","110.4",110.4,"","",106.2,114.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"355927",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"","Number","16883",16883,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","NMBR","RACE","WHT",NA,NA,NA,NA
"356943",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"cases per 100,000","Age-adjusted Rate","94.6",94.6,"","",93.4,95.7,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"357510",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"cases per 100,000","Crude Rate","46.1",46.1,"","",44.8,47.3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","CRDRATE","RACE","HIS",NA,NA,NA,NA
"358261",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"","Number","5141",5141,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","NMBR","RACE","HIS",NA,NA,NA,NA
"358307",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"cases per 100,000","Crude Rate","36.3",36.3,"","",25.7,49.8,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"358765",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"cases per 100,000","Crude Rate","71.0",71,"","",69.6,72.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"359046",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"","Number","467",467,"","",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","NMBR","RACE","API",NA,NA,NA,NA
"360467",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"cases per 100,000","Crude Rate","86.3",86.3,"","",83.2,89.4,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","CRDRATE","RACE","BLK",NA,NA,NA,NA
"362256",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"","Number","15474",15474,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","NMBR","GENDER","GENM",NA,NA,NA,NA
"362306",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"cases per 100,000","Age-adjusted Rate","35.2",35.2,"","",24.5,48.9,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"362900",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"cases per 100,000","Age-adjusted Rate","101.1",101.1,"","",99.5,102.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"363320",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease",NA,"cases per 100,000","Crude Rate","32.1",32.1,"","",29.2,35,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_3","CRDRATE","RACE","API",NA,NA,NA,NA
"363730",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"cases per 100,000","Age-adjusted Rate","85.8",85.8,"","",84.3,87.3,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"364003",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"cases per 100,000","Crude Rate","19.8",19.8,"","",17.5,22.1,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","CRDRATE","RACE","API",NA,NA,NA,NA
"364412",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"cases per 100,000","Crude Rate","26.9",26.9,"","",24.3,29.6,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","CRDRATE","RACE","API",NA,NA,NA,NA
"364870",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"","Number","1463",1463,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","NMBR","RACE","BLK",NA,NA,NA,NA
"365000",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"cases per 100,000","Crude Rate","91.4",91.4,"","",90.3,92.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"365570",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"cases per 100,000","Age-adjusted Rate","41.3",41.3,"","",40.5,42.1,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"365612",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"cases per 100,000","Crude Rate","40.5",40.5,"","",39.4,41.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","CRDRATE","RACE","HIS",NA,NA,NA,NA
"365622",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"cases per 100,000","Crude Rate","20.6",20.6,"","",19.7,21.4,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","CRDRATE","RACE","HIS",NA,NA,NA,NA
"365913",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"cases per 100,000","Age-adjusted Rate","31.4",31.4,"","",27.6,35.2,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","AGEADJRATE","RACE","API",NA,NA,NA,NA
"367139",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"cases per 100,000","Age-adjusted Rate","42.1",42.1,"","",40.9,43.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"367162",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"cases per 100,000","Age-adjusted Rate","37.5",37.5,"","",26.2,52.2,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"367658",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"cases per 100,000","Age-adjusted Rate","118.1",118.1,"","",116,120.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"367829",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"","Number","6044",6044,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","NMBR","GENDER","GENF",NA,NA,NA,NA
"367909",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"","Number","25883",25883,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","NMBR","OVERALL","OVR",NA,NA,NA,NA
"368230",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"","Number","392",392,"","",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","NMBR","RACE","API",NA,NA,NA,NA
"368251",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"cases per 100,000","Crude Rate","55.4",55.4,"","",54.1,56.7,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","CRDRATE","RACE","WHT",NA,NA,NA,NA
"368611",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"cases per 100,000","Crude Rate","42.2",42.2,"","",40,44.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","CRDRATE","RACE","BLK",NA,NA,NA,NA
"368991",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"","Number","2931",2931,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","NMBR","RACE","BLK",NA,NA,NA,NA
"369265",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"cases per 100,000","Crude Rate","35.3",35.3,"","",24.9,48.7,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"369647",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"","Number","17960",17960,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","NMBR","RACE","WHT",NA,NA,NA,NA
"369969",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"cases per 100,000","Crude Rate","38.1",38.1,"","",37.4,38.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"370067",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"cases per 100,000","Age-adjusted Rate","75.0",75,"","",72.7,77.2,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"370186",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"","Number","2296",2296,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","NMBR","RACE","HIS",NA,NA,NA,NA
"370384",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"cases per 100,000","Age-adjusted Rate","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"370706",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"cases per 100,000","Crude Rate","91.2",91.2,"","",89.6,92.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"370873",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"cases per 100,000","Crude Rate","42.4",42.4,"","",41.4,43.5,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"371263",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"cases per 100,000","Age-adjusted Rate","40.6",40.6,"","",39.6,41.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"371600",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"cases per 100,000","Age-adjusted Rate","58.3",58.3,"","",55.1,61.4,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"371905",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"cases per 100,000","Age-adjusted Rate","107.8",107.8,"","",106.2,109.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"372206",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"cases per 100,000","Age-adjusted Rate","117.6",117.6,"","",113.2,122.1,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"372833",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"","Number","12820",12820,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","NMBR","GENDER","GENM",NA,NA,NA,NA
"373201",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"","Number","6715",6715,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","NMBR","RACE","WHT",NA,NA,NA,NA
"373256",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"","Number","37",37,"","",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","NMBR","RACE","AIAN",NA,NA,NA,NA
"373447",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"cases per 100,000","Crude Rate","84.5",84.5,"","",81.4,87.6,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","CRDRATE","RACE","BLK",NA,NA,NA,NA
"373571",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"","Number","13063",13063,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","NMBR","GENDER","GENF",NA,NA,NA,NA
"373882",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"cases per 100,000","Crude Rate","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"374412",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"cases per 100,000","Crude Rate","33.8",33.8,"","",32.8,34.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"374865",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"","Number","288",288,"","",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","NMBR","RACE","API",NA,NA,NA,NA
"375088",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"cases per 100,000","Crude Rate","91.7",91.7,"","",90.1,93.3,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"375247",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"","Number","10790",10790,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","NMBR","OVERALL","OVR",NA,NA,NA,NA
"375749",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"cases per 100,000","Age-adjusted Rate","40.0",40,"","",39,41,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"375863",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"cases per 100,000","Crude Rate","148.2",148.2,"","",146,150.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","CRDRATE","RACE","WHT",NA,NA,NA,NA
"376159",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"cases per 100,000","Age-adjusted Rate","45.4",45.4,"","",40.7,50.1,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","AGEADJRATE","RACE","API",NA,NA,NA,NA
"376343",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"","Number","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","NMBR","RACE","AIAN",NA,NA,NA,NA
"376694",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"cases per 100,000","Age-adjusted Rate","99.7",99.7,"","",98.5,101,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"376952",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"cases per 100,000","Age-adjusted Rate","36.4",36.4,"","",34.9,37.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"377858",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)",NA,"","Number","4746",4746,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_5","NMBR","GENDER","GENM",NA,NA,NA,NA
"377911",2017,2017,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure",NA,"","Number","4522",4522,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD1_4","NMBR","RACE","HIS",NA,NA,NA,NA
"378490",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","23.72",23.72,"","",23.52,23.93,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"378562",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","17.29",17.29,"","",16,18.59,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","CRDRATE","RACE","API",NA,NA,NA,NA
"379425",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","24.29",24.29,"","",23.98,24.59,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"380150",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"","Number","37795",37795,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","NMBR","RACE","WHT",NA,NA,NA,NA
"380164",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","29.69",29.69,"","",28.57,30.81,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"380978",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"","Number","8129",8129,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","NMBR","RACE","BLK",NA,NA,NA,NA
"381087",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","28.40",28.4,"","",22.61,34.2,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"381789",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","19.76",19.76,"","",18.26,21.25,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","AGEADJRATE","RACE","API",NA,NA,NA,NA
"382416",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","21.61",21.61,"","",21.39,21.82,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","CRDRATE","RACE","WHT",NA,NA,NA,NA
"383872",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","26.81",26.81,"","",21.41,32.22,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"384341",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","49.90",49.9,"","",48.84,50.95,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","CRDRATE","RACE","BLK",NA,NA,NA,NA
"384596",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","27.65",27.65,"","",26.62,28.69,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","CRDRATE","RACE","HIS",NA,NA,NA,NA
"384817",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","25.81",25.81,"","",25.59,26.04,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"385585",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","54.16",54.16,"","",52.97,55.34,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"386422",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","23.41",23.41,"","",23.18,23.64,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"386447",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","23.24",23.24,"","",22.96,23.51,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"386589",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"","Number","92",92,"","",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","NMBR","RACE","AIAN",NA,NA,NA,NA
"387370",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"","Number","2674",2674,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","NMBR","RACE","HIS",NA,NA,NA,NA
"388717",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"","Number","50214",50214,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","NMBR","OVERALL","OVR",NA,NA,NA,NA
"389166",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","27.41",27.41,"","",27.06,27.76,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"389569",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"","Number","675",675,"","",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","NMBR","RACE","API",NA,NA,NA,NA
"390033",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"","Number","26433",26433,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","NMBR","GENDER","GENF",NA,NA,NA,NA
"390372",2017,2017,"TX","Texas","CMS Part A Claims Data","Cardiovascular Disease","Hospitalization for heart failure among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","24.53",24.53,"","",24.24,24.83,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD2_0","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"391253",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","CRDRATE","RACE","HIS",NA,NA,NA,NA
"391503",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"392190",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","CRDRATE","RACE","API",NA,NA,NA,NA
"392360",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","NMBR","GENDER","GENM",NA,NA,NA,NA
"393006",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"394781",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","NMBR","RACE","BLK",NA,NA,NA,NA
"395044",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","NMBR","RACE","API",NA,NA,NA,NA
"395510",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","AGEADJRATE","RACE","API",NA,NA,NA,NA
"396116",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"396665",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","CRDRATE","RACE","WHT",NA,NA,NA,NA
"396822",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","NMBR","GENDER","GENF",NA,NA,NA,NA
"397026",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"397770",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"398942",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","NMBR","RACE","AIAN",NA,NA,NA,NA
"399145",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","NMBR","RACE","WHT",NA,NA,NA,NA
"399784",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"400723",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"400959",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"402530",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"","Number","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","NMBR","OVERALL","OVR",NA,NA,NA,NA
"403038",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"403279",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"403657",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","CRDRATE","RACE","BLK",NA,NA,NA,NA
"405465",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"405656",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for stroke",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_1","NMBR","RACE","HIS",NA,NA,NA,NA
"405974",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","CRDRATE","RACE","HIS",NA,NA,NA,NA
"406742",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"cases per 100,000","Age-adjusted Rate","105.5",105.5,"","",102.9,108.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"407203",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","NMBR","RACE","AIAN",NA,NA,NA,NA
"407275",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"cases per 100,000","Age-adjusted Rate","70.9",70.9,"","",69.6,72.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"407504",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"407519",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"cases per 100,000","Crude Rate","87.7",87.7,"","",86.1,89.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"408051",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"408137",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"cases per 100,000","Crude Rate","80.1",80.1,"","",79.1,81.1,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"408262",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"cases per 100,000","Crude Rate","97.5",97.5,"","",95.8,99.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","CRDRATE","RACE","WHT",NA,NA,NA,NA
"408266",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","NMBR","RACE","WHT",NA,NA,NA,NA
"408428",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"cases per 100,000","Crude Rate","34.9",34.9,"","",31.8,37.9,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","CRDRATE","RACE","API",NA,NA,NA,NA
"408589",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"409783",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","NMBR","RACE","HIS",NA,NA,NA,NA
"410051",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"","Number","10344",10344,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","NMBR","GENDER","GENF",NA,NA,NA,NA
"410498",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"","Number","507",507,"","",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","NMBR","RACE","API",NA,NA,NA,NA
"410591",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"410946",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"cases per 100,000","Age-adjusted Rate","101.5",101.5,"","",99.6,103.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"411225",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"cases per 100,000","Age-adjusted Rate","36.8",36.8,"","",25.9,50.8,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"411477",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"cases per 100,000","Crude Rate","38.2",38.2,"","",27.3,52,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"411504",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","NMBR","RACE","API",NA,NA,NA,NA
"411766",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"cases per 100,000","Age-adjusted Rate","121.1",121.1,"","",116.7,125.4,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"411860",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","CRDRATE","RACE","WHT",NA,NA,NA,NA
"411901",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"412528",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"412612",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"","Number","11821",11821,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","NMBR","RACE","WHT",NA,NA,NA,NA
"413490",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"","Number","6965",6965,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","NMBR","RACE","HIS",NA,NA,NA,NA
"413945",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","NMBR","RACE","BLK",NA,NA,NA,NA
"414413",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"cases per 100,000","Crude Rate","72.6",72.6,"","",71.2,74,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"414595",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"414893",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","CRDRATE","RACE","API",NA,NA,NA,NA
"415064",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"415067",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"","Number","12327",12327,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","NMBR","GENDER","GENM",NA,NA,NA,NA
"415297",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"415633",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","NMBR","GENDER","GENF",NA,NA,NA,NA
"415825",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"416317",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"","Number","40",40,"","",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","NMBR","RACE","AIAN",NA,NA,NA,NA
"416497",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"cases per 100,000","Crude Rate","94.5",94.5,"","",91.3,97.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","CRDRATE","RACE","BLK",NA,NA,NA,NA
"416990",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"cases per 100,000","Age-adjusted Rate","68.3",68.3,"","",67,69.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"417459",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","AGEADJRATE","RACE","API",NA,NA,NA,NA
"417871",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"","Number","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","NMBR","OVERALL","OVR",NA,NA,NA,NA
"418923",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"","Number","22671",22671,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","NMBR","OVERALL","OVR",NA,NA,NA,NA
"419201",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"cases per 100,000","Age-adjusted Rate","52.0",52,"","",47.2,56.7,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","AGEADJRATE","RACE","API",NA,NA,NA,NA
"419409",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","NMBR","GENDER","GENM",NA,NA,NA,NA
"419612",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"cases per 100,000","Crude Rate","62.4",62.4,"","",61,63.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","CRDRATE","RACE","HIS",NA,NA,NA,NA
"419884",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"cases per 100,000","Age-adjusted Rate","83.2",83.2,"","",82.1,84.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"420222",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","CRDRATE","RACE","BLK",NA,NA,NA,NA
"420386",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death",NA,"","Number","3278",3278,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_1","NMBR","RACE","BLK",NA,NA,NA,NA
"420409",2017,2017,"TX","Texas","SEDD; SID","Cardiovascular Disease","Hospitalization for acute myocardial infarction",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD3_2","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"420593",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"cases per 100,000","Crude Rate","1.5",1.5,"","",1.3,1.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"421166",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"cases per 100,000","Crude Rate","2.7",2.7,"","",2.2,3.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","CRDRATE","RACE","BLK",NA,NA,NA,NA
"421371",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"cases per 100,000","Age-adjusted Rate","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"421731",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"cases per 100,000","Crude Rate","2.2",2.2,"","",1.9,2.5,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","CRDRATE","RACE","WHT",NA,NA,NA,NA
"422494",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"cases per 100,000","Age-adjusted Rate","1.8",1.8,"","",1.7,2,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"423091",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"","Number","149",149,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","NMBR","RACE","HIS",NA,NA,NA,NA
"423841",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"cases per 100,000","Age-adjusted Rate","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","AGEADJRATE","RACE","API",NA,NA,NA,NA
"424749",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"cases per 100,000","Age-adjusted Rate","2.9",2.9,"","",2.3,3.6,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"425144",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"cases per 100,000","Crude Rate","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"425416",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"cases per 100,000","Age-adjusted Rate","1.8",1.8,"","",1.6,2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"425514",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"","Number","215",215,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","NMBR","GENDER","GENF",NA,NA,NA,NA
"425830",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"","Number","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","NMBR","RACE","AIAN",NA,NA,NA,NA
"426216",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"","Number","302",302,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","NMBR","GENDER","GENM",NA,NA,NA,NA
"426409",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"cases per 100,000","Age-adjusted Rate","2.2",2.2,"","",2,2.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"427592",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"","Number","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","NMBR","RACE","API",NA,NA,NA,NA
"428766",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"cases per 100,000","Age-adjusted Rate","2.0",2,"","",1.7,2.3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"429686",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"cases per 100,000","Crude Rate","2.1",2.1,"","",1.9,2.4,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"430859",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"","Number","517",517,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","NMBR","OVERALL","OVR",NA,NA,NA,NA
"431072",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"","Number","267",267,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","NMBR","RACE","WHT",NA,NA,NA,NA
"431341",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"","Number","93",93,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","NMBR","RACE","BLK",NA,NA,NA,NA
"432857",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"cases per 100,000","Crude Rate","1.3",1.3,"","",1.1,1.5,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","CRDRATE","RACE","HIS",NA,NA,NA,NA
"433536",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"cases per 100,000","Crude Rate","1.8",1.8,"","",1.7,2,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"433663",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"cases per 100,000","Age-adjusted Rate","1.4",1.4,"","",1.2,1.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"433937",2017,2017,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death",NA,"cases per 100,000","Crude Rate","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA1_2","CRDRATE","RACE","API",NA,NA,NA,NA
"434711",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"434715",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"435329",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"435588",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"436185",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","NMBR","GENDER","GENF",NA,NA,NA,NA
"437433",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","NMBR","RACE","AIAN",NA,NA,NA,NA
"437461",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"","Number","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","NMBR","OVERALL","OVR",NA,NA,NA,NA
"437734",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"438008",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","AGEADJRATE","RACE","API",NA,NA,NA,NA
"438587",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","NMBR","RACE","WHT",NA,NA,NA,NA
"438918",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"440050",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","NMBR","RACE","HIS",NA,NA,NA,NA
"440803",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","CRDRATE","RACE","BLK",NA,NA,NA,NA
"441247",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"441404",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","CRDRATE","RACE","API",NA,NA,NA,NA
"442005",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","NMBR","GENDER","GENM",NA,NA,NA,NA
"444218",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","NMBR","RACE","BLK",NA,NA,NA,NA
"444332",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","CRDRATE","RACE","WHT",NA,NA,NA,NA
"444789",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","CRDRATE","RACE","HIS",NA,NA,NA,NA
"445924",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"446611",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","NMBR","RACE","API",NA,NA,NA,NA
"446792",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"447182",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"447497",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Amputation of a lower extremity attributable to diabetes",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA4_0","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"448610",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","NMBR","RACE","API",NA,NA,NA,NA
"448645",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","NMBR","OVERALL","OVR",NA,NA,NA,NA
"448802",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Soda consumption among high school students",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW12_2","CRDPREV","RACE","AIAN",NA,NA,NA,NA
"449436",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Participation in daily school physical education classes among high school students",NA,"%","Crude Prevalence","28.0",28,"","",17.4,41.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW12_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"449721",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"449842",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines among high school students",NA,"%","Crude Prevalence","31.6",31.6,"","",26.9,36.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_4","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"450554",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","CRDRATE","RACE","HIS",NA,NA,NA,NA
"450567",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"450874",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","NMBR","RACE","AIAN",NA,NA,NA,NA
"451256",2017,2017,"TX","Texas","ACS 1-Year Estimates","Disability","Disability among adults aged >= 65 years",NA,"%","Crude Prevalence","37.3",37.3,"","",36.9,37.7,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIS","DIS1_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"451284",2017,2017,"TX","Texas","ACS 1-Year Estimates","Disability","Disability among adults aged >= 65 years",NA,"%","Crude Prevalence","41.4",41.4,"","",39.9,42.9,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIS","DIS1_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"451289",2017,2017,"TX","Texas","CDC Breastfeeding Report Card","Nutrition, Physical Activity, and Weight Status","Live births occurring at Baby Friendly Facilities",NA,"%","Percent","17.0",17,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW18_0","PRCT","OVERALL","OVR",NA,NA,NA,NA
"451404",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","NMBR","GENDER","GENM",NA,NA,NA,NA
"451618",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Soda consumption among high school students",NA,"%","Crude Prevalence","18.0",18,"","",15.7,20.7,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW12_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"451973",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Participation in daily school physical education classes among high school students",NA,"%","Crude Prevalence","37.0",37,"","",29.9,44.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW12_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"452342",2017,2017,"TX","Texas","National Immunization Survey","Nutrition, Physical Activity, and Weight Status","Receiving formula supplementation within the first 2 days of life among breastfed infants",NA,"%","Crude Prevalence","22.5",22.5,"","",19.5,25.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW16_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"452355",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"452576",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Soda consumption among high school students",NA,"%","Crude Prevalence","13.4",13.4,"","",10.7,16.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW12_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"452870",2017,2017,"TX","Texas","ACS 1-Year Estimates","Disability","Disability among adults aged >= 65 years",NA,"%","Crude Prevalence","35.2",35.2,"","",34.7,35.7,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIS","DIS1_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"453168",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Participation in daily school physical education classes among high school students",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW12_1","CRDPREV","RACE","ASN",NA,NA,NA,NA
"453595",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines among high school students",NA,"%","Crude Prevalence","28.2",28.2,"","",21.1,36.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_4","CRDPREV","RACE","BLK",NA,NA,NA,NA
"453615",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","NMBR","GENDER","GENF",NA,NA,NA,NA
"453712",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines among high school students",NA,"%","Crude Prevalence","30.9",30.9,"","",25.8,36.5,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_4","CRDPREV","RACE","WHT",NA,NA,NA,NA
"453766",2017,2017,"TX","Texas","ACS 1-Year Estimates","Disability","Disability among adults aged >= 65 years",NA,"%","Crude Prevalence","37.5",37.5,"","",36.9,38.2,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIS","DIS1_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"453926",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"454100",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines among high school students",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_4","CRDPREV","RACE","ASN",NA,NA,NA,NA
"454345",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","CRDRATE","RACE","BLK",NA,NA,NA,NA
"454389",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines among high school students",NA,"%","Crude Prevalence","25.2",25.2,"","",22,28.7,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_4","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"454517",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Participation in daily school physical education classes among high school students",NA,"%","Crude Prevalence","28.2",28.2,"","",22.3,35,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW12_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"454806",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"454852",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"454970",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Soda consumption among high school students",NA,"%","Crude Prevalence","19.1",19.1,"","",15.5,23.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW12_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"455117",2017,2017,"TX","Texas","ACS 1-Year Estimates","Disability","Disability among adults aged >= 65 years",NA,"%","Crude Prevalence","28.4",28.4,"","",26.1,30.7,"Race/Ethnicity","Asian, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIS","DIS1_0","CRDPREV","RACE","ASN",NA,NA,NA,NA
"456291",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"456417",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines among high school students",NA,"%","Crude Prevalence","18.6",18.6,"","",15.8,21.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_4","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"456628",2017,2017,"TX","Texas","National Immunization Survey","Nutrition, Physical Activity, and Weight Status","Infants breastfed at 6 months",NA,"%","Crude Prevalence","55.1",55.1,"","",51.6,58.5,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW15_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"457021",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Participation in daily school physical education classes among high school students",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW12_1","CRDPREV","RACE","AIAN",NA,NA,NA,NA
"457068",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","CRDRATE","RACE","WHT",NA,NA,NA,NA
"457265",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Soda consumption among high school students",NA,"%","Crude Prevalence","14.9",14.9,"","",9.1,23.4,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW12_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"457268",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","NMBR","RACE","BLK",NA,NA,NA,NA
"457419",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Soda consumption among high school students",NA,"%","Crude Prevalence","18.2",18.2,"","",15.1,21.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW12_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"457445",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines among high school students",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_4","CRDPREV","RACE","AIAN",NA,NA,NA,NA
"457863",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Participation in daily school physical education classes among high school students",NA,"%","Crude Prevalence","32.3",32.3,"","",25.6,39.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW12_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"457992",2017,2017,"TX","Texas","ACS 1-Year Estimates","Disability","Disability among adults aged >= 65 years",NA,"%","Crude Prevalence","42.5",42.5,"","",41.7,43.3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIS","DIS1_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"458013",2017,2017,"TX","Texas","ACS 1-Year Estimates","Disability","Disability among adults aged >= 65 years",NA,"%","Crude Prevalence","40.7",40.7,"","",32.1,49.3,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIS","DIS1_0","CRDPREV","RACE","AIAN",NA,NA,NA,NA
"458222",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","NMBR","RACE","WHT",NA,NA,NA,NA
"459043",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"459166",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"459201",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Soda consumption among high school students",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW12_2","CRDPREV","RACE","ASN",NA,NA,NA,NA
"459847",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Participation in daily school physical education classes among high school students",NA,"%","Crude Prevalence","29.9",29.9,"","",24.4,36.1,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW12_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"459893",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"cases per 10,000","Crude Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","CRDRATE","RACE","API",NA,NA,NA,NA
"460130",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"460254",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines among high school students",NA,"%","Crude Prevalence","20.5",20.5,"","",17.3,24.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_4","CRDPREV","RACE","HIS",NA,NA,NA,NA
"461544",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"461570",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Soda consumption among high school students",NA,"%","Crude Prevalence","22.5",22.5,"","",19.5,25.8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW12_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"461938",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Participation in daily school physical education classes among high school students",NA,"%","Crude Prevalence","31.2",31.2,"","",25.4,37.7,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW12_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"462136",2017,2017,"TX","Texas","ACS 1-Year Estimates","Disability","Disability among adults aged >= 65 years",NA,"%","Crude Prevalence","37.1",37.1,"","",36.5,37.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIS","DIS1_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"462284",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"","Number","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","NMBR","RACE","HIS",NA,NA,NA,NA
"462336",2017,2017,"TX","Texas","SEDD; SID","Diabetes","Hospitalization with diabetes as a listed diagnosis",NA,"cases per 10,000","Age-adjusted Rate","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA9_0","AGEADJRATE","RACE","API",NA,NA,NA,NA
"462729",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Obesity among high school students",NA,"%","Crude Prevalence","20.5",20.5,"","",18,23.3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"463239",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Television viewing among high school students",NA,"%","Crude Prevalence","32.4",32.4,"","",24.9,40.9,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW20_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"463274",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of vegetable consumption among high school students",NA,"Number","Median","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW5_1","MEDIAN","RACE","AIAN",NA,NA,NA,NA
"463893",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among high school students",NA,"%","Crude Prevalence","59.5",59.5,"","",50,68.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"464009",2017,2017,"TX","Texas","USDA National Farmers' Market Directory","Nutrition, Physical Activity, and Weight Status","Farmers markets that accept Women and Infant Children (WIC) farmers market nutrition program coupons",NA,"%","Percent","9.8",9.8,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW7_1","PRCT","OVERALL","OVR",NA,NA,NA,NA
"464857",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among high school students",NA,"%","Crude Prevalence","38.8",38.8,"","",31.2,47,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"465124",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Computer use among high school students",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW21_0","CRDPREV","RACE","ASN",NA,NA,NA,NA
"465163",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Computer use among high school students",NA,"%","Crude Prevalence","46.7",46.7,"","",39.3,54.2,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW21_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"465276",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Television viewing among high school students",NA,"%","Crude Prevalence","19.8",19.8,"","",15.2,25.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW20_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"465800",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of vegetable consumption among high school students",NA,"Number","Median","1.0",1,"","",0.5,1.7,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW5_1","MEDIAN","RACE","WHT",NA,NA,NA,NA
"465943",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of fruit consumption among high school students",NA,"Number","Median","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW4_1","MEDIAN","RACE","AIAN",NA,NA,NA,NA
"466412",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Television viewing among high school students",NA,"%","Crude Prevalence","21.5",21.5,"","",18.4,25.1,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW20_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"466430",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of vegetable consumption among high school students",NA,"Number","Median","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW5_1","MEDIAN","RACE","ASN",NA,NA,NA,NA
"466645",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of fruit consumption among high school students",NA,"Number","Median","0.8",0.8,"","",0.3,2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW4_1","MEDIAN","GENDER","GENM",NA,NA,NA,NA
"466945",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of vegetable consumption among high school students",NA,"Number","Median","1.0",1,"","",0.3,1.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW5_1","MEDIAN","GENDER","GENM",NA,NA,NA,NA
"466957",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Obesity among high school students",NA,"%","Crude Prevalence","21.1",21.1,"","",17.8,24.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"467109",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Obesity among high school students",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_2","CRDPREV","RACE","AIAN",NA,NA,NA,NA
"467248",2017,2017,"TX","Texas","USDA National Farmers' Market Directory","Nutrition, Physical Activity, and Weight Status","Number of farmers markets per 100,000 residents",NA,"per 100,000 residents","Number","0.8",0.8,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW8_0","NMBR","OVERALL","OVR",NA,NA,NA,NA
"467781",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Computer use among high school students",NA,"%","Crude Prevalence","42.7",42.7,"","",40,45.5,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW21_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"467889",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of fruit consumption among high school students",NA,"Number","Median","0.8",0.8,"","",0.3,1.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW4_1","MEDIAN","RACE","HIS",NA,NA,NA,NA
"467931",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among high school students",NA,"%","Crude Prevalence","61.2",61.2,"","",58.2,64.2,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"467950",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Computer use among high school students",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW21_0","CRDPREV","RACE","AIAN",NA,NA,NA,NA
"467992",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Computer use among high school students",NA,"%","Crude Prevalence","39.3",39.3,"","",34.4,44.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW21_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"468075",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of fruit consumption among high school students",NA,"Number","Median","0.7",0.7,"","",0.3,1.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW4_1","MEDIAN","RACE","WHT",NA,NA,NA,NA
"468160",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among high school students",NA,"%","Crude Prevalence","36.9",36.9,"","",32.9,41,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"468770",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among high school students",NA,"%","Crude Prevalence","66.7",66.7,"","",59.3,73.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"468782",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of fruit consumption among high school students",NA,"Number","Median","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW4_1","MEDIAN","RACE","ASN",NA,NA,NA,NA
"469001",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Television viewing among high school students",NA,"%","Crude Prevalence","21.9",21.9,"","",18.6,25.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW20_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"469660",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Television viewing among high school students",NA,"%","Crude Prevalence","20.8",20.8,"","",17.8,24.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW20_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"469780",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of vegetable consumption among high school students",NA,"Number","Median","0.9",0.9,"","",0.4,1.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW5_1","MEDIAN","GENDER","GENF",NA,NA,NA,NA
"469900",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of fruit consumption among high school students",NA,"Number","Median","0.7",0.7,"","",0.3,1.9,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW4_1","MEDIAN","GENDER","GENF",NA,NA,NA,NA
"470066",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among high school students",NA,"%","Crude Prevalence","59.4",59.4,"","",55.2,63.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"470564",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of vegetable consumption among high school students",NA,"Number","Median","0.9",0.9,"","",0.3,1.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW5_1","MEDIAN","OVERALL","OVR",NA,NA,NA,NA
"470695",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of fruit consumption among high school students",NA,"Number","Median","0.8",0.8,"","",0.3,2,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW4_1","MEDIAN","OVERALL","OVR",NA,NA,NA,NA
"470999",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Obesity among high school students",NA,"%","Crude Prevalence","23.3",23.3,"","",17.7,29.9,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"471025",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Computer use among high school students",NA,"%","Crude Prevalence","43.7",43.7,"","",38.1,49.5,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW21_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"471224",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Obesity among high school students",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_2","CRDPREV","RACE","ASN",NA,NA,NA,NA
"471367",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among high school students",NA,"%","Crude Prevalence","41.3",41.3,"","",38.8,43.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"471588",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of fruit consumption among high school students",NA,"Number","Median","0.8",0.8,"","",0.3,2.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW4_1","MEDIAN","RACE","BLK",NA,NA,NA,NA
"471639",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of vegetable consumption among high school students",NA,"Number","Median","0.9",0.9,"","",0.3,1.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW5_1","MEDIAN","RACE","BLK",NA,NA,NA,NA
"471784",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Obesity among high school students",NA,"%","Crude Prevalence","15.2",15.2,"","",10.4,21.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"472074",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among high school students",NA,"%","Crude Prevalence","55.6",55.6,"","",53.1,58.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"472316",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Television viewing among high school students",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW20_0","CRDPREV","RACE","AIAN",NA,NA,NA,NA
"472571",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Computer use among high school students",NA,"%","Crude Prevalence","41.7",41.7,"","",39.2,44.3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW21_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"473367",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among high school students",NA,"%","Crude Prevalence","60.3",60.3,"","",57.5,63.1,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"473852",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Television viewing among high school students",NA,"%","Crude Prevalence","22.1",22.1,"","",17.7,27.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW20_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"474309",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Obesity among high school students",NA,"%","Crude Prevalence","16.1",16.1,"","",14,18.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"474361",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among high school students",NA,"%","Crude Prevalence","36.6",36.6,"","",34.1,39.2,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"474423",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among high school students",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_2","CRDPREV","RACE","ASN",NA,NA,NA,NA
"474589",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among high school students",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_2","CRDPREV","RACE","ASN",NA,NA,NA,NA
"474826",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of vegetable consumption among high school students",NA,"Number","Median","0.8",0.8,"","",0.3,1.6,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW5_1","MEDIAN","RACE","HIS",NA,NA,NA,NA
"475021",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Computer use among high school students",NA,"%","Crude Prevalence","46.1",46.1,"","",41.8,50.3,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW21_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"475360",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Obesity among high school students",NA,"%","Crude Prevalence","18.6",18.6,"","",16.3,21.2,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"475405",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among high school students",NA,"%","Crude Prevalence","30.8",30.8,"","",24.6,37.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"476291",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among high school students",NA,"%","Crude Prevalence","36.4",36.4,"","",33.9,39,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"476353",2017,2017,"TX","Texas","YRBSS","Nutrition, Physical Activity, and Weight Status","Television viewing among high school students",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW20_0","CRDPREV","RACE","ASN",NA,NA,NA,NA
"477213",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","6.05",6.05,"","",5.67,6.42,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","CRDRATE","RACE","BLK",NA,NA,NA,NA
"477370",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"","Number","23066",23066,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","NMBR","OVERALL","OVR",NA,NA,NA,NA
"477986",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","6.32",6.32,"","",5.45,7.19,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","AGEADJRATE","RACE","API",NA,NA,NA,NA
"478122",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","7.22",7.22,"","",7.05,7.38,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"479666",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"","Number","16000",16000,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","NMBR","GENDER","GENF",NA,NA,NA,NA
"479912",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"","Number","985",985,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","NMBR","RACE","BLK",NA,NA,NA,NA
"480363",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","7.13",7.13,"","",6.67,7.58,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"480926",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","10.90",10.9,"","",10.76,11.04,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"481581",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"","Number","1105",1105,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","NMBR","RACE","HIS",NA,NA,NA,NA
"481768",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","8.72",8.72,"","",8.51,8.92,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"482462",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","12.97",12.97,"","",12.21,13.73,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"482906",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"","Number","34",34,"","",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","NMBR","RACE","AIAN",NA,NA,NA,NA
"483563",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"","Number","206",206,"","",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","NMBR","RACE","API",NA,NA,NA,NA
"484343",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","15.28",15.28,"","",15.05,15.52,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"485222",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","11.43",11.43,"","",10.76,12.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","CRDRATE","RACE","HIS",NA,NA,NA,NA
"485444",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","12.46",12.46,"","",12.3,12.62,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"486118",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","9.91",9.91,"","",6.6,13.22,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"486897",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"","Number","20448",20448,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","NMBR","RACE","WHT",NA,NA,NA,NA
"487283",2017,2017,"TX","Texas","ACS 1-Year Estimates","Overarching Conditions","Poverty",NA,"%","Crude Prevalence","8.5",8.5,"","",8.3,8.7,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC3_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"487367",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","13.12",13.12,"","",12.94,13.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"487596",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","5.28",5.28,"","",4.56,6,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","CRDRATE","RACE","API",NA,NA,NA,NA
"487948",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","14.07",14.07,"","",13.85,14.28,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"488485",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Age-adjusted Rate","11.11",11.11,"","",7.36,14.86,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"489636",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"cases per 1,000","Crude Rate","11.69",11.69,"","",11.53,11.85,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","CRDRATE","RACE","WHT",NA,NA,NA,NA
"489808",2017,2017,"TX","Texas","CMS Part A Claims Data","Older Adults","Hospitalization for hip fracture among Medicare-eligible persons aged >= 65 years",NA,"","Number","7066",7066,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD1_0","NMBR","GENDER","GENM",NA,NA,NA,NA
"490286",2017,2017,"TX","Texas","ACS 1-Year Estimates","Overarching Conditions","High school completion among women aged 18-44 years",NA,"%","Crude Prevalence","87.4",87.4,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC2_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"491560",2017,2017,"TX","Texas","ACS 1-Year Estimates","Overarching Conditions","High school completion among adults aged 18-24 years",NA,"%","Crude Prevalence","83.3",83.3,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC2_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"492261",2017,2018,"TX","Texas","NSCH","Oral Health","Preventive dental visits among children and adolescents aged 1-17 years",NA,"%","Crude Prevalence","77.3",77.3,"","",71.5,82.1,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ORH","ORH2_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"493121",2017,2017,"TX","Texas","CMS CCW","Older Adults","Prevalence of 2 or more chronic conditions among Medicare-enrolled persons aged >= 65 years",NA,"%","Crude Prevalence","69.6",69.6,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD4_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"493463",2017,2017,"TX","Texas","CMS CCW","Older Adults","Prevalence of 2 or more chronic conditions among Medicare-enrolled persons aged >= 65 years",NA,"%","Crude Prevalence","69.4",69.4,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD4_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"493514",2017,2017,"TX","Texas","CMS CCW","Older Adults","Prevalence of 2 or more chronic conditions among Medicare-enrolled persons aged >= 65 years",NA,"%","Crude Prevalence","73.3",73.3,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD4_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"493694",2017,2017,"TX","Texas","ACS 1-Year Estimates","Overarching Conditions","Poverty",NA,"%","Crude Prevalence","18.9",18.9,"","",18,19.8,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC3_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"493880",2017,2017,"TX","Texas","CMS CCW","Older Adults","Prevalence of 2 or more chronic conditions among Medicare-enrolled persons aged >= 65 years",NA,"%","Crude Prevalence","67.4",67.4,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD4_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"494165",2017,2017,"TX","Texas","ACS 1-Year Estimates","Overarching Conditions","High school completion among adults aged 18-24 years",NA,"%","Crude Prevalence","86.8",86.8,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC2_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"495393",2017,2017,"TX","Texas","HRSA, UDS","Oral Health","Oral health services at Federally Qualified Health Centers",NA,"%","Crude Prevalence","16.1",16.1,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ORH","ORH3_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"496730",2017,2017,"TX","Texas","CMS CCW","Older Adults","Prevalence of 2 or more chronic conditions among Medicare-enrolled persons aged >= 65 years",NA,"%","Crude Prevalence","70.5",70.5,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD4_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"496734",2017,2018,"TX","Texas","NSCH","Oral Health","Dental visits among children and adolescents aged 1-17 years",NA,"%","Crude Prevalence","81.3",81.3,"","",77.4,84.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ORH","ORH1_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"496776",2017,2018,"TX","Texas","NSCH","Oral Health","Preventive dental visits among children and adolescents aged 1-17 years",NA,"%","Crude Prevalence","80.6",80.6,"","",74.7,85.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ORH","ORH2_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"496827",2017,2017,"TX","Texas","ACS 1-Year Estimates","Overarching Conditions","Poverty",NA,"%","Crude Prevalence","20.7",20.7,"","",20.2,21.2,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC3_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"497018",2017,2017,"TX","Texas","ACS 1-Year Estimates","Overarching Conditions","Poverty",NA,"%","Crude Prevalence","16.1",16.1,"","",15.8,16.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC3_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"497987",2017,2017,"TX","Texas","CMS CCW","Older Adults","Prevalence of 2 or more chronic conditions among Medicare-enrolled persons aged >= 65 years",NA,"%","Crude Prevalence","71.4",71.4,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD4_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"498347",2017,2018,"TX","Texas","NSCH","Oral Health","Dental visits among children and adolescents aged 1-17 years",NA,"%","Crude Prevalence","79.7",79.7,"","",74.1,84.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ORH","ORH1_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"499137",2017,2017,"TX","Texas","Current Population Survey","Overarching Conditions","Poverty among women aged 18-44 years",NA,"%","Crude Prevalence","34.6",34.6,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC3_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"499283",2017,2018,"TX","Texas","NSCH","Oral Health","Preventive dental visits among children and adolescents aged 1-17 years",NA,"%","Crude Prevalence","78.8",78.8,"","",74.8,82.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ORH","ORH2_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"499850",2017,2017,"TX","Texas","CMS CCW","Older Adults","Prevalence of 2 or more chronic conditions among Medicare-enrolled persons aged >= 65 years",NA,"%","Crude Prevalence","68.0",68,"","",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD4_0","CRDPREV","RACE","API",NA,NA,NA,NA
"499990",2017,2017,"TX","Texas","ACS 1-Year Estimates","Overarching Conditions","Poverty",NA,"%","Crude Prevalence","17.2",17.2,"","",13.7,20.7,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC3_1","CRDPREV","RACE","AIAN",NA,NA,NA,NA
"500366",2017,2017,"TX","Texas","PRAMS","Oral Health","Preventive dental care before pregnancy",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ORH","ORH2_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"501404",2017,2017,"TX","Texas","ACS 1-Year Estimates","Overarching Conditions","Poverty",NA,"%","Crude Prevalence","13.3",13.3,"","",13.1,13.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC3_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"503338",2017,2017,"TX","Texas","ACS 1-Year Estimates","Overarching Conditions","High school completion among adults aged 18-24 years",NA,"%","Crude Prevalence","85.0",85,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC2_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"503950",2017,2017,"TX","Texas","CMS CCW","Older Adults","Prevalence of 2 or more chronic conditions among Medicare-enrolled persons aged >= 65 years",NA,"%","Crude Prevalence","74.9",74.9,"","",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OLD","OLD4_0","CRDPREV","RACE","AIAN",NA,NA,NA,NA
"503971",2017,2017,"TX","Texas","ACS 1-Year Estimates","Overarching Conditions","Poverty",NA,"%","Crude Prevalence","14.7",14.7,"","",14.5,14.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC3_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"504008",2017,2017,"TX","Texas","ACS 1-Year Estimates","Overarching Conditions","Poverty",NA,"%","Crude Prevalence","9.8",9.8,"","",9,10.6,"Race/Ethnicity","Asian, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC3_1","CRDPREV","RACE","ASN",NA,NA,NA,NA
"504875",2017,2018,"TX","Texas","NSCH","Oral Health","Dental visits among children and adolescents aged 1-17 years",NA,"%","Crude Prevalence","83.1",83.1,"","",77.4,87.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ORH","ORH1_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"505538",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"cases per 100,000","Age-adjusted Rate","452.2",452.2,"","",445.2,459.2,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","AGEADJRATE","GENDER","GENF",NA,NA,NA,NA
"506320",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"cases per 100,000","Crude Rate","638.4",638.4,"","",632.3,644.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","CRDRATE","OVERALL","OVR",NA,NA,NA,NA
"506599",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"","Number","81",81,"","",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","NMBR","RACE","AIAN",NA,NA,NA,NA
"506854",2017,2017,"TX","Texas","ACS 5-Year Estimates","Overarching Conditions","Gini Index of income inequality",NA,"","Number","0.48",0.48,"","",0.48,0.48,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC9_0","NMBR","OVERALL","OVR",NA,NA,NA,NA
"507824",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"cases per 100,000","Crude Rate","707.1",707.1,"","",698.1,716.1,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","CRDRATE","RACE","WHT",NA,NA,NA,NA
"508154",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"cases per 100,000","Crude Rate","488.8",488.8,"","",479.4,498.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","CRDRATE","RACE","HIS",NA,NA,NA,NA
"509548",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"cases per 100,000","Age-adjusted Rate","746.7",746.7,"","",737.6,755.8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","AGEADJRATE","GENDER","GENM",NA,NA,NA,NA
"510014",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"","Number","825",825,"","",NA,NA,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","NMBR","RACE","API",NA,NA,NA,NA
"510731",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"cases per 100,000","Age-adjusted Rate","596.3",596.3,"","",590.6,602,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","AGEADJRATE","OVERALL","OVR",NA,NA,NA,NA
"510897",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"","Number","23886",23886,"","",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","NMBR","RACE","WHT",NA,NA,NA,NA
"511020",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"cases per 100,000","Crude Rate","280.4",280.4,"","",222.7,348.5,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","CRDRATE","RACE","AIAN",NA,NA,NA,NA
"511322",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"cases per 100,000","Age-adjusted Rate","855.3",855.3,"","",835.7,874.8,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","AGEADJRATE","RACE","BLK",NA,NA,NA,NA
"512293",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"cases per 100,000","Crude Rate","486.1",486.1,"","",478.7,493.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","CRDRATE","GENDER","GENF",NA,NA,NA,NA
"513075",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"","Number","10559",10559,"","",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","NMBR","RACE","HIS",NA,NA,NA,NA
"514556",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"cases per 100,000","Crude Rate","243.0",243,"","",226.4,259.6,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","CRDRATE","RACE","API",NA,NA,NA,NA
"514566",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"cases per 100,000","Age-adjusted Rate","639.5",639.5,"","",631.1,647.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","AGEADJRATE","RACE","WHT",NA,NA,NA,NA
"515212",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"","Number","26313",26313,"","",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","NMBR","GENDER","GENM",NA,NA,NA,NA
"515336",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"cases per 100,000","Crude Rate","907.5",907.5,"","",886.9,928,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","CRDRATE","RACE","BLK",NA,NA,NA,NA
"515529",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"cases per 100,000","Age-adjusted Rate","259.8",259.8,"","",205,324.7,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","AGEADJRATE","RACE","AIAN",NA,NA,NA,NA
"516012",2017,2017,"TX","Texas","PRAMS","Reproductive Health","Postpartum checkup",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"RPH","RPH2_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"516282",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"","Number","16653",16653,"","",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","NMBR","GENDER","GENF",NA,NA,NA,NA
"517187",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"","Number","42966",42966,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","NMBR","OVERALL","OVR",NA,NA,NA,NA
"517446",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"","Number","7476",7476,"","",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","NMBR","RACE","BLK",NA,NA,NA,NA
"518066",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"cases per 100,000","Age-adjusted Rate","238.2",238.2,"","",221.9,254.5,"Race/Ethnicity","Asian or Pacific Islander",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","AGEADJRATE","RACE","API",NA,NA,NA,NA
"518668",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"cases per 100,000","Crude Rate","796.3",796.3,"","",786.7,805.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","CRDRATE","GENDER","GENM",NA,NA,NA,NA
"520256",2017,2017,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years",NA,"cases per 100,000","Age-adjusted Rate","480.8",480.8,"","",471.6,489.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC5_0","AGEADJRATE","RACE","HIS",NA,NA,NA,NA
"520505",2017,2017,"TX","Texas","STATE","Tobacco","Amount of tobacco product excise tax",NA,"","Yes/No","No",NA,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB7_0","YESNO","OVERALL","OVR",NA,NA,NA,NA
"521153",2017,2017,"TX","Texas","YRBSS","Tobacco","Current cigarette smoking among youth",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_1","CRDPREV","RACE","ASN",NA,NA,NA,NA
"522293",2017,2017,"TX","Texas","YRBSS","Tobacco","Current cigarette smoking among youth",NA,"%","Crude Prevalence","6.9",6.9,"","",5.5,8.5,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"522466",2017,2017,"TX","Texas","YRBSS","Tobacco","Current smokeless tobacco use among youth",NA,"%","Crude Prevalence","3.9",3.9,"","",3,5.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"523288",2017,2017,"TX","Texas","YRBSS","Tobacco","Current smokeless tobacco use among youth",NA,"%","Crude Prevalence","6.5",6.5,"","",4.2,10,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"523464",2017,2017,"TX","Texas","STATE","Tobacco","States with strong polices that require retail licenses to sell tobacco products",NA,"","Yes/No","Yes",NA,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB5_0","YESNO","OVERALL","OVR",NA,NA,NA,NA
"523477",2017,2017,"TX","Texas","YRBSS","Tobacco","Current cigarette smoking among youth",NA,"%","Crude Prevalence","3.7",3.7,"","",1.4,9.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"523489",2017,2017,"TX","Texas","PRAMS","Reproductive Health","Folic acid supplementation",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"RPH","RPH3_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"525279",2017,2017,"TX","Texas","YRBSS","Tobacco","Current smokeless tobacco use among youth",NA,"%","Crude Prevalence","2.4",2.4,"","",1.5,3.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"526400",2017,2017,"TX","Texas","YRBSS","Tobacco","Current cigarette smoking among youth",NA,"%","Crude Prevalence","9.4",9.4,"","",6.7,13.1,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"526504",2017,2017,"TX","Texas","YRBSS","Tobacco","Current smokeless tobacco use among youth",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_1","CRDPREV","RACE","AIAN",NA,NA,NA,NA
"526689",2017,2017,"TX","Texas","YRBSS","Tobacco","Current cigarette smoking among youth",NA,"%","Crude Prevalence","5.5",5.5,"","",3.7,7.9,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"526786",2017,2017,"TX","Texas","YRBSS","Tobacco","Current smokeless tobacco use among youth",NA,"%","Crude Prevalence","5.4",5.4,"","",4.3,6.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"526837",2017,2017,"TX","Texas","PRAMS","Tobacco","Cigarette smoking before pregnancy",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_4","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"527443",2017,2017,"TX","Texas","YRBSS","Tobacco","Current smokeless tobacco use among youth",NA,"%","Crude Prevalence","6.9",6.9,"","",3.7,12.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"528876",2017,2017,"TX","Texas","STATE","Tobacco","States that allow stronger local tobacco control and prevention laws",NA,"","Yes/No","No",NA,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB4_0","YESNO","OVERALL","OVR",NA,NA,NA,NA
"528932",2017,2017,"TX","Texas","YRBSS","Tobacco","Current smokeless tobacco use among youth",NA,"%","Crude Prevalence","7.9",7.9,"","",6,10.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"529155",2017,2017,"TX","Texas","YRBSS","Tobacco","Current cigarette smoking among youth",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","American Indian or Alaska Native",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_1","CRDPREV","RACE","AIAN",NA,NA,NA,NA
"529215",2017,2017,"TX","Texas","YRBSS","Tobacco","Current cigarette smoking among youth",NA,"%","Crude Prevalence","7.4",7.4,"","",6.2,8.7,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"529373",2017,2017,"TX","Texas","STATE","Tobacco","Sale of cigarette packs",NA,"pack sales per capita","Number","31.9",31.9,"","",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB10_0","NMBR","OVERALL","OVR",NA,NA,NA,NA
"529519",2017,2017,"TX","Texas","YRBSS","Tobacco","Current smokeless tobacco use among youth",NA,"%","Crude Prevalence","",NA,"~","Data not shown because of too few respondents or cases",NA,NA,"Race/Ethnicity","Asian, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_1","CRDPREV","RACE","ASN",NA,NA,NA,NA
"530694",2017,2017,"TX","Texas","YRBSS","Tobacco","Current cigarette smoking among youth",NA,"%","Crude Prevalence","8.9",8.9,"","",7.4,10.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"533696",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have diabetes",NA,"%","Crude Prevalence","50.9",50.9,"","",43.4,58.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_3","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"533739",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have heart disease",NA,"%","Crude Prevalence","40.5",40.5,"","",31.4,50.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_4","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"533744",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","8.6",8.6,"","",7,10.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"533748",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","23.0",23,"","",20.8,25.4,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_2","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"533775",2017,2017,"TX","Texas","BRFSS","Arthritis","Fair or poor health among adults aged >= 18 years with arthritis",NA,"%","Crude Prevalence","40.3",40.3,"","",36.4,44.2,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART4_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"533915",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who are obese",NA,"%","Age-adjusted Prevalence","29.6",29.6,"","",25.7,33.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_2","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"534033",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have diabetes",NA,"%","Crude Prevalence","33.6",33.6,"","",26.8,41.3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_3","CRDPREV","RACE","HIS",NA,NA,NA,NA
"534069",2017,2017,"TX","Texas","BRFSS","Mental Health","Recent mentally unhealthy days among adults aged >= 18 years",NA,"Number","Mean","3.7",3.7,"","",3.1,4.2,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH1_0","MEAN","RACE","HIS",NA,NA,NA,NA
"534175",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who are obese",NA,"%","Age-adjusted Prevalence","26.7",26.7,"","",24.1,29.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_2","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1038976",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","18.2",18.2,"","",15.4,21.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_3","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1041010",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","25.7",25.7,"","",23.6,27.8,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1043375",2017,2017,"TX","Texas","BRFSS","Tobacco","Quit attempts in the past year among current smokers",NA,"%","Crude Prevalence","64.8",64.8,"","",59.9,69.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB3_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1053288",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smoking among adults aged >= 18 years",NA,"%","Crude Prevalence","17.8",17.8,"","",15.7,20.1,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1056758",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smoking among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","17.7",17.7,"","",15.7,20,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_2","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1063534",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 18",NA,"%","Crude Prevalence","3.5",3.5,"","",2.7,4.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1063547",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","10.4",10.4,"","",5.8,18,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1063659",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Influenza vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","43.2",43.2,"","",32.7,54.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD7_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1063661",2017,2017,"TX","Texas","BRFSS","Chronic Kidney Disease","Prevalence of chronic kidney disease among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD3_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1063696",2017,2017,"TX","Texas","BRFSS","Arthritis","Physical inactivity among adults aged >= 18 years with arthritis",NA,"%","Crude Prevalence","44.6",44.6,"","",39.3,50.1,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART3_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1063698",2017,2017,"TX","Texas","BRFSS","Arthritis","Physical inactivity among adults aged >= 18 years with arthritis",NA,"%","Age-adjusted Prevalence","42.6",42.6,"","",35.6,49.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART3_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1063724",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1063778",2017,2017,"TX","Texas","BRFSS","Arthritis","Adults aged >= 18 years with arthritis who have taken a class to learn how to manage arthritis symptoms",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART5_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1063779",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1063792",2017,2017,"TX","Texas","BRFSS","Asthma","Current asthma prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1063798",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 45 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1063802",2017,2017,"TX","Texas","BRFSS","Asthma","Current asthma prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1063844",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years",NA,"%","Crude Prevalence","18.7",18.7,"","",10.4,31.4,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1063911",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","16.7",16.7,"","",12.8,21.4,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_3","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1063914",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 45 years",NA,"%","Crude Prevalence","10.3",10.3,"","",8.3,12.8,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1063942",2017,2017,"TX","Texas","BRFSS","Chronic Kidney Disease","Prevalence of chronic kidney disease among adults aged >= 18 years",NA,"%","Crude Prevalence","4.3",4.3,"","",2.5,7.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD3_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1063951",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have diabetes",NA,"%","Crude Prevalence","56.4",56.4,"","",39.5,71.9,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_3","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1063962",2017,2017,"TX","Texas","BRFSS","Arthritis","Severe joint pain due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","27.5",27.5,"","",23,32.5,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1063980",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking frequency among adults aged >= 18 years who binge drink",NA,"Number","Mean","4.5",4.5,"","",2.8,6.1,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC3_0","MEAN","RACE","BLK",NA,NA,NA,NA
"1063995",2017,2017,"TX","Texas","BRFSS","Asthma","Current asthma prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","7.2",7.2,"","",6.3,8.2,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1064021",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among adults aged >= 18 years",NA,"%","Crude Prevalence","8.1",8.1,"","",6.6,9.8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1064034",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking frequency among adults aged >= 18 years who binge drink",NA,"Number","Age-adjusted Mean","5.3",5.3,"","",4.3,6.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC3_0","AGEADJMEAN","RACE","WHT",NA,NA,NA,NA
"1064044",2017,2017,"TX","Texas","BRFSS","Arthritis","Fair or poor health among adults aged >= 18 years with arthritis",NA,"%","Crude Prevalence","63.9",63.9,"","",55.3,71.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART4_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1064210",2017,2017,"TX","Texas","BRFSS","Arthritis","Severe joint pain due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","29.2",29.2,"","",22.3,37.2,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_2","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1064230",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have diabetes",NA,"%","Crude Prevalence","36.5",36.5,"","",29.9,43.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_3","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1064302",2017,2017,"TX","Texas","BRFSS","Arthritis","Severe joint pain due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","26.4",26.4,"","",20.8,32.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1064364",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who are obese",NA,"%","Crude Prevalence","29.4",29.4,"","",26.4,32.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1064415",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking intensity among adults aged >= 18 years who binge drink",NA,"Number","Age-adjusted Mean","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC4_0","AGEADJMEAN","RACE","MRC",NA,NA,NA,NA
"1064418",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 18",NA,"%","Crude Prevalence","5.9",5.9,"","",4.8,7.3,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1064487",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","18.5",18.5,"","",16.2,21,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_2","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1064496",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Influenza vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD7_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1064543",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1064563",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who are obese",NA,"%","Age-adjusted Prevalence","37.8",37.8,"","",24.9,52.7,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_2","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1064565",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1064576",2017,2017,"TX","Texas","BRFSS","Arthritis","Work limitation due to arthritis among adults aged 18-64 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","51.0",51,"","",41.4,60.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_3","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1064585",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1064592",2017,2017,"TX","Texas","BRFSS","Arthritis","Adults aged >= 18 years with arthritis who have taken a class to learn how to manage arthritis symptoms",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART5_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1064618",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who are obese",NA,"%","Crude Prevalence","37.9",37.9,"","",33.1,42.8,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1064675",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Crude Prevalence","41.1",41.1,"","",27.2,56.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1064688",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Crude Prevalence","46.0",46,"","",36.3,56.1,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1064754",2017,2017,"TX","Texas","BRFSS","Arthritis","Work limitation due to arthritis among adults aged 18-64 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_3","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1064759",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among women aged 18-44 years",NA,"%","Crude Prevalence","0.0",0,"##","Estimate is 0.0% because no cases were reported with this condition",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1064763",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among adults aged >= 18 years",NA,"%","Crude Prevalence","5.9",5.9,"","",4.8,7.3,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1064791",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 45 years with diagnosed chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1064804",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking frequency among adults aged >= 18 years who binge drink",NA,"Number","Mean","4.3",4.3,"","",3.3,5.2,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC3_0","MEAN","RACE","HIS",NA,NA,NA,NA
"1064815",2017,2017,"TX","Texas","BRFSS","Chronic Kidney Disease","Prevalence of chronic kidney disease among adults aged >= 18 years",NA,"%","Crude Prevalence","2.9",2.9,"","",2.4,3.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD3_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1064819",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Influenza vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","52.9",52.9,"","",32.9,72.1,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD7_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1064885",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Age-adjusted Prevalence","26.8",26.8,"","",15.4,42.5,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1064895",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking intensity among adults aged >= 18 years who binge drink",NA,"Number","Mean","5.6",5.6,"","",5.1,6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC4_0","MEAN","GENDER","GENF",NA,NA,NA,NA
"1064914",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Age-adjusted Prevalence","69.5",69.5,"","",45.3,86.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_2","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1064922",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have heart disease",NA,"%","Age-adjusted Prevalence","37.2",37.2,"","",28.4,46.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_4","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1064979",2017,2017,"TX","Texas","BRFSS","Asthma","Asthma prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","5.7",5.7,"","",3.7,8.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1065027",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1065053",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have heart disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_4","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1065096",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_3","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1065120",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 45 years with diagnosed chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1065248",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 18",NA,"%","Age-adjusted Prevalence","4.7",4.7,"","",4,5.5,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1065266",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who are obese",NA,"%","Age-adjusted Prevalence","21.4",21.4,"","",17.8,25.4,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_2","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1065290",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","31.3",31.3,"","",22.7,41.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1065377",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Crude Prevalence","88.6",88.6,"","",75.3,95.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1065393",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Crude Prevalence","60.1",60.1,"","",44.9,73.5,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1065416",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_2","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1065450",2017,2017,"TX","Texas","BRFSS","Arthritis","Work limitation due to arthritis among adults aged 18-64 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","54.0",54,"","",42.5,65.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_3","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1065453",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 45 years with diagnosed chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1065455",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","7.1",7.1,"","",6.1,8.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1065554",2017,2017,"TX","Texas","BRFSS","Arthritis","Physical inactivity among adults aged >= 18 years with arthritis",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART3_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1065589",2017,2017,"TX","Texas","BRFSS","Arthritis","Fair or poor health among adults aged >= 18 years with arthritis",NA,"%","Crude Prevalence","33.2",33.2,"","",28.7,38.1,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART4_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1065618",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Age-adjusted Prevalence","50.3",50.3,"","",32,68.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1065732",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking frequency among adults aged >= 18 years who binge drink",NA,"Number","Mean","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC3_0","MEAN","RACE","MRC",NA,NA,NA,NA
"1065781",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking intensity among adults aged >= 18 years who binge drink",NA,"Number","Mean","8.4",8.4,"","",7.8,9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC4_0","MEAN","GENDER","GENM",NA,NA,NA,NA
"1065855",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","17.5",17.5,"","",15.5,19.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1065861",2017,2017,"TX","Texas","BRFSS","Asthma","Current asthma prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","10.1",10.1,"","",8.6,11.8,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1065882",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","29.6",29.6,"","",25.1,34.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1065894",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have heart disease",NA,"%","Age-adjusted Prevalence","36.1",36.1,"","",27.8,45.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_4","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1065919",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have heart disease",NA,"%","Crude Prevalence","44.1",44.1,"","",30.7,58.4,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_4","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1065944",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Influenza vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD7_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1066013",2017,2017,"TX","Texas","BRFSS","Arthritis","Adults aged >= 18 years with arthritis who have taken a class to learn how to manage arthritis symptoms",NA,"%","Age-adjusted Prevalence","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART5_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1066016",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking intensity among adults aged >= 18 years who binge drink",NA,"Number","Mean","7.3",7.3,"","",6.9,7.7,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC4_0","MEAN","OVERALL","OVR",NA,NA,NA,NA
"1066029",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_2","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1066034",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1066036",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have diabetes",NA,"%","Age-adjusted Prevalence","38.1",38.1,"","",28.2,49.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_3","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1066115",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_2","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1066117",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Influenza vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","43.2",43.2,"","",32.2,54.9,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD7_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1066132",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","21.0",21,"","",19.6,22.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1066137",2017,2017,"TX","Texas","BRFSS","Chronic Kidney Disease","Prevalence of chronic kidney disease among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","2.4",2.4,"","",1.6,3.6,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD3_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1066198",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 45 years",NA,"%","Crude Prevalence","9.8",9.8,"","",7.9,12,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1066213",2017,2017,"TX","Texas","BRFSS","Arthritis","Adults aged >= 18 years with arthritis who have taken a class to learn how to manage arthritis symptoms",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART5_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1066283",2017,2017,"TX","Texas","BRFSS","Arthritis","Fair or poor health among adults aged >= 18 years with arthritis",NA,"%","Age-adjusted Prevalence","44.0",44,"","",35.8,52.5,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART4_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1066305",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 45 years",NA,"%","Crude Prevalence","6.3",6.3,"","",4.8,8.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1066306",2017,2017,"TX","Texas","BRFSS","Asthma","Current asthma prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","4.4",4.4,"","",3.4,5.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1066445",2017,2017,"TX","Texas","BRFSS","Arthritis","Physical inactivity among adults aged >= 18 years with arthritis",NA,"%","Age-adjusted Prevalence","36.5",36.5,"","",25.7,48.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART3_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1066500",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 45 years with diagnosed chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","40.2",40.2,"","",29.3,52.1,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1066543",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_3","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1066574",2017,2017,"TX","Texas","BRFSS","Chronic Kidney Disease","Prevalence of chronic kidney disease among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","4.3",4.3,"","",2.5,7.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD3_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1066621",2017,2017,"TX","Texas","BRFSS","Arthritis","Severe joint pain due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","26.3",26.3,"","",19.7,34.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_2","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1066630",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking frequency among adults aged >= 18 years who binge drink",NA,"Number","Age-adjusted Mean","4.4",4.4,"","",2.8,5.9,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC3_0","AGEADJMEAN","RACE","BLK",NA,NA,NA,NA
"1066631",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","8.2",8.2,"","",6.7,10,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1066669",2017,2017,"TX","Texas","BRFSS","Arthritis","Fair or poor health among adults aged >= 18 years with arthritis",NA,"%","Age-adjusted Prevalence","58.9",58.9,"","",49.8,67.4,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART4_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1066803",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1066857",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","26.7",26.7,"","",18.7,36.7,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1066858",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Crude Prevalence","73.8",73.8,"","",58.5,84.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1066884",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_2","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1066966",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have diabetes",NA,"%","Age-adjusted Prevalence","61.5",61.5,"","",49.2,72.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_3","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1066993",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 45 years",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1066998",2017,2017,"TX","Texas","BRFSS","Arthritis","Work limitation due to arthritis among adults aged 18-64 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_3","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1067010",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Crude Prevalence","64.6",64.6,"","",47.2,78.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1067017",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Age-adjusted Prevalence","30.7",30.7,"","",19.9,44.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1067057",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking frequency among adults aged >= 18 years who binge drink",NA,"Number","Age-adjusted Mean","4.2",4.2,"","",3.2,5.2,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC3_0","AGEADJMEAN","GENDER","GENF",NA,NA,NA,NA
"1067068",2017,2017,"TX","Texas","BRFSS","Chronic Kidney Disease","Prevalence of chronic kidney disease among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD3_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1067118",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking intensity among adults aged >= 18 years who binge drink",NA,"Number","Age-adjusted Mean","6.8",6.8,"","",6.3,7.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC4_0","AGEADJMEAN","RACE","WHT",NA,NA,NA,NA
"1067128",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Influenza vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","38.5",38.5,"","",27.7,50.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD7_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1067137",2017,2017,"TX","Texas","BRFSS","Arthritis","Physical inactivity among adults aged >= 18 years with arthritis",NA,"%","Age-adjusted Prevalence","39.9",39.9,"","",31.3,49,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART3_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1067160",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 45 years",NA,"%","Crude Prevalence","10.7",10.7,"","",6.2,17.8,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1067188",2017,2017,"TX","Texas","BRFSS","Arthritis","Work limitation due to arthritis among adults aged 18-64 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","49.3",49.3,"","",43.8,54.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_3","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1067212",2017,2017,"TX","Texas","BRFSS","Arthritis","Adults aged >= 18 years with arthritis who have taken a class to learn how to manage arthritis symptoms",NA,"%","Age-adjusted Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART5_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1067232",2017,2017,"TX","Texas","BRFSS","Arthritis","Adults aged >= 18 years with arthritis who have taken a class to learn how to manage arthritis symptoms",NA,"%","Age-adjusted Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART5_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1067251",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","30.8",30.8,"","",22.8,40.2,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1067266",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking intensity among adults aged >= 18 years who binge drink",NA,"Number","Age-adjusted Mean","5.3",5.3,"","",4.9,5.8,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC4_0","AGEADJMEAN","GENDER","GENF",NA,NA,NA,NA
"1067389",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","6.1",6.1,"","",4.9,7.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1067399",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 18",NA,"%","Age-adjusted Prevalence","3.6",3.6,"","",2.8,4.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1067462",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have heart disease",NA,"%","Crude Prevalence","49.0",49,"","",41.6,56.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_4","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1067501",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","23.2",23.2,"","",20.9,25.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1067503",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have diabetes",NA,"%","Crude Prevalence","43.3",43.3,"","",38.1,48.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_3","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1067572",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","40.5",40.5,"","",30.4,51.5,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1067588",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1067616",2017,2017,"TX","Texas","BRFSS","Arthritis","Severe joint pain due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","49.8",49.8,"","",37.9,61.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_2","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1067663",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_2","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1067672",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among adults aged >= 18 years",NA,"%","Crude Prevalence","7.9",7.9,"","",6.6,9.5,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1067866",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 45 years with diagnosed chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1067885",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 18",NA,"%","Age-adjusted Prevalence","5.7",5.7,"","",4.6,6.9,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1067898",2017,2017,"TX","Texas","BRFSS","Asthma","Current asthma prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","8.7",8.7,"","",7.3,10.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1067903",2017,2017,"TX","Texas","BRFSS","Arthritis","Work limitation due to arthritis among adults aged 18-64 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","49.2",49.2,"","",42,56.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_3","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1067976",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Influenza vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD7_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1067999",2017,2017,"TX","Texas","BRFSS","Arthritis","Physical inactivity among adults aged >= 18 years with arthritis",NA,"%","Crude Prevalence","41.7",41.7,"","",37.6,45.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART3_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1068015",2017,2017,"TX","Texas","BRFSS","Chronic Kidney Disease","Prevalence of chronic kidney disease among adults aged >= 18 years",NA,"%","Crude Prevalence","2.3",2.3,"","",1.6,3.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD3_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1068081",2017,2017,"TX","Texas","BRFSS","Arthritis","Adults aged >= 18 years with arthritis who have taken a class to learn how to manage arthritis symptoms",NA,"%","Age-adjusted Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART5_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1068121",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who are obese",NA,"%","Age-adjusted Prevalence","33.3",33.3,"","",29.3,37.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_2","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1068149",2017,2017,"TX","Texas","BRFSS","Arthritis","Fair or poor health among adults aged >= 18 years with arthritis",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART4_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1068187",2017,2017,"TX","Texas","BRFSS","Arthritis","Severe joint pain due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","25.0",25,"","",17.8,33.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_2","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1068194",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 45 years",NA,"%","Age-adjusted Prevalence","4.6",4.6,"","",3,6.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1068267",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","22.6",22.6,"","",20.6,24.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1068379",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","12.8",12.8,"","",11.1,14.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1068387",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Influenza vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","40.2",40.2,"","",29.9,51.5,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD7_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1068442",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1068452",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking frequency among adults aged >= 18 years who binge drink",NA,"Number","Mean","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC3_0","MEAN","RACE","OTH",NA,NA,NA,NA
"1068461",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who are obese",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1068488",2017,2017,"TX","Texas","BRFSS","Arthritis","Severe joint pain due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1068559",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","15.9",15.9,"","",14.2,17.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1068650",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_3","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1068655",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","22.3",22.3,"","",14.7,32.3,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_2","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1068726",2017,2017,"TX","Texas","BRFSS","Arthritis","Fair or poor health among adults aged >= 18 years with arthritis",NA,"%","Age-adjusted Prevalence","39.4",39.4,"","",33.4,45.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART4_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1068733",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 45 years with diagnosed chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1068755",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Crude Prevalence","45.7",45.7,"","",25.7,67.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1068837",2017,2017,"TX","Texas","BRFSS","Chronic Kidney Disease","Prevalence of chronic kidney disease among adults aged >= 18 years",NA,"%","Crude Prevalence","3.5",3.5,"","",2.7,4.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD3_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1068844",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 18",NA,"%","Crude Prevalence","4.8",4.8,"","",4.1,5.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1068968",2017,2017,"TX","Texas","BRFSS","Asthma","Current asthma prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","4.4",4.4,"","",3.5,5.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1069007",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Age-adjusted Prevalence","34.5",34.5,"","",23.9,46.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1069010",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 18",NA,"%","Age-adjusted Prevalence","5.8",5.8,"","",4.7,7,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1069018",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have heart disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_4","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1069049",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 45 years",NA,"%","Age-adjusted Prevalence","29.7",29.7,"","",17.3,46.2,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1069059",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1069110",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 45 years with diagnosed chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1069176",2017,2017,"TX","Texas","BRFSS","Arthritis","Adults aged >= 18 years with arthritis who have taken a class to learn how to manage arthritis symptoms",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART5_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1069224",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who are obese",NA,"%","Crude Prevalence","18.7",18.7,"","",14.8,23.3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1069252",2017,2017,"TX","Texas","BRFSS","Arthritis","Fair or poor health among adults aged >= 18 years with arthritis",NA,"%","Age-adjusted Prevalence","41.4",41.4,"","",32,51.4,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART4_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1069263",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1069294",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking frequency among adults aged >= 18 years who binge drink",NA,"Number","Mean","4.7",4.7,"","",4.1,5.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC3_0","MEAN","OVERALL","OVR",NA,NA,NA,NA
"1069301",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Crude Prevalence","30.7",30.7,"","",20.2,43.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1069326",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Crude Prevalence","44.1",44.1,"","",29.5,59.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1069361",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have heart disease",NA,"%","Age-adjusted Prevalence","37.3",37.3,"","",25.4,50.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_4","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1069452",2017,2017,"TX","Texas","BRFSS","Arthritis","Work limitation due to arthritis among adults aged 18-64 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","53.2",53.2,"","",42.3,63.8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_3","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1069456",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Age-adjusted Prevalence","38.9",38.9,"","",23.3,57.2,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1069466",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years",NA,"%","Crude Prevalence","30.6",30.6,"","",25,36.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1069477",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have heart disease",NA,"%","Crude Prevalence","60.4",60.4,"","",49.7,70.3,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_4","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1069511",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","18.0",18,"","",16.6,19.5,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_2","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1069512",2017,2017,"TX","Texas","BRFSS","Arthritis","Physical inactivity among adults aged >= 18 years with arthritis",NA,"%","Age-adjusted Prevalence","32.0",32,"","",26.5,38.1,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART3_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1069517",2017,2017,"TX","Texas","BRFSS","Arthritis","Fair or poor health among adults aged >= 18 years with arthritis",NA,"%","Crude Prevalence","43.9",43.9,"","",38.8,49,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART4_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1069518",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 45 years",NA,"%","Age-adjusted Prevalence","9.3",9.3,"","",7.5,11.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1069533",2017,2017,"TX","Texas","BRFSS","Arthritis","Physical inactivity among adults aged >= 18 years with arthritis",NA,"%","Crude Prevalence","48.2",48.2,"","",39.3,57.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART3_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1069537",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 45 years with diagnosed chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","43.1",43.1,"","",31.7,55.3,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1069548",2017,2017,"TX","Texas","BRFSS","Chronic Kidney Disease","Prevalence of chronic kidney disease among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","3.0",3,"","",2.3,4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD3_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1069576",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1069600",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1069605",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1069682",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years",NA,"%","Crude Prevalence","21.3",21.3,"","",19.8,22.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1069689",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","25.4",25.4,"","",14.3,41,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1069704",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking frequency among adults aged >= 18 years who binge drink",NA,"Number","Age-adjusted Mean","5.6",5.6,"","",4.6,6.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC3_0","AGEADJMEAN","GENDER","GENM",NA,NA,NA,NA
"1069749",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among women aged 18-44 years",NA,"%","Crude Prevalence","7.0",7,"","",5.3,9.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1069763",2017,2017,"TX","Texas","BRFSS","Asthma","Asthma prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1069767",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","24.9",24.9,"","",19.9,30.7,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_3","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1069800",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking intensity among adults aged >= 18 years who binge drink",NA,"Number","Age-adjusted Mean","8.2",8.2,"","",7.6,8.8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC4_0","AGEADJMEAN","GENDER","GENM",NA,NA,NA,NA
"1069820",2017,2017,"TX","Texas","BRFSS","Asthma","Current asthma prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","10.0",10,"","",8.5,11.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1069866",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have heart disease",NA,"%","Age-adjusted Prevalence","33.4",33.4,"","",21.9,47.2,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_4","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1069884",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_2","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1069902",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Influenza vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD7_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1069967",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Age-adjusted Prevalence","74.6",74.6,"","",59.4,85.5,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_2","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1069974",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years",NA,"%","Crude Prevalence","12.7",12.7,"","",10.8,14.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1069983",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 45 years with diagnosed chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1070023",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1070050",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years",NA,"%","Crude Prevalence","14.2",14.2,"","",8.5,22.7,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1070069",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who are obese",NA,"%","Crude Prevalence","40.1",40.1,"","",30.4,50.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1070078",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among adults aged >= 18 years",NA,"%","Crude Prevalence","7.1",7.1,"","",5.4,9.4,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1070106",2017,2017,"TX","Texas","BRFSS","Arthritis","Adults aged >= 18 years with arthritis who have taken a class to learn how to manage arthritis symptoms",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART5_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1070124",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking frequency among adults aged >= 18 years who binge drink",NA,"Number","Mean","3.8",3.8,"","",3,4.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC3_0","MEAN","GENDER","GENF",NA,NA,NA,NA
"1070133",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 45 years with diagnosed chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","24.5",24.5,"","",15.2,37,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1070157",2017,2017,"TX","Texas","BRFSS","Arthritis","Fair or poor health among adults aged >= 18 years with arthritis",NA,"%","Crude Prevalence","33.8",33.8,"","",28.3,39.8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART4_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1070182",2017,2017,"TX","Texas","BRFSS","Chronic Kidney Disease","Prevalence of chronic kidney disease among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD3_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1070243",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking intensity among adults aged >= 18 years who binge drink",NA,"Number","Mean","8.0",8,"","",7.3,8.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC4_0","MEAN","RACE","HIS",NA,NA,NA,NA
"1070269",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 45 years",NA,"%","Age-adjusted Prevalence","10.5",10.5,"","",5.7,18.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1070286",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 45 years with diagnosed chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","35.4",35.4,"","",27.1,44.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1070429",2017,2017,"TX","Texas","BRFSS","Arthritis","Severe joint pain due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","46.1",46.1,"","",37.9,54.5,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1070434",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","15.1",15.1,"","",10.8,20.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1070478",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 18",NA,"%","Crude Prevalence","2.1",2.1,"","",1.5,3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1070482",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who are obese",NA,"%","Crude Prevalence","35.6",35.6,"","",31.2,40.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1070565",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Age-adjusted Prevalence","76.9",76.9,"","",57.2,89.2,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_2","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1070607",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Age-adjusted Prevalence","38.0",38,"","",28.2,48.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1070614",2017,2017,"TX","Texas","BRFSS","Arthritis","Physical inactivity among adults aged >= 18 years with arthritis",NA,"%","Crude Prevalence","36.1",36.1,"","",25.3,48.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART3_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1070657",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Influenza vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","45.6",45.6,"","",36.7,54.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD7_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1070688",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","25.8",25.8,"","",16.6,37.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1070692",2017,2017,"TX","Texas","BRFSS","Arthritis","Work limitation due to arthritis among adults aged 18-64 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","52.8",52.8,"","",44.8,60.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_3","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1070732",2017,2017,"TX","Texas","BRFSS","Arthritis","Physical inactivity among adults aged >= 18 years with arthritis",NA,"%","Crude Prevalence","36.3",36.3,"","",30.5,42.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART3_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1070735",2017,2017,"TX","Texas","BRFSS","Arthritis","Adults aged >= 18 years with arthritis who have taken a class to learn how to manage arthritis symptoms",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART5_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1070750",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 45 years",NA,"%","Crude Prevalence","8.4",8.4,"","",7.1,10,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1070781",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Crude Prevalence","64.2",64.2,"","",45.9,79.2,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1070827",2017,2017,"TX","Texas","BRFSS","Arthritis","Fair or poor health among adults aged >= 18 years with arthritis",NA,"%","Age-adjusted Prevalence","29.3",29.3,"","",24.2,34.9,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART4_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1070832",2017,2017,"TX","Texas","BRFSS","Arthritis","Fair or poor health among adults aged >= 18 years with arthritis",NA,"%","Age-adjusted Prevalence","28.2",28.2,"","",18.4,40.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART4_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1070836",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_3","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1070837",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 45 years",NA,"%","Crude Prevalence","4.5",4.5,"","",2.9,6.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1070874",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years",NA,"%","Crude Prevalence","26.7",26.7,"","",24.5,29,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1070916",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Age-adjusted Prevalence","67.5",67.5,"","",52,79.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_2","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1070963",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1070984",2017,2017,"TX","Texas","BRFSS","Asthma","Current asthma prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","9.0",9,"","",7.5,10.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1070987",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Age-adjusted Prevalence","40.4",40.4,"","",30.3,51.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1071023",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Crude Prevalence","44.1",44.1,"","",33.8,54.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1071070",2017,2017,"TX","Texas","BRFSS","Arthritis","Severe joint pain due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","49.3",49.3,"","",37.6,61,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1071122",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_2","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1071141",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking frequency among adults aged >= 18 years who binge drink",NA,"Number","Age-adjusted Mean","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC3_0","AGEADJMEAN","RACE","OTH",NA,NA,NA,NA
"1071216",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking intensity among adults aged >= 18 years who binge drink",NA,"Number","Age-adjusted Mean","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC4_0","AGEADJMEAN","RACE","OTH",NA,NA,NA,NA
"1071223",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have heart disease",NA,"%","Age-adjusted Prevalence","45.6",45.6,"","",31.2,60.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_4","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1071340",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 18",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1071382",2017,2017,"TX","Texas","BRFSS","Arthritis","Severe joint pain due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","35.7",35.7,"","",31.8,39.7,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1071403",2017,2017,"TX","Texas","BRFSS","Arthritis","Work limitation due to arthritis among adults aged 18-64 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","52.5",52.5,"","",41.7,63.1,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_3","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1071462",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have diabetes",NA,"%","Age-adjusted Prevalence","29.1",29.1,"","",23.6,35.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_3","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1071474",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking intensity among adults aged >= 18 years who binge drink",NA,"Number","Mean","7.0",7,"","",6.4,7.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC4_0","MEAN","RACE","WHT",NA,NA,NA,NA
"1071503",2017,2017,"TX","Texas","BRFSS","Arthritis","Physical inactivity among adults aged >= 18 years with arthritis",NA,"%","Age-adjusted Prevalence","39.1",39.1,"","",32.2,46.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART3_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1071520",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","40.1",40.1,"","",29.8,51.3,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1071524",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","40.9",40.9,"","",29.8,53.1,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1071528",2017,2017,"TX","Texas","BRFSS","Chronic Kidney Disease","Prevalence of chronic kidney disease among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","2.4",2.4,"","",1.7,3.4,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD3_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1071536",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among adults aged >= 18 years",NA,"%","Crude Prevalence","6.9",6.9,"","",6,8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1071565",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Age-adjusted Prevalence","42.7",42.7,"","",34.9,50.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1071625",2017,2017,"TX","Texas","BRFSS","Arthritis","Adults aged >= 18 years with arthritis who have taken a class to learn how to manage arthritis symptoms",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART5_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1071646",2017,2017,"TX","Texas","BRFSS","Asthma","Current asthma prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","4.5",4.5,"","",3.6,5.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1071698",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 18",NA,"%","Crude Prevalence","6.8",6.8,"","",5.6,8.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1071720",2017,2017,"TX","Texas","BRFSS","Arthritis","Work limitation due to arthritis among adults aged 18-64 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","49.4",49.4,"","",41.2,57.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_3","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1071730",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 45 years",NA,"%","Crude Prevalence","33.1",33.1,"","",18,52.7,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1071753",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among women aged 18-44 years",NA,"%","Crude Prevalence","4.9",4.9,"","",2.7,8.5,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1071794",2017,2017,"TX","Texas","BRFSS","Arthritis","Physical inactivity among adults aged >= 18 years with arthritis",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART3_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1071820",2017,2017,"TX","Texas","BRFSS","Arthritis","Physical inactivity among adults aged >= 18 years with arthritis",NA,"%","Age-adjusted Prevalence","38.7",38.7,"","",28.2,50.4,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART3_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1071882",2017,2017,"TX","Texas","BRFSS","Asthma","Current asthma prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","13.4",13.4,"","",9.6,18.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1072131",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have heart disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_4","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1072176",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","29.5",29.5,"","",15.4,48.9,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1072184",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_3","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1072211",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Influenza vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","46.1",46.1,"","",30.6,62.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD7_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1072284",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking intensity among adults aged >= 18 years who binge drink",NA,"Number","Mean","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC4_0","MEAN","RACE","OTH",NA,NA,NA,NA
"1072302",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Age-adjusted Prevalence","57.5",57.5,"","",41.7,71.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_2","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1072350",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","13.1",13.1,"","",11.4,15.1,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_2","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1072354",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Influenza vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","40.8",40.8,"","",23.5,60.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD7_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1072361",2017,2017,"TX","Texas","BRFSS","Chronic Kidney Disease","Prevalence of chronic kidney disease among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","3.3",3.3,"","",2.6,4.3,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD3_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1072364",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who are obese",NA,"%","Age-adjusted Prevalence","20.3",20.3,"","",17.3,23.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_2","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1072416",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1072424",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1072442",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among women aged 18-44 years",NA,"%","Crude Prevalence","10.4",10.4,"","",7.1,15,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1072511",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years",NA,"%","Crude Prevalence","15.4",15.4,"","",13.7,17.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1072547",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking intensity among adults aged >= 18 years who binge drink",NA,"Number","Age-adjusted Mean","5.2",5.2,"","",4.4,6.1,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC4_0","AGEADJMEAN","RACE","BLK",NA,NA,NA,NA
"1072556",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1072576",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Crude Prevalence","33.8",33.8,"","",18,54.4,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1072597",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1072630",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 45 years with diagnosed chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","35.3",35.3,"","",25.6,46.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1072632",2017,2017,"TX","Texas","BRFSS","Arthritis","Work limitation due to arthritis among adults aged 18-64 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_3","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1072648",2017,2017,"TX","Texas","BRFSS","Chronic Kidney Disease","Prevalence of chronic kidney disease among adults aged >= 18 years",NA,"%","Crude Prevalence","3.8",3.8,"","",2.9,5,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD3_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1072662",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking frequency among adults aged >= 18 years who binge drink",NA,"Number","Mean","5.2",5.2,"","",4.4,6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC3_0","MEAN","GENDER","GENM",NA,NA,NA,NA
"1072670",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 45 years with diagnosed chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","41.5",41.5,"","",30.3,53.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1072687",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have diabetes",NA,"%","Age-adjusted Prevalence","18.9",18.9,"","",15.2,23.3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_3","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1072705",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1072756",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 18",NA,"%","Age-adjusted Prevalence","5.8",5.8,"","",3.5,9.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1072758",2017,2017,"TX","Texas","BRFSS","Arthritis","Fair or poor health among adults aged >= 18 years with arthritis",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART4_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1072771",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who are obese",NA,"%","Age-adjusted Prevalence","33.1",33.1,"","",26.5,40.4,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_2","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1072790",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking frequency among adults aged >= 18 years who binge drink",NA,"Number","Age-adjusted Mean","5.1",5.1,"","",4.4,5.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC3_0","AGEADJMEAN","OVERALL","OVR",NA,NA,NA,NA
"1072813",2017,2017,"TX","Texas","BRFSS","Arthritis","Adults aged >= 18 years with arthritis who have taken a class to learn how to manage arthritis symptoms",NA,"%","Age-adjusted Prevalence","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART5_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1072821",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Age-adjusted Prevalence","40.6",40.6,"","",27.7,55,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1072825",2017,2017,"TX","Texas","BRFSS","Asthma","Asthma prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1072848",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have heart disease",NA,"%","Crude Prevalence","51.0",51,"","",41.9,60,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_4","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1072878",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","5.0",5,"","",2.8,8.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1072894",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Crude Prevalence","42.9",42.9,"","",32.6,53.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1072912",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Crude Prevalence","77.4",77.4,"","",59.2,89,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1072963",2017,2017,"TX","Texas","BRFSS","Asthma","Asthma prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","8.9",8.9,"","",6.9,11.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1072996",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","17.8",17.8,"","",16.4,19.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1073062",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Crude Prevalence","40.7",40.7,"","",32.6,49.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1073091",2017,2017,"TX","Texas","BRFSS","Arthritis","Adults aged >= 18 years with arthritis who have taken a class to learn how to manage arthritis symptoms",NA,"%","Age-adjusted Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART5_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1073137",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 18",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1073139",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who are obese",NA,"%","Age-adjusted Prevalence","28.4",28.4,"","",16.7,43.9,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_2","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1073169",2017,2017,"TX","Texas","BRFSS","Arthritis","Work limitation due to arthritis among adults aged 18-64 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","60.9",60.9,"","",45.1,74.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_3","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1073229",2017,2017,"TX","Texas","BRFSS","Asthma","Current asthma prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","7.3",7.3,"","",6.4,8.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1073237",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 18",NA,"%","Age-adjusted Prevalence","2.5",2.5,"","",1.7,3.5,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1073275",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","15.0",15,"","",10.6,20.8,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_2","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1073307",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1073356",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Crude Prevalence","40.5",40.5,"","",31,50.8,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1073358",2017,2017,"TX","Texas","BRFSS","Arthritis","Physical inactivity among adults aged >= 18 years with arthritis",NA,"%","Age-adjusted Prevalence","36.4",36.4,"","",26.6,47.6,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART3_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1073361",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking intensity among adults aged >= 18 years who binge drink",NA,"Number","Age-adjusted Mean","8.9",8.9,"","",7.6,10.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC4_0","AGEADJMEAN","RACE","HIS",NA,NA,NA,NA
"1073367",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Influenza vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","40.8",40.8,"","",32.6,49.5,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD7_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1073389",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1073426",2017,2017,"TX","Texas","BRFSS","Arthritis","Work limitation due to arthritis among adults aged 18-64 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","43.4",43.4,"","",36.7,50.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_3","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1073469",2017,2017,"TX","Texas","BRFSS","Asthma","Current asthma prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1073475",2017,2017,"TX","Texas","BRFSS","Asthma","Current asthma prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1073486",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 45 years with diagnosed chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1073583",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 45 years",NA,"%","Age-adjusted Prevalence","10.2",10.2,"","",8.2,12.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1073587",2017,2017,"TX","Texas","BRFSS","Arthritis","Severe joint pain due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","43.3",43.3,"","",36.5,50.3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_2","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1073631",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","6.7",6.7,"","",5.1,8.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1073738",2017,2017,"TX","Texas","BRFSS","Arthritis","Fair or poor health among adults aged >= 18 years with arthritis",NA,"%","Age-adjusted Prevalence","30.1",30.1,"","",23.2,37.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART4_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1073784",2017,2017,"TX","Texas","BRFSS","Arthritis","Severe joint pain due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","36.8",36.8,"","",29.9,44.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_2","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1073806",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Crude Prevalence","65.6",65.6,"","",36.6,86.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1073873",2017,2017,"TX","Texas","BRFSS","Arthritis","Severe joint pain due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1073895",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","20.8",20.8,"","",14.5,28.9,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1073929",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","16.6",16.6,"","",14.4,19.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1073968",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Age-adjusted Prevalence","48.0",48,"","",38.4,57.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1074012",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","9.2",9.2,"","",5.5,15.2,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_2","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1074055",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have diabetes",NA,"%","Age-adjusted Prevalence","32.9",32.9,"","",25.2,41.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_3","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1074059",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 18",NA,"%","Age-adjusted Prevalence","15.7",15.7,"","",9,25.8,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1074072",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 45 years with diagnosed chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","17.3",17.3,"","",11.2,25.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1074080",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking frequency among adults aged >= 18 years who binge drink",NA,"Number","Age-adjusted Mean","4.6",4.6,"","",3.6,5.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC3_0","AGEADJMEAN","RACE","HIS",NA,NA,NA,NA
"1074186",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Crude Prevalence","29.3",29.3,"","",15.7,48,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1074248",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1074333",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_3","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1074379",2017,2017,"TX","Texas","BRFSS","Chronic Kidney Disease","Prevalence of chronic kidney disease among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","2.9",2.9,"","",2.4,3.5,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD3_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1074400",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have heart disease",NA,"%","Age-adjusted Prevalence","35.0",35,"","",23.3,48.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_4","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1074416",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1074449",2017,2017,"TX","Texas","BRFSS","Arthritis","Severe joint pain due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","32.8",32.8,"","",27.3,38.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_2","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1074465",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1074466",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking intensity among adults aged >= 18 years who binge drink",NA,"Number","Mean","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC4_0","MEAN","RACE","MRC",NA,NA,NA,NA
"1074470",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking frequency among adults aged >= 18 years who binge drink",NA,"Number","Mean","5.0",5,"","",4.1,6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC3_0","MEAN","RACE","WHT",NA,NA,NA,NA
"1074491",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Influenza vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD7_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1074522",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Age-adjusted Prevalence","43.1",43.1,"","",33.5,53.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1074547",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","20.4",20.4,"","",17.8,23.3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1074610",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Crude Prevalence","41.4",41.4,"","",33.7,49.5,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1074645",2017,2017,"TX","Texas","BRFSS","Arthritis","Adults aged >= 18 years with arthritis who have taken a class to learn how to manage arthritis symptoms",NA,"%","Age-adjusted Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART5_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1074653",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 45 years",NA,"%","Age-adjusted Prevalence","8.3",8.3,"","",7,9.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1074675",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have diabetes",NA,"%","Age-adjusted Prevalence","26.4",26.4,"","",19.1,35.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_3","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1074686",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Age-adjusted Prevalence","62.3",62.3,"","",42.7,78.5,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_2","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1074696",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1074746",2017,2017,"TX","Texas","BRFSS","Arthritis","Fair or poor health among adults aged >= 18 years with arthritis",NA,"%","Crude Prevalence","36.5",36.5,"","",26.5,47.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART4_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1074814",2017,2017,"TX","Texas","BRFSS","Arthritis","Work limitation due to arthritis among adults aged 18-64 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_3","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1074855",2017,2017,"TX","Texas","BRFSS","Arthritis","Fair or poor health among adults aged >= 18 years with arthritis",NA,"%","Age-adjusted Prevalence","41.9",41.9,"","",34.8,49.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART4_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1074889",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Crude Prevalence","50.1",50.1,"","",25.2,74.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1074984",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 18",NA,"%","Crude Prevalence","6.1",6.1,"","",3.7,10,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1074995",2017,2017,"TX","Texas","BRFSS","Chronic Kidney Disease","Prevalence of chronic kidney disease among adults aged >= 18 years",NA,"%","Crude Prevalence","1.9",1.9,"","",1.3,2.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD3_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1075022",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking frequency among adults aged >= 18 years who binge drink",NA,"Number","Age-adjusted Mean","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC3_0","AGEADJMEAN","RACE","MRC",NA,NA,NA,NA
"1075088",2017,2017,"TX","Texas","BRFSS","Arthritis","Adults aged >= 18 years with arthritis who have taken a class to learn how to manage arthritis symptoms",NA,"%","Age-adjusted Prevalence","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART5_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1075100",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_2","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1075121",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have heart disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_4","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1075139",2017,2017,"TX","Texas","BRFSS","Asthma","Current asthma prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","13.5",13.5,"","",9.7,18.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1075190",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Age-adjusted Prevalence","60.9",60.9,"","",44.3,75.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_2","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1075210",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Influenza vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","50.0",50,"","",35.8,64.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD7_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1075306",2017,2017,"TX","Texas","BRFSS","Arthritis","Adults aged >= 18 years with arthritis who have taken a class to learn how to manage arthritis symptoms",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART5_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1075321",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who are obese",NA,"%","Crude Prevalence","21.8",21.8,"","",18.4,25.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1075354",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","34.8",34.8,"","",27.2,43.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1075422",2017,2017,"TX","Texas","BRFSS","Asthma","Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST5_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1075536",2017,2017,"TX","Texas","BRFSS","Arthritis","Work limitation due to arthritis among adults aged 18-64 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","52.5",52.5,"","",35.3,69.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_3","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1075566",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have heart disease",NA,"%","Crude Prevalence","53.5",53.5,"","",29.9,75.6,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_4","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1075584",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_3","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1075624",2017,2017,"TX","Texas","BRFSS","Arthritis","Physical inactivity among adults aged >= 18 years with arthritis",NA,"%","Age-adjusted Prevalence","48.0",48,"","",31.7,64.6,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART3_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1075703",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking intensity among adults aged >= 18 years who binge drink",NA,"Number","Age-adjusted Mean","7.1",7.1,"","",6.7,7.5,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC4_0","AGEADJMEAN","OVERALL","OVR",NA,NA,NA,NA
"1075739",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma",NA,"%","Age-adjusted Prevalence","39.8",39.8,"","",31.2,49,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1075750",2017,2017,"TX","Texas","BRFSS","Chronic Kidney Disease","Prevalence of chronic kidney disease among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CKD","CKD3_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1075765",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 18",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1075797",2017,2017,"TX","Texas","BRFSS","Arthritis","Physical inactivity among adults aged >= 18 years with arthritis",NA,"%","Crude Prevalence","41.1",41.1,"","",36.1,46.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART3_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1075895",2017,2017,"TX","Texas","BRFSS","Arthritis","Work limitation due to arthritis among adults aged 18-64 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","58.0",58,"","",35.9,77.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_3","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1075905",2017,2017,"TX","Texas","BRFSS","Asthma","Asthma prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1075919",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among adults aged >= 18 years",NA,"%","Crude Prevalence","5.2",5.2,"","",2.9,9,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1075980",2017,2017,"TX","Texas","BRFSS","Arthritis","Severe joint pain due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","32.4",32.4,"","",18.3,50.7,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_2","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1076000",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking intensity among adults aged >= 18 years who binge drink",NA,"Number","Mean","5.6",5.6,"","",4.7,6.4,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC4_0","MEAN","RACE","BLK",NA,NA,NA,NA
"1076012",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of chronic obstructive pulmonary disease among adults >= 45 years",NA,"%","Age-adjusted Prevalence","6.1",6.1,"","",4.6,8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD2_0_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1076013",2017,2017,"TX","Texas","BRFSS","Asthma","Current asthma prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","4.7",4.7,"","",3.6,6.2,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1076063",2017,2017,"TX","Texas","BRFSS","Asthma","Asthma prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","12.6",12.6,"","",8.9,17.5,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST1_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1076146",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who have diabetes",NA,"%","Crude Prevalence","48.3",48.3,"","",40.8,55.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_3","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1076178",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Prevalence of current smoking among adults >= 45 years with diagnosed chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","43.5",43.5,"","",31.2,56.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD3_0_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1076216",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Influenza vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","39.0",39,"","",29.6,49.2,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD7_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1076236",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years who are obese",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1076264",2017,2017,"TX","Texas","BRFSS","Asthma","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma",NA,"%","Age-adjusted Prevalence","90.9",90.9,"","",80.8,95.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"AST","AST6_2","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1076386",2017,2017,"TX","Texas","BRFSS","Arthritis","Arthritis among adults aged >= 18 years",NA,"%","Crude Prevalence","27.0",27,"","",24.7,29.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART1_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1076399",2017,2017,"TX","Texas","BRFSS","Alcohol","Heavy drinking among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC5_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1076431",2017,2017,"TX","Texas","BRFSS","Arthritis","Severe joint pain due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","40.8",40.8,"","",35.8,46,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1076483",2017,2017,"TX","Texas","BRFSS","Alcohol","Binge drinking prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","19.5",19.5,"","",17.4,21.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ALC","ALC2_2","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1076504",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smoking among adults aged >= 18 years",NA,"%","Crude Prevalence","15.3",15.3,"","",13,18.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1076532",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_3","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1076588",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high blood pressure among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","70.9",70.9,"","",63.7,77.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1076601",2017,2017,"TX","Texas","BRFSS","Diabetes","Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course",NA,"%","Age-adjusted Prevalence","51.6",51.6,"","",39.1,63.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA10_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1076606",2017,2017,"TX","Texas","BRFSS","Diabetes","Diabetes prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","5.0",5,"","",3.1,7.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1076618",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smokeless tobacco use among adults aged >= 18 years",NA,"%","Crude Prevalence","3.1",3.1,"","",2.1,4.4,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1076654",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","81.7",81.7,"","",70.4,89.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_2","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1076667",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits and for muscle-strengthening activity among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1076674",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","23.3",23.3,"","",21.1,25.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1076710",2017,2017,"TX","Texas","BRFSS","Diabetes","Foot examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","59.2",59.2,"","",48.4,69.2,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA5_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1076723",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1076744",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits and for muscle-strengthening activity among adults aged >= 18 years",NA,"%","Crude Prevalence","20.0",20,"","",17.8,22.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1076770",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smoking among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","16.4",16.4,"","",12.4,21.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_2","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1076793",2017,2017,"TX","Texas","BRFSS","Diabetes","Glycosylated hemoglobin measurement among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","75.3",75.3,"","",68.5,81.1,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA6_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1076808",2017,2017,"TX","Texas","BRFSS","Tobacco","Quit attempts in the past year among current smokers",NA,"%","Crude Prevalence","70.1",70.1,"","",63.4,76,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB3_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1076819",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among adults aged >= 18 years",NA,"%","Crude Prevalence","34.2",34.2,"","",31.6,36.9,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1076841",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Taking medicine for high blood pressure control among adults aged >= 18 years with high blood pressure",NA,"%","Crude Prevalence","66.0",66,"","",61.5,70.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD7_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1076856",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","34.4",34.4,"","",32,36.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1076865",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high cholesterol among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","59.6",59.6,"","",54.1,64.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1076912",2017,2017,"TX","Texas","BRFSS","Diabetes","Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course",NA,"%","Age-adjusted Prevalence","52.3",52.3,"","",36.9,67.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA10_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1076916",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1076919",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of vegetable consumption among adults aged >= 18 years",NA,"Number","Median","1.8",1.8,"###","Median frequency (50th percentile) reported with quartiles (25th & 75th percentiles)",1.3,2.5,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW5_2","MEDIAN","RACE","WHT",NA,NA,NA,NA
"1076923",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent physically unhealthy days among adults aged >= 18 years",NA,"Number","Mean","4.4",4.4,"","",3.9,4.8,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_1","MEAN","GENDER","GENF",NA,NA,NA,NA
"1076934",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_2","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1076959",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of vegetable consumption among adults aged >= 18 years",NA,"Number","Median","1.7",1.7,"###","Median frequency (50th percentile) reported with quartiles (25th & 75th percentiles)",1.1,2.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW5_2","MEDIAN","GENDER","GENF",NA,NA,NA,NA
"1076965",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","High cholesterol prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","30.1",30.1,"","",27.8,32.5,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD5_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1076980",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","64.6",64.6,"","",51.7,75.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1076982",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of diagnosed diabetes among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","15.0",15,"","",11.1,20,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1077039",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high cholesterol among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1077073",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_3","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1077096",2017,2017,"TX","Texas","BRFSS","Immunization","Influenza vaccination among noninstitutionalized adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","37.2",37.2,"","",33.9,40.5,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"IMM","IMM1_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1077156",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for additional and more extensive health benefits among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","25.8",25.8,"","",23.4,28.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_3","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1077239",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","65.2",65.2,"","",45.2,81,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD8_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1077246",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smoking among adults aged >= 18 years",NA,"%","Crude Prevalence","16.5",16.5,"","",14.5,18.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1077272",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Cholesterol screening among adults aged >= 18 years",NA,"%","Crude Prevalence","86.3",86.3,"","",76.9,92.2,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD4_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1077286",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Crude Prevalence","61.2",61.2,"","",49.5,71.7,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1077288",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits and for muscle-strengthening activity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","16.9",16.9,"","",15.5,18.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_2","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1077306",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1077356",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current lack of health insurance among adults aged 18-64 years",NA,"%","Age-adjusted Prevalence","25.9",25.9,"","",20.2,32.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1077368",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","18.6",18.6,"","",13.9,24.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_3","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1077373",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current lack of health insurance among adults aged 18-64 years",NA,"%","Crude Prevalence","13.7",13.7,"","",8.4,21.4,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1077380",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_2","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1077435",2017,2017,"TX","Texas","BRFSS","Mental Health","Recent mentally unhealthy days among adults aged >= 18 years",NA,"Number","Mean","4.0",4,"","",3.1,5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH1_0","MEAN","RACE","BLK",NA,NA,NA,NA
"1077446",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Fair or poor self-rated health status among adults aged >= 18 years",NA,"%","Crude Prevalence","13.8",13.8,"","",8.2,22.5,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1077482",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","43.6",43.6,"","",40.7,46.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1077490",2017,2017,"TX","Texas","BRFSS","Mental Health","At least 14 recent mentally unhealthy days among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH2_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1077514",2017,2017,"TX","Texas","BRFSS","Immunization","Influenza vaccination among noninstitutionalized adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","37.8",37.8,"","",35.2,40.5,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"IMM","IMM1_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1077539",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Cholesterol screening among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","90.9",90.9,"","",86,94.2,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD4_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1077563",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among women aged 18-44 years",NA,"%","Crude Prevalence","13.7",13.7,"","",9.8,18.7,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1077571",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","41.7",41.7,"","",39.7,43.7,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1077585",2017,2017,"TX","Texas","BRFSS","Reproductive Health","Timeliness of routine health care checkup among women aged 18-44 years",NA,"%","Crude Prevalence","62.1",62.1,"","",56,67.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"RPH","RPH1_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1077649",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","No leisure-time physical activity among adults aged >= 18 years",NA,"%","Crude Prevalence","30.2",30.2,"","",27.6,33,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW10_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1077670",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke",NA,"%","Crude Prevalence","37.1",37.1,"","",23.8,52.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1077681",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","46.0",46,"","",32.3,60.4,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1077755",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Prevalence of sufficient sleep among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC8_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1077770",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","28.3",28.3,"","",21.2,36.6,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1077779",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent physically unhealthy days among adults aged >= 18 years",NA,"Number","Mean","3.8",3.8,"","",3.5,4.1,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_1","MEAN","OVERALL","OVR",NA,NA,NA,NA
"1077792",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_2","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1077795",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits among adults aged >= 18 years",NA,"%","Crude Prevalence","45.1",45.1,"","",29,62.2,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1077798",2017,2017,"TX","Texas","BRFSS","Diabetes","Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA10_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1077810",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke",NA,"%","Age-adjusted Prevalence","28.3",28.3,"","",15.6,45.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1077820",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of diagnosed diabetes among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","13.0",13,"","",11.4,14.8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1077839",2017,2017,"TX","Texas","BRFSS","Tobacco","Current cigarette smoking among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_3","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1077853",2017,2017,"TX","Texas","BRFSS","Reproductive Health","Timeliness of routine health care checkup among women aged 18-44 years",NA,"%","Crude Prevalence","71.0",71,"","",59.2,80.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"RPH","RPH1_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1077884",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","81.0",81,"","",71.8,87.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_2","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1077913",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years who smoke",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_2","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1077914",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","No leisure-time physical activity among adults aged >= 18 years",NA,"%","Crude Prevalence","33.9",33.9,"","",31.3,36.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW10_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1077918",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Taking medicine for high blood pressure control among adults aged >= 18 years with high blood pressure",NA,"%","Age-adjusted Prevalence","54.5",54.5,"","",51.2,57.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD7_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1077939",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease",NA,"%","Crude Prevalence","82.4",82.4,"","",69.2,90.7,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1077945",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Prevalence of sufficient sleep among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC8_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1077953",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current health care coverage among women aged 18-44 years",NA,"%","Crude Prevalence","78.5",78.5,"","",61.1,89.4,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1077958",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke",NA,"%","Age-adjusted Prevalence","83.5",83.5,"","",65.6,93.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_2","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1077980",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Crude Prevalence","45.8",45.8,"","",38.1,53.7,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1077990",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","75.8",75.8,"","",72.6,78.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1077994",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1078020",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for additional and more extensive health benefits among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","24.5",24.5,"","",22.9,26.2,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_3","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1078057",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high blood pressure among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","45.8",45.8,"","",35.2,56.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_2","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1078076",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Crude Prevalence","75.8",75.8,"","",49.6,90.9,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1078132",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Obesity among adults aged >= 18 years",NA,"%","Crude Prevalence","30.4",30.4,"","",28.1,32.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1078188",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","No leisure-time physical activity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","33.7",33.7,"","",31.1,36.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW10_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1078190",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke",NA,"%","Crude Prevalence","63.1",63.1,"","",53.2,72,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1078198",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current lack of health insurance among adults aged 18-64 years",NA,"%","Crude Prevalence","30.4",30.4,"","",27.7,33.4,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1078212",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high cholesterol among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","52.3",52.3,"","",43.8,60.6,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1078217",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current lack of health insurance among adults aged 18-64 years",NA,"%","Age-adjusted Prevalence","13.2",13.2,"","",11.2,15.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1078235",2017,2017,"TX","Texas","BRFSS","Immunization","Influenza vaccination among noninstitutionalized adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","36.2",36.2,"","",34.4,38.1,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"IMM","IMM1_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1078239",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","32.7",32.7,"","",30.2,35.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1078252",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Fair or poor self-rated health status among adults aged >= 18 years",NA,"%","Crude Prevalence","20.8",20.8,"","",19.3,22.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1078264",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","60.9",60.9,"","",49.5,71.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_2","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1078297",2017,2017,"TX","Texas","BRFSS","Diabetes","Dilated eye examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","56.3",56.3,"","",46.4,65.8,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA7_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1078339",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Taking medicine for high blood pressure control among adults aged >= 18 years with high blood pressure",NA,"%","Crude Prevalence","72.5",72.5,"","",68.4,76.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD7_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1078373",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Cholesterol screening among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","87.4",87.4,"","",85.1,89.4,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD4_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1078390",2017,2017,"TX","Texas","BRFSS","Mental Health","Recent mentally unhealthy days among adults aged >= 18 years",NA,"Number","Mean","3.8",3.8,"","",3.5,4.2,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH1_0","MEAN","OVERALL","OVR",NA,NA,NA,NA
"1078399",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Prevalence of sufficient sleep among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC8_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1078401",2017,2017,"TX","Texas","BRFSS","Diabetes","Dilated eye examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","54.9",54.9,"","",45.2,64.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA7_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1078425",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of diagnosed diabetes among adults aged >= 18 years",NA,"%","Crude Prevalence","12.9",12.9,"","",11.2,14.8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1078429",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","High cholesterol prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","31.2",31.2,"","",28.7,33.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD5_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1078459",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD8_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1078510",2017,2017,"TX","Texas","BRFSS","Diabetes","Glycosylated hemoglobin measurement among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA6_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1078527",2017,2017,"TX","Texas","BRFSS","Diabetes","Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course",NA,"%","Crude Prevalence","43.9",43.9,"","",35.9,52.3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA10_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1078531",2017,2017,"TX","Texas","BRFSS","Tobacco","Quit attempts in the past year among current smokers",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB3_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1078598",2017,2017,"TX","Texas","BRFSS","Diabetes","Dilated eye examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","65.2",65.2,"","",57.2,72.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA7_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1078614",2017,2017,"TX","Texas","BRFSS","Diabetes","Foot examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","68.3",68.3,"","",58.7,76.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA5_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1078616",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","54.6",54.6,"","",38.8,69.6,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1078624",2017,2017,"TX","Texas","BRFSS","Tobacco","Quit attempts in the past year among current smokers",NA,"%","Age-adjusted Prevalence","58.2",58.2,"","",52,64.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB3_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1078625",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke",NA,"%","Age-adjusted Prevalence","25.2",25.2,"","",13.6,41.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1078648",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of fruit consumption among adults aged >= 18 years",NA,"Number","Median","1.0",1,"###","Median frequency (50th percentile) reported with quartiles (25th & 75th percentiles)",0.5,2,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW4_2","MEDIAN","RACE","HIS",NA,NA,NA,NA
"1078654",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for additional and more extensive health benefits among adults aged >= 18 years",NA,"%","Crude Prevalence","22.9",22.9,"","",12.5,38.2,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_3","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1078664",2017,2017,"TX","Texas","BRFSS","Reproductive Health","Timeliness of routine health care checkup among women aged 18-44 years",NA,"%","Crude Prevalence","60.8",60.8,"","",56.9,64.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"RPH","RPH1_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1078671",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smokeless tobacco use among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","6.8",6.8,"","",5.5,8.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_2","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1078694",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current health care coverage among women aged 18-44 years",NA,"%","Crude Prevalence","48.5",48.5,"","",44.3,52.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1078695",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years who smoke",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1078705",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Prevalence of sufficient sleep among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC8_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1078722",2017,2017,"TX","Texas","BRFSS","Diabetes","Glycosylated hemoglobin measurement among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","75.1",75.1,"","",52,89.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA6_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1078749",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Prevalence of sufficient sleep among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC8_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1078782",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent physically unhealthy days among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","3.9",3.9,"","",3,4.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_1","AGEADJMEAN","RACE","BLK",NA,NA,NA,NA
"1078797",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Taking medicine for high blood pressure control among adults aged >= 18 years with high blood pressure",NA,"%","Age-adjusted Prevalence","61.8",61.8,"","",53.7,69.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD7_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1078811",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease",NA,"%","Age-adjusted Prevalence","82.1",82.1,"","",69,90.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_2","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1078842",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1078853",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","63.6",63.6,"","",51.5,74.2,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1078880",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Crude Prevalence","45.9",45.9,"","",35.5,56.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1078906",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","23.4",23.4,"","",13.8,36.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_3","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1078911",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent activity limitation among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","2.6",2.6,"","",2.1,3.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_2","AGEADJMEAN","RACE","HIS",NA,NA,NA,NA
"1078913",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high blood pressure among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","89.1",89.1,"","",68.2,96.9,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_2","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1078942",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","70.5",70.5,"","",45.4,87.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_2","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1078951",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent activity limitation among adults aged >= 18 years",NA,"Number","Mean","2.4",2.4,"","",1.9,2.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_2","MEAN","RACE","HIS",NA,NA,NA,NA
"1078973",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1078985",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","No leisure-time physical activity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","32.1",32.1,"","",30.2,34,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW10_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1079038",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of diagnosed diabetes among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","11.7",11.7,"","",10.6,12.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1079066",2017,2017,"TX","Texas","BRFSS","Tobacco","Quit attempts in the past year among current smokers",NA,"%","Age-adjusted Prevalence","59.0",59,"","",52.1,65.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB3_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1079098",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smoking among adults aged >= 18 years",NA,"%","Crude Prevalence","25.0",25,"","",14.6,39.5,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1079139",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","42.4",42.4,"","",33.3,52,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1079142",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent activity limitation among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","2.5",2.5,"","",2.3,2.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_2","AGEADJMEAN","OVERALL","OVR",NA,NA,NA,NA
"1079163",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","High cholesterol prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","30.0",30,"","",20.7,41.3,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD5_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1079165",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits and for muscle-strengthening activity among adults aged >= 18 years",NA,"%","Crude Prevalence","14.2",14.2,"","",12.5,16.2,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1079167",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smokeless tobacco use among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1079176",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high blood pressure among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1079215",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Fair or poor self-rated health status among adults aged >= 18 years",NA,"%","Crude Prevalence","23.2",23.2,"","",21.1,25.5,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1079221",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of fruit consumption among adults aged >= 18 years",NA,"Number","Median","1.0",1,"###","Median frequency (50th percentile) reported with quartiles (25th & 75th percentiles)",0.6,1.9,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW4_2","MEDIAN","RACE","OTH",NA,NA,NA,NA
"1079237",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smokeless tobacco use among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","2.7",2.7,"","",1.9,3.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_2","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1079297",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Self-rated health status among women aged 18-44 years",NA,"%","Crude Prevalence","82.9",82.9,"","",79.6,85.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1079333",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","64.7",64.7,"","",42.9,81.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD8_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1079334",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Cholesterol screening among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","88.5",88.5,"","",86.5,90.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD4_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1079377",2017,2017,"TX","Texas","BRFSS","Diabetes","Glycosylated hemoglobin measurement among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","68.7",68.7,"","",59.1,76.9,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA6_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1079435",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high cholesterol among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","60.3",60.3,"","",42,76.2,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1079436",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Crude Prevalence","82.2",82.2,"","",71.9,89.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1079439",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1079454",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke",NA,"%","Crude Prevalence","32.4",32.4,"","",20.3,47.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1079500",2017,2017,"TX","Texas","BRFSS","Tobacco","Current cigarette smoking among women aged 18-44 years",NA,"%","Crude Prevalence","17.9",17.9,"","",10.2,29.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_3","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1079515",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","35.3",35.3,"","",22.2,50.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1079533",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high blood pressure among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","68.9",68.9,"","",61.1,75.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1079542",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent physically unhealthy days among adults aged >= 18 years",NA,"Number","Mean","3.1",3.1,"","",2.7,3.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_1","MEAN","GENDER","GENM",NA,NA,NA,NA
"1079550",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years who smoke",NA,"%","Crude Prevalence","30.0",30,"","",25,35.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1079553",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among adults aged >= 18 years",NA,"%","Crude Prevalence","69.4",69.4,"","",67.6,71.2,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1079595",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years who smoke",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1079602",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years who smoke",NA,"%","Age-adjusted Prevalence","29.3",29.3,"","",20.5,39.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1079661",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Taking medicine for high blood pressure control among adults aged >= 18 years with high blood pressure",NA,"%","Age-adjusted Prevalence","54.6",54.6,"","",48.8,60.3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD7_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1079707",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","45.6",45.6,"","",40.5,50.8,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1079722",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of vegetable consumption among adults aged >= 18 years",NA,"Number","Median","1.6",1.6,"###","Median frequency (50th percentile) reported with quartiles (25th & 75th percentiles)",1.3,2.2,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW5_2","MEDIAN","RACE","MRC",NA,NA,NA,NA
"1079733",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current lack of health insurance among adults aged 18-64 years",NA,"%","Age-adjusted Prevalence","45.8",45.8,"","",42.5,49.2,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1079741",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease",NA,"%","Crude Prevalence","85.1",85.1,"","",64,94.8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1079751",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of vegetable consumption among adults aged >= 18 years",NA,"Number","Median","1.3",1.3,"###","Median frequency (50th percentile) reported with quartiles (25th & 75th percentiles)",0.8,2.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW5_2","MEDIAN","RACE","HIS",NA,NA,NA,NA
"1079757",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits among adults aged >= 18 years",NA,"%","Crude Prevalence","36.8",36.8,"","",30.5,43.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1079769",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","49.1",49.1,"","",27.2,71.4,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD8_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1079786",2017,2017,"TX","Texas","BRFSS","Diabetes","Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course",NA,"%","Crude Prevalence","54.1",54.1,"","",46,62.1,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA10_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1079794",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smoking among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1079813",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Obesity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","34.1",34.1,"","",31.6,36.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1079822",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1079854",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Cholesterol screening among adults aged >= 18 years",NA,"%","Crude Prevalence","86.9",86.9,"","",84.6,88.8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD4_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1079975",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Obesity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","37.6",37.6,"","",31.7,43.8,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1080019",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for additional and more extensive health benefits among adults aged >= 18 years",NA,"%","Crude Prevalence","20.1",20.1,"","",17.6,23,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_3","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1080021",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD8_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1080026",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Cholesterol screening among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","88.6",88.6,"","",87.3,89.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD4_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1080036",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Obesity among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1080037",2017,2017,"TX","Texas","BRFSS","Immunization","Influenza vaccination among noninstitutionalized adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","33.4",33.4,"","",30.9,35.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"IMM","IMM1_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1080074",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1080101",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among adults aged >= 18 years",NA,"%","Crude Prevalence","47.6",47.6,"","",41.5,53.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1080149",2017,2017,"TX","Texas","BRFSS","Diabetes","Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course",NA,"%","Crude Prevalence","50.1",50.1,"","",44.3,55.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA10_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1080242",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Crude Prevalence","77.8",77.8,"","",66,86.3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1080259",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smokeless tobacco use among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_2","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1080264",2017,2017,"TX","Texas","BRFSS","Diabetes","Diabetes prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1080268",2017,2017,"TX","Texas","BRFSS","Mental Health","Recent mentally unhealthy days among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","2.9",2.9,"","",2.5,3.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH1_0","AGEADJMEAN","GENDER","GENM",NA,NA,NA,NA
"1080274",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years who smoke",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1080306",2017,2017,"TX","Texas","BRFSS","Immunization","Influenza vaccination among noninstitutionalized adults aged >= 18 years",NA,"%","Crude Prevalence","31.7",31.7,"","",25.9,38.1,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"IMM","IMM1_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1080307",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among women aged 18-44 years",NA,"%","Crude Prevalence","13.3",13.3,"","",10.7,16.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1080326",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","40.2",40.2,"","",26.1,56.1,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1080349",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke",NA,"%","Crude Prevalence","88.9",88.9,"","",75.9,95.3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1080359",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke",NA,"%","Crude Prevalence","62.4",62.4,"","",50.9,72.7,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1080385",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among adults aged >= 18 years",NA,"%","Crude Prevalence","64.4",64.4,"","",50.2,76.4,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1080389",2017,2017,"TX","Texas","BRFSS","Diabetes","Dilated eye examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA7_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1080396",2017,2017,"TX","Texas","BRFSS","Diabetes","Foot examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","82.7",82.7,"","",65.8,92.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA5_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1080405",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke",NA,"%","Age-adjusted Prevalence","25.5",25.5,"","",16.6,37.1,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1080410",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","No leisure-time physical activity among adults aged >= 18 years",NA,"%","Crude Prevalence","28.4",28.4,"","",26.1,30.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW10_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1080457",2017,2017,"TX","Texas","BRFSS","Diabetes","Glycosylated hemoglobin measurement among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA6_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1080474",2017,2017,"TX","Texas","BRFSS","Tobacco","Quit attempts in the past year among current smokers",NA,"%","Age-adjusted Prevalence","67.2",67.2,"","",58.6,74.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB3_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1080475",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Taking medicine for high blood pressure control among adults aged >= 18 years with high blood pressure",NA,"%","Age-adjusted Prevalence","61.7",61.7,"","",42.6,77.7,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD7_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1080479",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_2","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1080521",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1080536",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years who smoke",NA,"%","Age-adjusted Prevalence","83.8",83.8,"","",70.3,91.9,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_2","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1080573",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","32.7",32.7,"","",24.1,42.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_3","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1080615",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years who smoke",NA,"%","Age-adjusted Prevalence","40.9",40.9,"","",28.8,54.2,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1080633",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease",NA,"%","Crude Prevalence","79.1",79.1,"","",59.8,90.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1080663",2017,2017,"TX","Texas","BRFSS","Mental Health","At least 14 recent mentally unhealthy days among women aged 18-44 years",NA,"%","Crude Prevalence","38.4",38.4,"","",21,59.4,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH2_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1080666",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent activity limitation among adults aged >= 18 years",NA,"Number","Mean","2.5",2.5,"","",2.3,2.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_2","MEAN","OVERALL","OVR",NA,NA,NA,NA
"1080671",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease",NA,"%","Crude Prevalence","49.6",49.6,"","",29.3,70,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1080684",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high blood pressure among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_2","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1080699",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among women aged 18-44 years",NA,"%","Crude Prevalence","58.3",58.3,"","",54,62.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_3","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1080711",2017,2017,"TX","Texas","BRFSS","Diabetes","Foot examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","66.5",66.5,"","",52.7,77.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA5_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1080712",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","No leisure-time physical activity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","38.9",38.9,"","",35.6,42.3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW10_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1080743",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits among adults aged >= 18 years",NA,"%","Crude Prevalence","41.9",41.9,"","",39.9,43.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1080854",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smoking among adults aged >= 18 years",NA,"%","Crude Prevalence","17.0",17,"","",12.8,22.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1080863",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high blood pressure among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","68.6",68.6,"","",60.9,75.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1080870",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among women aged 18-44 years",NA,"%","Crude Prevalence","63.9",63.9,"","",51.4,74.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_3","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1080899",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits and for muscle-strengthening activity among adults aged >= 18 years",NA,"%","Crude Prevalence","17.0",17,"","",15.6,18.5,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1080909",2017,2017,"TX","Texas","BRFSS","Diabetes","Glycosylated hemoglobin measurement among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","72.5",72.5,"","",66.7,77.5,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA6_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1080944",2017,2017,"TX","Texas","BRFSS","Mental Health","At least 14 recent mentally unhealthy days among women aged 18-44 years",NA,"%","Crude Prevalence","14.6",14.6,"","",11.9,17.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH2_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1080981",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high cholesterol among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","52.3",52.3,"","",40.2,64.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1080987",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among adults aged >= 18 years",NA,"%","Crude Prevalence","22.7",22.7,"","",20.2,25.4,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1081012",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","84.7",84.7,"","",76.2,90.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_2","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1081023",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","High cholesterol prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","32.1",32.1,"","",29.7,34.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD5_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1081055",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1081067",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent physically unhealthy days among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","3.8",3.8,"","",3.3,4.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_1","AGEADJMEAN","RACE","WHT",NA,NA,NA,NA
"1081086",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of diagnosed diabetes among adults aged >= 18 years",NA,"%","Crude Prevalence","11.0",11,"","",9.5,12.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1081093",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Fair or poor self-rated health status among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","13.9",13.9,"","",7.7,23.6,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1081100",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smoking among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","14.2",14.2,"","",12.1,16.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_2","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1081102",2017,2017,"TX","Texas","BRFSS","Mental Health","Recent mentally unhealthy days among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","4.7",4.7,"","",4.3,5.2,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH1_0","AGEADJMEAN","GENDER","GENF",NA,NA,NA,NA
"1081105",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","34.3",34.3,"","",31.7,37,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1081109",2017,2017,"TX","Texas","BRFSS","Diabetes","Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA10_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1081110",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of diagnosed diabetes among adults aged >= 18 years",NA,"%","Crude Prevalence","15.6",15.6,"","",11.4,21,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1081119",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smokeless tobacco use among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","7.5",7.5,"","",6.2,9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_2","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1081129",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among adults aged >= 18 years",NA,"%","Crude Prevalence","73.9",73.9,"","",68,79,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1081144",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","52.0",52,"","",36.9,66.8,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1081154",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Fair or poor self-rated health status among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","23.1",23.1,"","",21,25.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1081166",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high cholesterol among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1081172",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among women aged 18-44 years",NA,"%","Crude Prevalence","26.9",26.9,"","",17.9,38.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1081177",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among adults aged >= 18 years",NA,"%","Crude Prevalence","23.7",23.7,"","",21.3,26.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1081197",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years who smoke",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1081201",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Obesity among adults aged >= 18 years",NA,"%","Crude Prevalence","33.0",33,"","",31.2,34.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1081238",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among adults aged >= 18 years",NA,"%","Crude Prevalence","74.7",74.7,"","",71.4,77.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1081255",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smokeless tobacco use among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","1.1",1.1,"","",0.8,1.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_2","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1081259",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","62.9",62.9,"","",48.5,75.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1081264",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Prevalence of sufficient sleep among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC8_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1081271",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for additional and more extensive health benefits among adults aged >= 18 years",NA,"%","Crude Prevalence","24.7",24.7,"","",23.1,26.5,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_3","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1081340",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","No leisure-time physical activity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","33.8",33.8,"","",23.5,45.8,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW10_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1081435",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high blood pressure among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","69.8",69.8,"","",64.7,74.5,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1081467",2017,2017,"TX","Texas","BRFSS","Diabetes","Dilated eye examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","63.8",63.8,"","",58.2,69,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA7_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1081481",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current lack of health insurance among adults aged 18-64 years",NA,"%","Age-adjusted Prevalence","28.3",28.3,"","",26.4,30.2,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1081495",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_3","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1081554",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent physically unhealthy days among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","4.3",4.3,"","",3.9,4.8,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_1","AGEADJMEAN","GENDER","GENF",NA,NA,NA,NA
"1081581",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years who smoke",NA,"%","Crude Prevalence","28.7",28.7,"","",22.4,36,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1081604",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent activity limitation among adults aged >= 18 years",NA,"Number","Mean","3.7",3.7,"","",1.6,5.7,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_2","MEAN","RACE","MRC",NA,NA,NA,NA
"1081606",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","High cholesterol prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","31.7",31.7,"","",29.9,33.5,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD5_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1081640",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Taking medicine for high blood pressure control among adults aged >= 18 years with high blood pressure",NA,"%","Crude Prevalence","72.3",72.3,"","",69.3,75.2,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD7_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1081681",2017,2017,"TX","Texas","BRFSS","Mental Health","Recent mentally unhealthy days among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","3.8",3.8,"","",3.5,4.1,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH1_0","AGEADJMEAN","OVERALL","OVR",NA,NA,NA,NA
"1081692",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Self-rated health status among women aged 18-44 years",NA,"%","Crude Prevalence","90.4",90.4,"","",75.9,96.6,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1081712",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","37.8",37.8,"","",30.3,45.9,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_3","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1081760",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","37.6",37.6,"","",31.4,44.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1081776",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent activity limitation among adults aged >= 18 years",NA,"Number","Mean","3.0",3,"","",2.6,3.5,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_2","MEAN","GENDER","GENF",NA,NA,NA,NA
"1081782",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD8_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1081818",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent activity limitation among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","5.2",5.2,"","",2.6,7.8,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_2","AGEADJMEAN","RACE","MRC",NA,NA,NA,NA
"1081820",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high cholesterol among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1081839",2017,2017,"TX","Texas","BRFSS","Diabetes","Glycosylated hemoglobin measurement among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA6_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1081878",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among adults aged >= 18 years",NA,"%","Crude Prevalence","24.1",24.1,"","",14.9,36.4,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1081881",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","63.5",63.5,"","",60.8,66.1,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1081894",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Obesity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","30.7",30.7,"","",28.2,33.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1081898",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke",NA,"%","Crude Prevalence","36.4",36.4,"","",23.7,51.3,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1081901",2017,2017,"TX","Texas","BRFSS","Tobacco","Current cigarette smoking among women aged 18-44 years",NA,"%","Crude Prevalence","21.6",21.6,"","",16.5,27.7,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_3","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1081904",2017,2017,"TX","Texas","BRFSS","Diabetes","Foot examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA5_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1081925",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current lack of health insurance among adults aged 18-64 years",NA,"%","Crude Prevalence","28.1",28.1,"","",26.2,30,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1081927",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","87.9",87.9,"","",79.3,93.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_2","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1081928",2017,2017,"TX","Texas","BRFSS","Reproductive Health","Timeliness of routine health care checkup among women aged 18-44 years",NA,"%","Crude Prevalence","55.2",55.2,"","",49.2,61.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"RPH","RPH1_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1081933",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent physically unhealthy days among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","2.7",2.7,"","",1.4,4,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_1","AGEADJMEAN","RACE","OTH",NA,NA,NA,NA
"1081960",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Fair or poor self-rated health status among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","16.8",16.8,"","",14.9,19,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1081975",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smoking among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","25.3",25.3,"","",15.9,37.7,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_2","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1081977",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Crude Prevalence","52.9",52.9,"","",41.1,64.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1081985",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Crude Prevalence","68.8",68.8,"","",61,75.7,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1081998",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smokeless tobacco use among adults aged >= 18 years",NA,"%","Crude Prevalence","4.3",4.3,"","",3.6,5.1,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1082030",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","High cholesterol prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","32.7",32.7,"","",24.6,41.9,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD5_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1082054",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1082061",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Self-rated health status among women aged 18-44 years",NA,"%","Crude Prevalence","79.0",79,"","",70.9,85.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1082066",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current health care coverage among women aged 18-44 years",NA,"%","Crude Prevalence","85.1",85.1,"","",81.7,88,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1082091",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Fair or poor self-rated health status among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","18.3",18.3,"","",16.3,20.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1082113",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among adults aged >= 18 years",NA,"%","Crude Prevalence","43.6",43.6,"","",33.4,54.4,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1082200",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Cholesterol screening among adults aged >= 18 years",NA,"%","Crude Prevalence","91.2",91.2,"","",89.5,92.7,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD4_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1082218",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high cholesterol among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","67.6",67.6,"","",59.7,74.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1082229",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years who smoke",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1082258",2017,2017,"TX","Texas","BRFSS","Mental Health","Recent mentally unhealthy days among adults aged >= 18 years",NA,"Number","Mean","2.5",2.5,"","",1.4,3.7,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH1_0","MEAN","RACE","OTH",NA,NA,NA,NA
"1082270",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years who smoke",NA,"%","Age-adjusted Prevalence","29.7",29.7,"","",23,37.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1082328",2017,2017,"TX","Texas","BRFSS","Diabetes","Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course",NA,"%","Age-adjusted Prevalence","59.7",59.7,"","",48.7,69.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA10_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1082331",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1082345",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_2","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1082354",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke",NA,"%","Crude Prevalence","34.6",34.6,"","",25.4,45.1,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1082361",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits and for muscle-strengthening activity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","18.4",18.4,"","",13.5,24.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_2","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1082367",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent physically unhealthy days among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","3.2",3.2,"","",2.7,3.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_1","AGEADJMEAN","GENDER","GENM",NA,NA,NA,NA
"1082368",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current lack of health insurance among adults aged 18-64 years",NA,"%","Age-adjusted Prevalence","21.1",21.1,"","",11.9,34.6,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1082378",2017,2017,"TX","Texas","BRFSS","Diabetes","Glycosylated hemoglobin measurement among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","78.8",78.8,"","",65.6,87.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA6_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1082385",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among adults aged >= 18 years",NA,"%","Crude Prevalence","28.8",28.8,"","",27,30.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1082400",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","73.4",73.4,"","",63.5,81.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD8_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1082436",2017,2017,"TX","Texas","BRFSS","Tobacco","Quit attempts in the past year among current smokers",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB3_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1082454",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","No leisure-time physical activity among adults aged >= 18 years",NA,"%","Crude Prevalence","36.2",36.2,"","",30.1,42.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW10_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1082473",2017,2017,"TX","Texas","BRFSS","Diabetes","Dilated eye examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","68.1",68.1,"","",50,82,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA7_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1082486",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits among adults aged >= 18 years",NA,"%","Crude Prevalence","43.6",43.6,"","",40.8,46.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1082502",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years who smoke",NA,"%","Crude Prevalence","31.5",31.5,"","",23.8,40.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1082510",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Taking medicine for high blood pressure control among adults aged >= 18 years with high blood pressure",NA,"%","Crude Prevalence","67.5",67.5,"","",45.4,83.8,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD7_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1082556",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Cholesterol screening among adults aged >= 18 years",NA,"%","Crude Prevalence","91.1",91.1,"","",89.2,92.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD4_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1082584",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for additional and more extensive health benefits among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","23.9",23.9,"","",18.6,30.1,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_3","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1082605",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current lack of health insurance among adults aged 18-64 years",NA,"%","Crude Prevalence","25.7",25.7,"","",23.2,28.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1082628",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","69.1",69.1,"","",57.4,78.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD8_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1082689",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease",NA,"%","Age-adjusted Prevalence","43.6",43.6,"","",28.4,60.1,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1082690",2017,2017,"TX","Texas","BRFSS","Diabetes","Dilated eye examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","55.3",55.3,"","",44.7,65.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA7_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1082706",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Crude Prevalence","70.9",70.9,"","",45.2,87.9,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1082732",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Cholesterol screening among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","92.1",92.1,"","",83.3,96.5,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD4_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1082740",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Obesity among adults aged >= 18 years",NA,"%","Crude Prevalence","37.3",37.3,"","",34,40.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1082804",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Obesity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","21.6",21.6,"","",14.6,30.8,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1082808",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke",NA,"%","Age-adjusted Prevalence","62.8",62.8,"","",52.9,71.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_2","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1082810",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_2","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1082811",2017,2017,"TX","Texas","BRFSS","Tobacco","Quit attempts in the past year among current smokers",NA,"%","Crude Prevalence","59.7",59.7,"","",52.8,66.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB3_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1082826",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of fruit consumption among adults aged >= 18 years",NA,"Number","Median","1.0",1,"###","Median frequency (50th percentile) reported with quartiles (25th & 75th percentiles)",0.4,1.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW4_2","MEDIAN","GENDER","GENM",NA,NA,NA,NA
"1082829",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high cholesterol among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","55.6",55.6,"","",42.8,67.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1082857",2017,2017,"TX","Texas","BRFSS","Diabetes","Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course",NA,"%","Crude Prevalence","65.2",65.2,"","",46.5,80.1,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA10_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1082863",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","33.1",33.1,"","",30.8,35.5,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1082865",2017,2017,"TX","Texas","BRFSS","Immunization","Influenza vaccination among noninstitutionalized adults aged >= 18 years",NA,"%","Crude Prevalence","29.7",29.7,"","",21.9,38.9,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"IMM","IMM1_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1082873",2017,2017,"TX","Texas","BRFSS","Diabetes","Foot examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","75.9",75.9,"","",50.7,90.6,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA5_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1082900",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of diagnosed diabetes among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1082902",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of vegetable consumption among adults aged >= 18 years",NA,"Number","Median","1.7",1.7,"###","Median frequency (50th percentile) reported with quartiles (25th & 75th percentiles)",1.1,2.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW5_2","MEDIAN","RACE","BLK",NA,NA,NA,NA
"1082921",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years who smoke",NA,"%","Crude Prevalence","82.4",82.4,"","",67.6,91.3,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1082925",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Prevalence of sufficient sleep among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC8_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1082955",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Taking medicine for high blood pressure control among adults aged >= 18 years with high blood pressure",NA,"%","Crude Prevalence","78.9",78.9,"","",74.7,82.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD7_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1082961",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","High cholesterol prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","29.9",29.9,"","",27.5,32.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD5_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1082967",2017,2017,"TX","Texas","BRFSS","Diabetes","Foot examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","70.5",70.5,"","",62.3,77.5,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA5_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1082971",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","29.9",29.9,"","",27.8,32.1,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1083000",2017,2017,"TX","Texas","BRFSS","Immunization","Influenza vaccination among noninstitutionalized adults aged >= 18 years",NA,"%","Crude Prevalence","34.5",34.5,"","",31.2,37.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"IMM","IMM1_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1083022",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1083042",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","53.2",53.2,"","",36.9,68.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1083044",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_2","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1083058",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smoking among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","15.9",15.9,"","",14.5,17.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_2","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1083075",2017,2017,"TX","Texas","BRFSS","Diabetes","Foot examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","62.7",62.7,"","",54.1,70.5,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA5_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1083077",2017,2017,"TX","Texas","BRFSS","Tobacco","Quit attempts in the past year among current smokers",NA,"%","Age-adjusted Prevalence","79.6",79.6,"","",68.3,87.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB3_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1083083",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years who smoke",NA,"%","Age-adjusted Prevalence","82.1",82.1,"","",71.7,89.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_2","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1083099",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Cholesterol screening among adults aged >= 18 years",NA,"%","Crude Prevalence","89.0",89,"","",87.6,90.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD4_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1083128",2017,2017,"TX","Texas","BRFSS","Immunization","Influenza vaccination among noninstitutionalized adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","31.4",31.4,"","",25.7,37.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"IMM","IMM1_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1083140",2017,2017,"TX","Texas","BRFSS","Diabetes","Glycosylated hemoglobin measurement among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","56.7",56.7,"","",42.3,70,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA6_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1083175",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","No leisure-time physical activity among adults aged >= 18 years",NA,"%","Crude Prevalence","23.5",23.5,"","",14.3,36,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW10_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1083214",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smokeless tobacco use among adults aged >= 18 years",NA,"%","Crude Prevalence","1.1",1.1,"","",0.8,1.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1083233",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1083238",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Crude Prevalence","44.3",44.3,"","",32.7,56.5,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1083278",2017,2017,"TX","Texas","BRFSS","Tobacco","Quit attempts in the past year among current smokers",NA,"%","Crude Prevalence","66.8",66.8,"","",57.5,74.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB3_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1083297",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","69.7",69.7,"","",67.9,71.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1083333",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years who smoke",NA,"%","Crude Prevalence","76.0",76,"","",61.4,86.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1083375",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high blood pressure among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","61.9",61.9,"","",52.7,70.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_2","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1083388",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits and for muscle-strengthening activity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","19.6",19.6,"","",17.5,22,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_2","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1083412",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","High cholesterol prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","27.7",27.7,"","",24.9,30.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD5_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1083419",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent physically unhealthy days among adults aged >= 18 years",NA,"Number","Mean","4.0",4,"","",3.6,4.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_1","MEAN","RACE","WHT",NA,NA,NA,NA
"1083427",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of vegetable consumption among adults aged >= 18 years",NA,"Number","Median","2.0",2,"###","Median frequency (50th percentile) reported with quartiles (25th & 75th percentiles)",1.3,3,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW5_2","MEDIAN","RACE","OTH",NA,NA,NA,NA
"1083441",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of fruit consumption among adults aged >= 18 years",NA,"Number","Median","0.9",0.9,"###","Median frequency (50th percentile) reported with quartiles (25th & 75th percentiles)",0.5,1.7,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW4_2","MEDIAN","RACE","MRC",NA,NA,NA,NA
"1083442",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke",NA,"%","Age-adjusted Prevalence","24.2",24.2,"","",13.9,38.8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1083454",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among adults aged >= 18 years",NA,"%","Crude Prevalence","66.3",66.3,"","",63.8,68.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1083503",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among adults aged >= 18 years",NA,"%","Crude Prevalence","24.4",24.4,"","",19.5,30.1,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1083514",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of diagnosed diabetes among adults aged >= 18 years",NA,"%","Crude Prevalence","10.7",10.7,"","",9.3,12.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1083525",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","71.5",71.5,"","",61.2,79.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_2","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1083533",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","No leisure-time physical activity among adults aged >= 18 years",NA,"%","Crude Prevalence","29.3",29.3,"","",18.1,43.7,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW10_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1083540",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among women aged 18-44 years",NA,"%","Crude Prevalence","67.2",67.2,"","",60.6,73.2,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_3","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1083578",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Taking medicine for high blood pressure control among adults aged >= 18 years with high blood pressure",NA,"%","Age-adjusted Prevalence","58.0",58,"","",52.7,63.2,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD7_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1083626",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","54.1",54.1,"","",44.9,63.2,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1083629",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Crude Prevalence","37.4",37.4,"","",27.7,48.4,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1083675",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among women aged 18-44 years",NA,"%","Crude Prevalence","9.5",9.5,"","",6.5,13.5,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1083724",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for additional and more extensive health benefits among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","19.9",19.9,"","",17.4,22.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_3","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1083727",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","70.3",70.3,"","",56.9,80.9,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD8_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1083739",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Obesity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","24.9",24.9,"","",16.2,36.2,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1083768",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits and for muscle-strengthening activity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","19.0",19,"","",16.9,21.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_2","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1083815",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current lack of health insurance among adults aged 18-64 years",NA,"%","Crude Prevalence","46.9",46.9,"","",43.4,50.3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1083821",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1083851",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","27.7",27.7,"","",22.9,32.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_3","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1083852",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Prevalence of sufficient sleep among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC8_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1083861",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_2","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1083894",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of diagnosed diabetes among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1083917",2017,2017,"TX","Texas","BRFSS","Mental Health","Recent mentally unhealthy days among adults aged >= 18 years",NA,"Number","Mean","4.7",4.7,"","",4.2,5.2,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH1_0","MEAN","GENDER","GENF",NA,NA,NA,NA
"1083927",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smokeless tobacco use among adults aged >= 18 years",NA,"%","Crude Prevalence","7.5",7.5,"","",6.2,9.1,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1083928",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","72.6",72.6,"","",67.1,77.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1083936",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high blood pressure among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1083983",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","35.3",35.3,"","",32.1,38.6,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1083997",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1084004",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Crude Prevalence","36.2",36.2,"","",18.9,57.9,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1084031",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","47.0",47,"","",44.2,49.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1084033",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Obesity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","33.3",33.3,"","",31.5,35.1,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1084037",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent activity limitation among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","2.5",2.5,"","",2.1,2.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_2","AGEADJMEAN","RACE","WHT",NA,NA,NA,NA
"1084068",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Prevalence of sufficient sleep among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC8_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1084092",2017,2017,"TX","Texas","BRFSS","Diabetes","Dilated eye examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA7_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1084123",2017,2017,"TX","Texas","BRFSS","Diabetes","Glycosylated hemoglobin measurement among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","64.7",64.7,"","",56,72.6,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA6_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1084156",2017,2017,"TX","Texas","BRFSS","Tobacco","Quit attempts in the past year among current smokers",NA,"%","Crude Prevalence","79.1",79.1,"","",67.7,87.2,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB3_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1084178",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","33.5",33.5,"","",23.6,45,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1084256",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","32.2",32.2,"","",30.6,33.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1084269",2017,2017,"TX","Texas","BRFSS","Diabetes","Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA10_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1084284",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Crude Prevalence","83.7",83.7,"","",77.3,88.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1084321",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke",NA,"%","Age-adjusted Prevalence","22.0",22,"","",13.6,33.5,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1084322",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease",NA,"%","Age-adjusted Prevalence","79.1",79.1,"","",60.1,90.5,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_2","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1084335",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent physically unhealthy days among adults aged >= 18 years",NA,"Number","Mean","4.0",4,"","",3,5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_1","MEAN","RACE","BLK",NA,NA,NA,NA
"1084351",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of fruit consumption among adults aged >= 18 years",NA,"Number","Median","1.1",1.1,"###","Median frequency (50th percentile) reported with quartiles (25th & 75th percentiles)",0.5,2.1,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW4_2","MEDIAN","RACE","BLK",NA,NA,NA,NA
"1084366",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high cholesterol among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","51.1",51.1,"","",34.2,67.8,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1084368",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","No leisure-time physical activity among adults aged >= 18 years",NA,"%","Crude Prevalence","36.8",36.8,"","",33.4,40.2,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW10_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1084386",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among women aged 18-44 years",NA,"%","Crude Prevalence","48.9",48.9,"","",42.4,55.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_3","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1084395",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease",NA,"%","Age-adjusted Prevalence","42.4",42.4,"","",33.5,51.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1084399",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of diagnosed diabetes among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","17.1",17.1,"","",14.9,19.6,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1084413",2017,2017,"TX","Texas","BRFSS","Diabetes","Foot examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","70.5",70.5,"","",63.3,76.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA5_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1084423",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years who smoke",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_2","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1084424",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Taking medicine for high blood pressure control among adults aged >= 18 years with high blood pressure",NA,"%","Age-adjusted Prevalence","50.8",50.8,"","",46.3,55.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD7_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1084433",2017,2017,"TX","Texas","BRFSS","Diabetes","Foot examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","70.0",70,"","",56,81.1,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA5_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1084441",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current health care coverage among women aged 18-44 years",NA,"%","Crude Prevalence","71.4",71.4,"","",67.7,74.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1084450",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease",NA,"%","Crude Prevalence","89.9",89.9,"","",77.6,95.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1084475",2017,2017,"TX","Texas","BRFSS","Immunization","Influenza vaccination among noninstitutionalized adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","39.3",39.3,"","",36.6,42,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"IMM","IMM1_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1084478",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke",NA,"%","Age-adjusted Prevalence","69.5",69.5,"","",55.6,80.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_2","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1084501",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smokeless tobacco use among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1084512",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","75.5",75.5,"","",73.1,77.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1084515",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1084521",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","53.3",53.3,"","",42.8,63.5,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_3","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1084528",2017,2017,"TX","Texas","BRFSS","Diabetes","Diabetes prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1084537",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for additional and more extensive health benefits among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","28.8",28.8,"","",26.2,31.5,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_3","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1084604",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Cholesterol screening among adults aged >= 18 years",NA,"%","Crude Prevalence","90.7",90.7,"","",78.7,96.2,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD4_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1084608",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current health care coverage among women aged 18-44 years",NA,"%","Crude Prevalence","72.9",72.9,"","",64.2,80.1,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1084624",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1084657",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years who smoke",NA,"%","Crude Prevalence","30.8",30.8,"","",23.9,38.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1084662",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1084673",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Obesity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","38.4",38.4,"","",35.1,41.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1084696",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high blood pressure among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","61.0",61,"","",47.9,72.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_2","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1084736",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for additional and more extensive health benefits among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","23.6",23.6,"","",21.3,26.1,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_3","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1084762",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years who smoke",NA,"%","Crude Prevalence","31.7",31.7,"","",17.6,50.2,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1084764",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years who smoke",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1084766",2017,2017,"TX","Texas","BRFSS","Tobacco","Quit attempts in the past year among current smokers",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB3_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1084798",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smoking among adults aged >= 18 years",NA,"%","Crude Prevalence","13.6",13.6,"","",11.8,15.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1084801",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current lack of health insurance among adults aged 18-64 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1084828",2017,2017,"TX","Texas","BRFSS","Mental Health","At least 14 recent mentally unhealthy days among women aged 18-44 years",NA,"%","Crude Prevalence","11.2",11.2,"","",8.8,14.2,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH2_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1084831",2017,2017,"TX","Texas","BRFSS","Mental Health","Recent mentally unhealthy days among adults aged >= 18 years",NA,"Number","Mean","2.9",2.9,"","",2.6,3.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH1_0","MEAN","GENDER","GENM",NA,NA,NA,NA
"1084860",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent activity limitation among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_2","AGEADJMEAN","RACE","OTH",NA,NA,NA,NA
"1084899",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Self-rated health status among women aged 18-44 years",NA,"%","Crude Prevalence","82.2",82.2,"","",78.9,85,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1084911",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Fair or poor self-rated health status among adults aged >= 18 years",NA,"%","Crude Prevalence","24.3",24.3,"","",19.6,29.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1084915",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smokeless tobacco use among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1084926",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","High cholesterol prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","29.5",29.5,"","",27.3,31.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD5_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1084936",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","34.3",34.3,"","",24,46.3,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1085006",2017,2017,"TX","Texas","BRFSS","Diabetes","Foot examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","70.7",70.7,"","",58.3,80.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA5_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1085024",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smoking among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","14.0",14,"","",12.2,16.1,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_2","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1085059",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Obesity among adults aged >= 18 years",NA,"%","Crude Prevalence","38.6",38.6,"","",32.6,45,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1085097",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high cholesterol among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1085103",2017,2017,"TX","Texas","BRFSS","Diabetes","Glycosylated hemoglobin measurement among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","75.6",75.6,"","",53.4,89.3,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA6_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1085105",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","33.6",33.6,"","",25.3,43.1,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1085157",2017,2017,"TX","Texas","BRFSS","Diabetes","Dilated eye examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","52.2",52.2,"","",37.1,66.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA7_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1085163",2017,2017,"TX","Texas","BRFSS","Immunization","Influenza vaccination among noninstitutionalized adults aged >= 18 years",NA,"%","Crude Prevalence","32.8",32.8,"","",30.2,35.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"IMM","IMM1_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1085178",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke",NA,"%","Age-adjusted Prevalence","29.4",29.4,"","",16.8,46.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1085197",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1085199",2017,2017,"TX","Texas","BRFSS","Diabetes","Foot examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA5_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1085201",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent physically unhealthy days among adults aged >= 18 years",NA,"Number","Mean","3.6",3.6,"","",3.1,4.1,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_1","MEAN","RACE","HIS",NA,NA,NA,NA
"1085212",2017,2017,"TX","Texas","BRFSS","Diabetes","Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course",NA,"%","Age-adjusted Prevalence","51.0",51,"","",41,60.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA10_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1085219",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","74.6",74.6,"","",60,85.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD8_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1085227",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","44.5",44.5,"","",29.4,60.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1085229",2017,2017,"TX","Texas","BRFSS","Tobacco","Current cigarette smoking among women aged 18-44 years",NA,"%","Crude Prevalence","15.4",15.4,"","",12.6,18.6,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_3","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1085232",2017,2017,"TX","Texas","BRFSS","Reproductive Health","Timeliness of routine health care checkup among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"RPH","RPH1_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1085260",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of diagnosed diabetes among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","10.4",10.4,"","",9.1,12,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1085267",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years who smoke",NA,"%","Age-adjusted Prevalence","30.1",30.1,"","",23.5,37.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1085283",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years who smoke",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1085285",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Prevalence of sufficient sleep among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC8_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1085294",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke",NA,"%","Age-adjusted Prevalence","56.7",56.7,"","",42.6,69.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_2","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1085340",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Taking medicine for high blood pressure control among adults aged >= 18 years with high blood pressure",NA,"%","Age-adjusted Prevalence","56.6",56.6,"","",44.8,67.8,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD7_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1085349",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1085365",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years who smoke",NA,"%","Age-adjusted Prevalence","70.4",70.4,"","",54,82.9,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_2","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1085487",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high blood pressure among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","58.7",58.7,"","",44.5,71.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_2","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1085499",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smoking among adults aged >= 18 years",NA,"%","Crude Prevalence","15.6",15.6,"","",14.3,17.2,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1085500",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","14.8",14.8,"","",9.3,22.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_3","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1085509",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease",NA,"%","Crude Prevalence","46.7",46.7,"","",29.4,64.8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1085528",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Cholesterol screening among adults aged >= 18 years",NA,"%","Crude Prevalence","85.8",85.8,"","",83,88.2,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD4_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1085604",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Crude Prevalence","85.0",85,"","",76.1,91,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1085674",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Fair or poor self-rated health status among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1085683",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among adults aged >= 18 years",NA,"%","Crude Prevalence","37.7",37.7,"","",35.3,40.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1085694",2017,2017,"TX","Texas","BRFSS","Immunization","Influenza vaccination among noninstitutionalized adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","37.3",37.3,"","",29.3,46.1,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"IMM","IMM1_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1085732",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","28.6",28.6,"","",26.9,30.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1085754",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","High cholesterol prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","19.2",19.2,"","",11.7,29.9,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD5_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1085795",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits and for muscle-strengthening activity among adults aged >= 18 years",NA,"%","Crude Prevalence","15.2",15.2,"","",12.8,17.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1085810",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among adults aged >= 18 years",NA,"%","Crude Prevalence","31.2",31.2,"","",28.8,33.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1085832",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Fair or poor self-rated health status among adults aged >= 18 years",NA,"%","Crude Prevalence","24.9",24.9,"","",22.2,27.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1085920",2017,2017,"TX","Texas","BRFSS","Mental Health","Recent mentally unhealthy days among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","3.9",3.9,"","",3,4.8,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH1_0","AGEADJMEAN","RACE","BLK",NA,NA,NA,NA
"1085953",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","76.6",76.6,"","",58.4,88.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD8_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1085954",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for additional and more extensive health benefits among adults aged >= 18 years",NA,"%","Crude Prevalence","22.8",22.8,"","",17.6,29,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_3","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1085969",2017,2017,"TX","Texas","BRFSS","Diabetes","Glycosylated hemoglobin measurement among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","66.1",66.1,"","",54.9,75.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA6_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1086004",2017,2017,"TX","Texas","BRFSS","Tobacco","Quit attempts in the past year among current smokers",NA,"%","Age-adjusted Prevalence","62.8",62.8,"","",57.9,67.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB3_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1086064",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke",NA,"%","Crude Prevalence","69.5",69.5,"","",55.6,80.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1086079",2017,2017,"TX","Texas","BRFSS","Diabetes","Glycosylated hemoglobin measurement among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","81.4",81.4,"","",75.2,86.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA6_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1086094",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Taking medicine for high blood pressure control among adults aged >= 18 years with high blood pressure",NA,"%","Age-adjusted Prevalence","51.8",51.8,"","",47.8,55.8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD7_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1086106",2017,2017,"TX","Texas","BRFSS","Diabetes","Diabetes prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","5.6",5.6,"","",3.9,7.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1086114",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits and for muscle-strengthening activity among adults aged >= 18 years",NA,"%","Crude Prevalence","17.5",17.5,"","",12.8,23.4,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1086116",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1086123",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among adults aged >= 18 years",NA,"%","Crude Prevalence","54.1",54.1,"","",43.5,64.4,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1086133",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","High cholesterol prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","32.6",32.6,"","",27.4,38.1,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD5_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1086186",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years who smoke",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_2","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1086229",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent physically unhealthy days among adults aged >= 18 years",NA,"Number","Mean","2.9",2.9,"","",1.4,4.4,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_1","MEAN","RACE","MRC",NA,NA,NA,NA
"1086250",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent physically unhealthy days among adults aged >= 18 years",NA,"Number","Mean","2.1",2.1,"","",1,3.1,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_1","MEAN","RACE","OTH",NA,NA,NA,NA
"1086271",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_2","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1086293",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","No leisure-time physical activity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","27.2",27.2,"","",24.8,29.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW10_0","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1086310",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Crude Prevalence","46.1",46.1,"","",38.6,53.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1086320",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current lack of health insurance among adults aged 18-64 years",NA,"%","Age-adjusted Prevalence","25.9",25.9,"","",23.4,28.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1086332",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for additional and more extensive health benefits among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","21.6",21.6,"","",13.2,33.3,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_3","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1086338",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent activity limitation among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","3.0",3,"","",2.6,3.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_2","AGEADJMEAN","GENDER","GENF",NA,NA,NA,NA
"1086356",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years who smoke",NA,"%","Crude Prevalence","75.6",75.6,"","",64.9,83.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_2","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1086361",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high blood pressure among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","64.2",64.2,"","",52.1,74.8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_2","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1086379",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","67.4",67.4,"","",56,77,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_2","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1086395",2017,2017,"TX","Texas","BRFSS","Mental Health","Recent mentally unhealthy days among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","2.4",2.4,"","",1.3,3.4,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH1_0","AGEADJMEAN","RACE","OTH",NA,NA,NA,NA
"1086411",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent activity limitation among adults aged >= 18 years",NA,"Number","Mean","2.0",2,"","",1.7,2.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_2","MEAN","GENDER","GENM",NA,NA,NA,NA
"1086427",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1086442",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease",NA,"%","Crude Prevalence","49.7",49.7,"","",27.8,71.8,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1086481",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1086483",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_3","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1086494",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","No leisure-time physical activity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","36.0",36,"","",29.9,42.5,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW10_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1086533",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among adults aged >= 18 years",NA,"%","Crude Prevalence","32.5",32.5,"","",30.8,34.2,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1086544",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","69.2",69.2,"","",61.5,75.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_2","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1086561",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of diagnosed diabetes among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","8.6",8.6,"","",7.4,9.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1086583",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Crude Prevalence","46.3",46.3,"","",35.9,57,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1086590",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","41.6",41.6,"","",29.5,54.8,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1086595",2017,2017,"TX","Texas","BRFSS","Mental Health","Recent mentally unhealthy days among adults aged >= 18 years",NA,"Number","Mean","4.0",4,"","",3.6,4.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH1_0","MEAN","RACE","WHT",NA,NA,NA,NA
"1086605",2017,2017,"TX","Texas","BRFSS","Diabetes","Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course",NA,"%","Age-adjusted Prevalence","43.3",43.3,"","",31.3,56.2,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA10_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1086608",2017,2017,"TX","Texas","BRFSS","Diabetes","Dilated eye examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","56.0",56,"","",42.3,68.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA7_0","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1086612",2017,2017,"TX","Texas","BRFSS","Diabetes","Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course",NA,"%","Age-adjusted Prevalence","60.2",60.2,"","",36.6,79.8,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA10_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1086630",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of fruit consumption among adults aged >= 18 years",NA,"Number","Median","1.0",1,"###","Median frequency (50th percentile) reported with quartiles (25th & 75th percentiles)",0.5,1.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW4_2","MEDIAN","RACE","WHT",NA,NA,NA,NA
"1086636",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","High cholesterol prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","25.5",25.5,"","",22.7,28.5,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD5_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1086672",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Cholesterol screening among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","90.4",90.4,"","",88.6,92,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD4_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1086682",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Crude Prevalence","70.6",70.6,"","",59.9,79.4,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1086732",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD8_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1086735",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of diagnosed diabetes among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1086792",2017,2017,"TX","Texas","BRFSS","Diabetes","Dilated eye examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","60.5",60.5,"","",51.7,68.6,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA7_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1086824",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits among adults aged >= 18 years",NA,"%","Crude Prevalence","40.3",40.3,"","",37.6,43,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1086828",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Fair or poor self-rated health status among adults aged >= 18 years",NA,"%","Crude Prevalence","18.3",18.3,"","",16.3,20.5,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1086848",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high cholesterol among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","58.2",58.2,"","",50.1,65.9,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1086875",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Prevalence of sufficient sleep among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC8_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1086891",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1086913",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","48.3",48.3,"","",36.9,59.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1086928",2017,2017,"TX","Texas","BRFSS","Diabetes","Foot examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","68.4",68.4,"","",60.3,75.5,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA5_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1086985",2017,2017,"TX","Texas","BRFSS","Diabetes","Glycosylated hemoglobin measurement among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","68.0",68,"","",55.5,78.4,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA6_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1087059",2017,2017,"TX","Texas","BRFSS","Tobacco","Quit attempts in the past year among current smokers",NA,"%","Age-adjusted Prevalence","68.1",68.1,"","",61.5,74,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB3_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1087082",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high cholesterol among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","49.9",49.9,"","",36.9,63,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1087108",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_2","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1087110",2017,2017,"TX","Texas","BRFSS","Diabetes","Dilated eye examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","65.5",65.5,"","",57.1,73.1,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA7_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1087134",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent physically unhealthy days among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","4.0",4,"","",3.4,4.6,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_1","AGEADJMEAN","RACE","HIS",NA,NA,NA,NA
"1087137",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current lack of health insurance among adults aged 18-64 years",NA,"%","Age-adjusted Prevalence","30.5",30.5,"","",27.8,33.4,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1087141",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","44.2",44.2,"","",31.6,57.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_3","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1087238",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high blood pressure among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_2","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1087241",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","No leisure-time physical activity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","21.1",21.1,"","",14.3,30.1,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW10_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1087244",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent activity limitation among adults aged >= 18 years",NA,"Number","Mean","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_2","MEAN","RACE","OTH",NA,NA,NA,NA
"1087246",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","High cholesterol prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","35.9",35.9,"","",33.4,38.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD5_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1087307",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits and for muscle-strengthening activity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","13.3",13.3,"","",7.5,22.5,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_2","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1087320",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Self-rated health status among women aged 18-44 years",NA,"%","Crude Prevalence","86.6",86.6,"","",83.3,89.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1087385",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits and for muscle-strengthening activity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","18.2",18.2,"","",12.3,26,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_2","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1087407",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Obesity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","32.3",32.3,"","",29.7,34.9,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1087436",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for additional and more extensive health benefits among adults aged >= 18 years",NA,"%","Crude Prevalence","23.7",23.7,"","",21.4,26.1,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_3","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1087440",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Crude Prevalence","50.0",50,"","",38.8,61.3,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1087466",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits and for muscle-strengthening activity among adults aged >= 18 years",NA,"%","Crude Prevalence","17.3",17.3,"","",11.6,24.9,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1087473",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Obesity among adults aged >= 18 years",NA,"%","Crude Prevalence","33.9",33.9,"","",31.3,36.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1087503",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high cholesterol among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","60.8",60.8,"","",53,68.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1087531",2017,2017,"TX","Texas","BRFSS","Diabetes","Dilated eye examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","62.1",62.1,"","",38.4,81.2,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA7_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1087550",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among adults aged >= 18 years",NA,"%","Crude Prevalence","21.3",21.3,"","",14.3,30.4,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1087570",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","83.2",83.2,"","",76.6,88.2,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_2","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1087597",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke",NA,"%","Crude Prevalence","29.4",29.4,"","",17.3,45.2,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1087607",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years who smoke",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_2","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1087615",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","High cholesterol prevalence among adults aged >= 18 years",NA,"%","Crude Prevalence","35.1",35.1,"","",29.3,41.4,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD5_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1087626",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of diagnosed diabetes among adults aged >= 18 years",NA,"%","Crude Prevalence","13.1",13.1,"","",11.2,15.3,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1087631",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Fair or poor self-rated health status among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","22.7",22.7,"","",15.1,32.6,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1087639",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","22.5",22.5,"","",19.6,25.7,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1087647",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Crude Prevalence","67.3",67.3,"","",55.7,77.1,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1087679",2017,2017,"TX","Texas","BRFSS","Diabetes","Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course",NA,"%","Crude Prevalence","51.7",51.7,"","",43.6,59.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA10_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1087697",2017,2017,"TX","Texas","BRFSS","Immunization","Influenza vaccination among noninstitutionalized adults aged >= 18 years",NA,"%","Crude Prevalence","40.3",40.3,"","",37.7,42.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"IMM","IMM1_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1087713",2017,2017,"TX","Texas","BRFSS","Mental Health","Recent mentally unhealthy days among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","6.9",6.9,"","",4.3,9.5,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH1_0","AGEADJMEAN","RACE","MRC",NA,NA,NA,NA
"1087723",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smokeless tobacco use among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_2","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1087729",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Crude Prevalence","81.5",81.5,"","",71.6,88.5,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1087734",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among adults aged >= 18 years",NA,"%","Crude Prevalence","23.6",23.6,"","",20.7,26.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1087750",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Taking medicine for high blood pressure control among adults aged >= 18 years with high blood pressure",NA,"%","Crude Prevalence","81.5",81.5,"","",72.9,87.9,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD7_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1087751",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Prevalence of sufficient sleep among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC8_0","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1087752",2017,2017,"TX","Texas","BRFSS","Immunization","Influenza vaccination among noninstitutionalized adults aged >= 18 years",NA,"%","Crude Prevalence","40.0",40,"","",37.4,42.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"IMM","IMM1_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1087757",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Fair or poor self-rated health status among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","23.9",23.9,"","",19.3,29.2,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1087771",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Obesity among adults aged >= 18 years",NA,"%","Crude Prevalence","19.5",19.5,"","",12.5,29.1,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1087780",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for additional and more extensive health benefits among adults aged >= 18 years",NA,"%","Crude Prevalence","19.8",19.8,"","",13.9,27.5,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_3","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1087786",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","42.7",42.7,"","",32.3,53.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1087800",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among adults aged >= 18 years",NA,"%","Crude Prevalence","63.6",63.6,"","",60.8,66.2,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1087807",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","High cholesterol prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","30.2",30.2,"","",22.6,39.2,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD5_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1087813",2017,2017,"TX","Texas","BRFSS","Diabetes","Dilated eye examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA7_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1087883",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Crude Prevalence","47.7",47.7,"","",36.1,59.5,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1087922",2017,2017,"TX","Texas","BRFSS","Diabetes","Glycosylated hemoglobin measurement among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","65.3",65.3,"","",50.7,77.4,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA6_0","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1087937",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Prevalence of sufficient sleep among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC8_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1087978",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","47.7",47.7,"","",38.5,57,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1087994",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of vegetable consumption among adults aged >= 18 years",NA,"Number","Median","1.6",1.6,"###","Median frequency (50th percentile) reported with quartiles (25th & 75th percentiles)",1,2.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW5_2","MEDIAN","OVERALL","OVR",NA,NA,NA,NA
"1087995",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current lack of health insurance among adults aged 18-64 years",NA,"%","Age-adjusted Prevalence","13.2",13.2,"","",8.1,20.8,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1088008",2017,2017,"TX","Texas","BRFSS","Mental Health","At least 14 recent mentally unhealthy days among women aged 18-44 years",NA,"%","Crude Prevalence","15.7",15.7,"","",13,18.7,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH2_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1088011",2017,2017,"TX","Texas","BRFSS","Tobacco","Quit attempts in the past year among current smokers",NA,"%","Crude Prevalence","60.5",60.5,"","",53.6,67,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB3_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1088020",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years who smoke",NA,"%","Age-adjusted Prevalence","30.1",30.1,"","",22.8,38.5,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1088085",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent activity limitation among adults aged >= 18 years",NA,"Number","Mean","2.5",2.5,"","",2.2,2.9,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_2","MEAN","RACE","WHT",NA,NA,NA,NA
"1088097",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits among adults aged >= 18 years",NA,"%","Crude Prevalence","36.4",36.4,"","",33.1,39.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1088098",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease",NA,"%","Age-adjusted Prevalence","89.5",89.5,"","",76.7,95.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_2","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1088110",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","No leisure-time physical activity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","30.2",30.2,"","",27.5,33,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW10_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1088119",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Taking medicine for high blood pressure control among adults aged >= 18 years with high blood pressure",NA,"%","Crude Prevalence","68.1",68.1,"","",47.1,83.7,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD7_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1088133",2017,2017,"TX","Texas","BRFSS","Diabetes","Foot examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA5_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1088177",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Fair or poor self-rated health status among adults aged >= 18 years",NA,"%","Crude Prevalence","17.6",17.6,"","",15.7,19.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1088204",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","27.0",27,"","",14.7,44.4,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_3","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1088215",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Crude Prevalence","87.3",87.3,"","",77.6,93.2,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1088252",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","71.6",71.6,"","",59.2,81.5,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD8_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1088275",2017,2017,"TX","Texas","BRFSS","Immunization","Influenza vaccination among noninstitutionalized adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","43.2",43.2,"","",31.9,55.3,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"IMM","IMM1_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1088297",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Cholesterol screening among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","88.3",88.3,"","",80.3,93.4,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD4_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1088305",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Obesity among adults aged >= 18 years",NA,"%","Crude Prevalence","32.1",32.1,"","",29.6,34.8,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW1_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1088330",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among adults aged >= 18 years",NA,"%","Crude Prevalence","33.8",33.8,"","",31.3,36.4,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1088339",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high cholesterol among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","53.0",53,"","",44.1,61.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1088376",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","76.3",76.3,"","",51.5,90.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_2","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1088387",2017,2017,"TX","Texas","BRFSS","Diabetes","Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course",NA,"%","Crude Prevalence","48.6",48.6,"","",40.8,56.6,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA10_0","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1088426",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease",NA,"%","Age-adjusted Prevalence","43.6",43.6,"","",30.1,58.1,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1088434",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent activity limitation among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","3.0",3,"","",2.1,4,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_2","AGEADJMEAN","RACE","BLK",NA,NA,NA,NA
"1088447",2017,2017,"TX","Texas","BRFSS","Tobacco","Current cigarette smoking among women aged 18-44 years",NA,"%","Crude Prevalence","11.8",11.8,"","",8.3,16.6,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_3","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1088452",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1088480",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years who smoke",NA,"%","Crude Prevalence","65.5",65.5,"","",49.1,78.8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_2","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1088485",2017,2017,"TX","Texas","BRFSS","Diabetes","Diabetes prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1088519",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Prevalence of sufficient sleep among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"-","No data available",NA,NA,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC8_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1088526",2017,2017,"TX","Texas","BRFSS","Immunization","Influenza vaccination among noninstitutionalized adults aged >= 18 years",NA,"%","Crude Prevalence","36.5",36.5,"","",34.7,38.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"IMM","IMM1_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1088542",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Prevalence of sufficient sleep among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"-","No data available",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC8_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1088561",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current health care coverage among women aged 18-44 years",NA,"%","Crude Prevalence","86.1",86.1,"","",77.2,91.9,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1088573",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke",NA,"%","Crude Prevalence","56.6",56.6,"","",42.5,69.7,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_2","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1088574",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smokeless tobacco use among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","4.3",4.3,"","",3.6,5.1,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_2","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1088588",2017,2017,"TX","Texas","BRFSS","Diabetes","Foot examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","69.5",69.5,"","",64.2,74.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA5_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1088606",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Prevalence of sufficient sleep among adults aged >= 18 years",NA,"%","Crude Prevalence","",NA,"-","No data available",NA,NA,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC8_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1088607",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of diagnosed diabetes among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1088614",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smokeless tobacco use among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_2","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1088626",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of vegetable consumption among adults aged >= 18 years",NA,"Number","Median","1.6",1.6,"###","Median frequency (50th percentile) reported with quartiles (25th & 75th percentiles)",1,2.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW5_2","MEDIAN","GENDER","GENM",NA,NA,NA,NA
"1088639",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1088643",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Self-rated health status among women aged 18-44 years",NA,"%","Crude Prevalence","94.1",94.1,"","",85.9,97.6,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_2","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1088725",2017,2017,"TX","Texas","BRFSS","Tobacco","Quit attempts in the past year among current smokers",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB3_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1088736",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of fruit consumption among adults aged >= 18 years",NA,"Number","Median","1.0",1,"###","Median frequency (50th percentile) reported with quartiles (25th & 75th percentiles)",0.6,2,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW4_2","MEDIAN","GENDER","GENF",NA,NA,NA,NA
"1088747",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease",NA,"%","Age-adjusted Prevalence","85.4",85.4,"","",68.6,94,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_2","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1088766",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among adults aged >= 18 years",NA,"%","Crude Prevalence","75.1",75.1,"","",72.5,77.4,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1088770",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease",NA,"%","Age-adjusted Prevalence","38.1",38.1,"","",25.2,52.9,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1088851",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for additional and more extensive health benefits among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","23.0",23,"","",16.4,31.2,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_3","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1088863",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent activity limitation among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","2.0",2,"","",1.7,2.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_2","AGEADJMEAN","GENDER","GENM",NA,NA,NA,NA
"1088864",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1088898",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years who smoke",NA,"%","Age-adjusted Prevalence","78.9",78.9,"","",68.7,86.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_2","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1088902",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits among adults aged >= 18 years",NA,"%","Crude Prevalence","42.6",42.6,"","",32.5,53.3,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1088911",2017,2017,"TX","Texas","BRFSS","Mental Health","At least 14 recent mentally unhealthy days among women aged 18-44 years",NA,"%","Crude Prevalence","8.7",8.7,"","",5,14.6,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH2_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1088912",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years who smoke",NA,"%","Crude Prevalence","28.5",28.5,"","",20,38.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1088932",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease",NA,"%","Crude Prevalence","48.2",48.2,"","",33.7,62.9,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1088967",2017,2017,"TX","Texas","BRFSS","Mental Health","Recent mentally unhealthy days among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","4.2",4.2,"","",3.7,4.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH1_0","AGEADJMEAN","RACE","WHT",NA,NA,NA,NA
"1089004",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for additional and more extensive health benefits among adults aged >= 18 years",NA,"%","Crude Prevalence","29.0",29,"","",26.6,31.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_3","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1089050",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","40.1",40.1,"","",37.4,42.9,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1089063",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD8_0","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1089080",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high blood pressure among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","91.6",91.6,"","",79.8,96.8,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_2","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1089094",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","21.2",21.2,"","",15.7,27.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_3","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1089135",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Cholesterol screening among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","86.9",86.9,"","",84.9,88.7,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD4_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1089136",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1089195",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","83.5",83.5,"","",74.8,89.6,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_2","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1089211",2017,2017,"TX","Texas","BRFSS","Diabetes","Dilated eye examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA7_0","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1089221",2017,2017,"TX","Texas","BRFSS","Tobacco","Current cigarette smoking among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_3","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1089223",2017,2017,"TX","Texas","BRFSS","Diabetes","Foot examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA5_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1089237",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke",NA,"%","Age-adjusted Prevalence","62.4",62.4,"","",50.9,72.7,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_2","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1089240",2017,2017,"TX","Texas","BRFSS","Diabetes","Influenza vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA12_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1089241",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Awareness of high blood pressure among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","27.5",27.5,"","",24.8,30.4,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD6_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1089260",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high cholesterol among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","55.8",55.8,"","",43.7,67.2,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1089265",2017,2017,"TX","Texas","BRFSS","Diabetes","Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA10_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1089266",2017,2017,"TX","Texas","BRFSS","Immunization","Influenza vaccination among noninstitutionalized adults aged >= 18 years",NA,"%","Crude Prevalence","34.2",34.2,"","",21.8,49.2,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"IMM","IMM1_0","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1089278",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smokeless tobacco use among adults aged >= 18 years",NA,"%","Crude Prevalence","6.0",6,"","",4.9,7.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB2_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1089293",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years who smoke",NA,"%","Age-adjusted Prevalence","30.6",30.6,"","",25.3,36.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1089305",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of diagnosed diabetes among adults aged >= 18 years",NA,"%","Crude Prevalence","11.9",11.9,"","",10.8,13.2,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1089429",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD10_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1089432",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1089539",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smoking among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","18.0",18,"","",15.8,20.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_2","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1089540",2017,2017,"TX","Texas","BRFSS","Mental Health","Recent mentally unhealthy days among adults aged >= 18 years",NA,"Number","Mean","8.5",8.5,"","",4.2,12.8,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH1_0","MEAN","RACE","MRC",NA,NA,NA,NA
"1089637",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","No leisure-time physical activity among adults aged >= 18 years",NA,"%","Crude Prevalence","32.1",32.1,"","",30.2,34,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW10_0","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1089643",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD9_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1089654",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_3","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1089659",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Crude Prevalence","38.9",38.9,"","",20.8,60.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1089684",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits and for muscle-strengthening activity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","14.3",14.3,"","",12.5,16.3,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_2","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1089686",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Crude Prevalence","78.6",78.6,"","",67.6,86.6,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD8_0","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1089714",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes",NA,"%","Crude Prevalence","56.2",56.2,"","",45,66.9,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1089738",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent physically unhealthy days among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","5.5",5.5,"","",3.3,7.7,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_1","AGEADJMEAN","RACE","MRC",NA,NA,NA,NA
"1089750",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among adults aged >= 18 years",NA,"%","Crude Prevalence","31.9",31.9,"","",29.5,34.4,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1089770",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","65.5",65.5,"","",62.9,68.1,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1089797",2017,2017,"TX","Texas","BRFSS","Tobacco","Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years who smoke",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB11_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1089799",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits and for muscle-strengthening activity among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","13.5",13.5,"","",11.5,15.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_2","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1089808",2017,2017,"TX","Texas","BRFSS","Diabetes","Dilated eye examination among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","62.1",62.1,"","",54.1,69.5,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA7_0","CRDPREV","GENDER","GENF",NA,NA,NA,NA
"1089812",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Overweight or obesity among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW2_3","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1089839",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","33.0",33,"","",25.8,41,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_3","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1089861",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Cholesterol screening among adults aged >= 18 years",NA,"%","Crude Prevalence","92.0",92,"","",87.7,94.9,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD4_0","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1089881",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits among adults aged >= 18 years",NA,"%","Crude Prevalence","47.1",47.1,"","",44.4,49.8,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1089888",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current lack of health insurance among adults aged 18-64 years",NA,"%","Crude Prevalence","25.1",25.1,"","",19.6,31.4,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1089953",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for additional and more extensive health benefits among adults aged >= 18 years",NA,"%","Crude Prevalence","25.8",25.8,"","",23.5,28.4,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_3","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1089964",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent activity limitation among adults aged >= 18 years",NA,"Number","Mean","3.2",3.2,"","",2.1,4.2,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_2","MEAN","RACE","BLK",NA,NA,NA,NA
"1089969",2017,2017,"TX","Texas","BRFSS","Chronic Obstructive Pulmonary Disease","Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease",NA,"%","Age-adjusted Prevalence","62.4",62.4,"","",47.4,75.3,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"COPD","COPD8_0","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1089987",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of high blood pressure among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","60.8",60.8,"","",52.1,68.8,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_2","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1090003",2017,2017,"TX","Texas","BRFSS","Diabetes","Glycosylated hemoglobin measurement among adults aged >= 18 years with diagnosed diabetes",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA6_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1090005",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","25.4",25.4,"","",20.5,31,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1090066",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Meeting aerobic physical activity guidelines for substantial health benefits and for muscle-strengthening activity among adults aged >= 18 years",NA,"%","Crude Prevalence","18.3",18.3,"","",16.4,20.5,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW11_2","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1090068",2017,2017,"TX","Texas","BRFSS","Diabetes","Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA13_2","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1090108",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Current lack of health insurance among adults aged 18-64 years",NA,"%","Crude Prevalence","12.9",12.9,"","",11,15.1,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC1_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1090131",2017,2017,"TX","Texas","BRFSS","Diabetes","Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes",NA,"%","Age-adjusted Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA11_3","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1090136",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Fair or poor self-rated health status among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","20.8",20.8,"","",19.4,22.4,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1090137",2017,2017,"TX","Texas","BRFSS","Diabetes","Diabetes prevalence among women aged 18-44 years",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"DIA","DIA2_2","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1090140",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","Taking medicine for high blood pressure control among adults aged >= 18 years with high blood pressure",NA,"%","Crude Prevalence","67.4",67.4,"","",61.1,73,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD7_0","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1090142",2017,2017,"TX","Texas","BRFSS","Reproductive Health","Timeliness of routine health care checkup among women aged 18-44 years",NA,"%","Crude Prevalence","73.1",73.1,"","",55.5,85.6,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"RPH","RPH1_0","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1090197",2017,2017,"TX","Texas","BRFSS","Mental Health","Recent mentally unhealthy days among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","3.6",3.6,"","",3.1,4.2,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"MTH","MTH1_0","AGEADJMEAN","RACE","HIS",NA,NA,NA,NA
"1090206",2017,2017,"TX","Texas","BRFSS","Tobacco","Current smoking among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","10.0",10,"","",5.7,16.8,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"TOB","TOB1_2","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1090240",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Healthy weight among adults aged >= 18 years",NA,"%","Crude Prevalence","33.8",33.8,"","",22.1,47.8,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW3_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1090246",2017,2017,"TX","Texas","BRFSS","Cardiovascular Disease","High cholesterol prevalence among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","30.0",30,"","",28.3,31.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"CVD","CVD5_0","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1090288",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Recent physically unhealthy days among adults aged >= 18 years",NA,"Number","Age-adjusted Mean","3.8",3.8,"","",3.5,4.1,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC7_1","AGEADJMEAN","OVERALL","OVR",NA,NA,NA,NA
"1090314",2017,2017,"TX","Texas","BRFSS","Nutrition, Physical Activity, and Weight Status","Median daily frequency of fruit consumption among adults aged >= 18 years",NA,"Number","Median","1.0",1,"###","Median frequency (50th percentile) reported with quartiles (25th & 75th percentiles)",0.5,2,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"NPAW","NPAW4_2","MEDIAN","OVERALL","OVR",NA,NA,NA,NA
"1090323",2017,2017,"TX","Texas","BRFSS","Overarching Conditions","Fair or poor self-rated health status among adults aged >= 18 years",NA,"%","Age-adjusted Prevalence","27.7",27.7,"","",24.9,30.6,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"OVC","OVC6_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1182527",2017,2017,"TX","Texas","BRFSS","Arthritis","Activity limitation due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","51.7",51.7,"","",46.7,56.7,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_1","CRDPREV","RACE","WHT",NA,NA,NA,NA
"1182844",2017,2017,"TX","Texas","BRFSS","Arthritis","Activity limitation due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","45.0",45,"","",37.3,53.1,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_1","AGEADJPREV","GENDER","GENM",NA,NA,NA,NA
"1182956",2017,2017,"TX","Texas","BRFSS","Arthritis","Activity limitation due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","58.7",58.7,"","",28.8,83.3,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_1","CRDPREV","RACE","MRC",NA,NA,NA,NA
"1183101",2017,2017,"TX","Texas","BRFSS","Arthritis","Activity limitation due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","56.6",56.6,"","",48,64.9,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_1","CRDPREV","RACE","HIS",NA,NA,NA,NA
"1183260",2017,2017,"TX","Texas","BRFSS","Arthritis","Activity limitation due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","56.2",56.2,"","",49.3,62.8,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_1","AGEADJPREV","OVERALL","OVR",NA,NA,NA,NA
"1183439",2017,2017,"TX","Texas","BRFSS","Arthritis","Activity limitation due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","55.3",55.3,"","",47.9,62.5,"Race/Ethnicity","White, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_1","AGEADJPREV","RACE","WHT",NA,NA,NA,NA
"1183605",2017,2017,"TX","Texas","BRFSS","Arthritis","Activity limitation due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","",NA,"****","Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%",NA,NA,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_1","CRDPREV","RACE","OTH",NA,NA,NA,NA
"1183916",2017,2017,"TX","Texas","BRFSS","Arthritis","Activity limitation due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","53.4",53.4,"","",49.4,57.3,"Overall","Overall",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_1","CRDPREV","OVERALL","OVR",NA,NA,NA,NA
"1184054",2017,2017,"TX","Texas","BRFSS","Arthritis","Activity limitation due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","67.3",67.3,"","",58.3,75.2,"Race/Ethnicity","Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_1","AGEADJPREV","RACE","HIS",NA,NA,NA,NA
"1184180",2017,2017,"TX","Texas","BRFSS","Arthritis","Activity limitation due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","57.1",57.1,"","",45.5,68.1,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_1","CRDPREV","RACE","BLK",NA,NA,NA,NA
"1184348",2017,2017,"TX","Texas","BRFSS","Arthritis","Activity limitation due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","37.1",37.1,"","",27.9,47.4,"Race/Ethnicity","Other, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_1","AGEADJPREV","RACE","OTH",NA,NA,NA,NA
"1184787",2017,2017,"TX","Texas","BRFSS","Arthritis","Activity limitation due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","62.5",62.5,"","",54.5,69.9,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_1","AGEADJPREV","GENDER","GENF",NA,NA,NA,NA
"1184970",2017,2017,"TX","Texas","BRFSS","Arthritis","Activity limitation due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","56.1",56.1,"","",44.9,66.7,"Race/Ethnicity","Black, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_1","AGEADJPREV","RACE","BLK",NA,NA,NA,NA
"1185026",2017,2017,"TX","Texas","BRFSS","Arthritis","Activity limitation due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","47.6",47.6,"","",41.4,53.8,"Gender","Male",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_1","CRDPREV","GENDER","GENM",NA,NA,NA,NA
"1185509",2017,2017,"TX","Texas","BRFSS","Arthritis","Activity limitation due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Age-adjusted Prevalence","64.5",64.5,"","",56.2,72,"Race/Ethnicity","Multiracial, non-Hispanic",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_1","AGEADJPREV","RACE","MRC",NA,NA,NA,NA
"1185609",2017,2017,"TX","Texas","BRFSS","Arthritis","Activity limitation due to arthritis among adults aged >= 18 years who have doctor-diagnosed arthritis",NA,"%","Crude Prevalence","56.6",56.6,"","",51.4,61.6,"Gender","Female",NA,NA,NA,NA,"POINT (-99.42677020599967 31.827240407000488)",NA,48,"ART","ART2_1","CRDPREV","GENDER","GENF",NA,NA,NA,NA
